{"attribute_content":[],"keywords":[],"symbol":"PVNH","medgen_id":"C1868720","alternate_names":[],"name":"Periventricular nodular heterotopia","id":"16776","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"MeSH\",\"id\":\"D054091\"}","{\"db\":\"OMIM\",\"id\":\"PS300049\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"98892\"}","{\"db\":\"OMIM\",\"id\":\"PS300049\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EIEE21","medgen_id":"C4014430","alternate_names":[],"name":"Early infantile epileptic encephalopathy 21","id":"18790","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"615833\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"442835\"}","{\"db\":\"OMIM\",\"id\":\"615833\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MECD1","medgen_id":"CN263284","alternate_names":["Juvenile epithelial corneal dystrophy"],"name":"Meesmann corneal dystrophy 1","id":"1567","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007755\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"122100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98954\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007755\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Juvenile epithelial corneal dystrophy\"}","{\"db\":\"OMIM\",\"id\":\"122100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0266463","alternate_names":["Agyria"],"name":"Lissencephaly","id":"16724","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001339\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002537\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0031882\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS607432\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"48471\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001339\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Agyria\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001339\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS607432\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"204036008\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0001768","alternate_names":["Agammaglobulinaemia"],"name":"Agammaglobulinemia","id":"36968","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004432\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008328\",\"type\":\"secondary\"}","{\"db\":\"MeSH\",\"id\":\"D000361\"}","{\"db\":\"OMIM\",\"id\":\"PS601495\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"183669\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004432\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Agammaglobulinaemia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004432\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS601495\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4017227","alternate_names":[],"name":"Neutrophil-specific antigens NA1/NA2","id":"11407","alternate_symbols":[],"type":"Disease","xrefs":[]}
{"attribute_content":[],"keywords":[],"symbol":"CTRCT4","medgen_id":"C3540850","alternate_names":["CATARACT 4 WITH MICROCORNEA","CATARACT 4, ACULEIFORM","CATARACT 4, CENTRAL NUCLEAR","CATARACT 4, CRYSTALLINE","CATARACT 4, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA","CATARACT 4, NONNUCLEAR POLYMORPHIC CONGENITAL","CATARACT 4, PUNCTATE","CATARACT, CONGENITAL, ''BLUE DOT'' TYPE, 3","CATARACT, NONNUCLEAR POLYMORPHIC CONGENITAL","Cataract congenital dominant non nuclear","Cataract, congenital, cerulean type, 3"],"name":"Cataract 4","id":"1326","alternate_symbols":["CACA","CCA3","CCP","PCC"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010926\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"115700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1377\"}","{\"db\":\"OMIM\",\"id\":\"123690.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 4 WITH MICROCORNEA\"}","{\"db\":\"OMIM\",\"id\":\"123690.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 4, ACULEIFORM\"}","{\"db\":\"OMIM\",\"id\":\"123690.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 4, CENTRAL NUCLEAR\"}","{\"db\":\"OMIM\",\"id\":\"123690.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 4, CRYSTALLINE\"}","{\"db\":\"OMIM\",\"id\":\"115700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 4, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA\"}","{\"db\":\"OMIM\",\"id\":\"123690.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 4, NONNUCLEAR POLYMORPHIC CONGENITAL\"}","{\"db\":\"OMIM\",\"id\":\"123690.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 4, PUNCTATE\"}","{\"db\":\"OMIM\",\"id\":\"608983\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT, CONGENITAL, ''BLUE DOT'' TYPE, 3\"}","{\"db\":\"OMIM\",\"id\":\"115700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT, NONNUCLEAR POLYMORPHIC CONGENITAL\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cataract+Congenital+Dominant+Non+Nuclear/1144\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cataract congenital dominant non nuclear\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cataract%2C+congenital%2C+cerulean+type%2C+3/7917\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cataract, congenital, cerulean type, 3\"}","{\"db\":\"OMIM\",\"id\":\"115700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CACA\"}","{\"db\":\"OMIM\",\"id\":\"115700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CCA3\"}","{\"db\":\"OMIM\",\"id\":\"608983\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CCA3\"}","{\"db\":\"OMIM\",\"id\":\"601286\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CCP\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1144\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CCP\"}","{\"db\":\"OMIM\",\"id\":\"115700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PCC\"}","{\"db\":\"OMIM\",\"id\":\"601286\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PCC\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1144\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PCC\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cataract%2C+crystalline+aculeiform/7921\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CDL1","medgen_id":"C1690006","alternate_names":[],"name":"Lattice corneal dystrophy Type I","id":"1566","alternate_symbols":["LCD","LCD1"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"122200\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98964\"}","{\"db\":\"OMIM\",\"id\":\"122200\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LCD\"}","{\"db\":\"OMIM\",\"id\":\"122200\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LCD1\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9678\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LCD1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Lattice+corneal+dystrophy+type+1/4117\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"419197009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"122200\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9678\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AMACRD","public_definition":"AMACR deficiency is a rare autosomal recessive peroxisomal disorder characterized by adult onset of variable neurodegenerative symptoms affecting the central and peripheral nervous systems. Features may include seizures, visual failure, sensorimotor neuropathy, spasticity, migraine, and white matter hyperintensities on brain imaging. Serum pristanic acid and C27 bile acid intermediates are increased (summary by Smith et al., 2010).","medgen_id":"C3280428","alternate_names":[],"name":"Alpha-methylacyl-CoA racemase deficiency","disease_mechanism":"loss of function","id":"10176","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"614307\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"79095\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000028499\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506362\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552359\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Alpha-methylacyl-coa+racemase+deficiency/7670\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614307\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614307\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Nearsightedness, also known as myopia, is an eye condition that causes blurry distance vision. People who are nearsighted have more trouble seeing things that are far away (such as when driving) than things that are close up (such as when reading or using a computer). If it is not treated with corrective lenses or surgery, nearsightedness can lead to squinting, eyestrain, headaches, and significant visual impairment.Nearsightedness usually begins in childhood or adolescence. It tends to worsen with age until adulthood, when it may stop getting worse (stabilize). In some people, nearsightedness improves in later adulthood.For normal vision, light passes through the clear cornea at the front of the eye and is focused by the lens onto the surface of the retina, which is the lining of the back of the eye that contains light-sensing cells. People who are nearsighted typically have eyeballs that are too long from front to back. As a result, light entering the eye is focused too far forward, in front of the retina instead of on its surface. It is this change that causes distant objects to appear blurry. The longer the eyeball is, the farther forward light rays will be focused and the more severely nearsighted a person will be.Nearsightedness is measured by how powerful a lens must be to correct it. The standard unit of lens power is called a diopter. Negative (minus) powered lenses are used to correct nearsightedness. The more severe a person's nearsightedness, the larger the number of diopters required for correction. In an individual with nearsightedness, one eye may be more nearsighted than the other.Eye doctors often refer to nearsightedness less than -5 or -6 diopters as \"common myopia.\" Nearsightedness of -6 diopters or more is commonly called \"high myopia.\" This distinction is important because high myopia increases a person's risk of developing other eye problems that can lead to permanent vision loss or blindness. These problems include tearing and detachment of the retina, clouding of the lens (cataract), and an eye disease called glaucoma that is usually related to increased pressure within the eye. The risk of these other eye problems increases with the severity of the nearsightedness. The term \"pathological myopia\" is used to describe cases in which high myopia leads to tissue damage within the eye.","medgen_id":"C0027092","alternate_names":["Close sighted","Near sighted","Near sightedness","Nearsightedness"],"name":"Myopia","id":"18121","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000545\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001110\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007847\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS160700\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000545\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Close sighted\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000545\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Near sighted\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000545\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Near sightedness\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000545\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Nearsightedness\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000545\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS160700\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"nearsightedness\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0007758","alternate_names":[],"name":"Cerebellar ataxia","id":"13515","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001251\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001253\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002513\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007050\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007157\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001251\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6018\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"85102008\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Alport syndrome is a genetic condition characterized by kidney disease, hearing loss, and eye abnormalities.People with Alport syndrome experience progressive loss of kidney function. Almost all affected individuals have blood in their urine (hematuria), which indicates abnormal functioning of the kidneys. Many people with Alport syndrome also develop high levels of protein in their urine (proteinuria). The kidneys become less able to function as this condition progresses, resulting in end-stage renal disease (ESRD).People with Alport syndrome frequently develop sensorineural hearing loss, which is caused by abnormalities of the inner ear, during late childhood or early adolescence. Affected individuals may also have misshapen lenses in the eyes (anterior lenticonus) and abnormal coloration of the light-sensitive tissue at the back of the eye (retina). These eye abnormalities seldom lead to vision loss.Significant hearing loss, eye abnormalities, and progressive kidney disease are more common in males with Alport syndrome than in affected females.","medgen_id":"C1567741","alternate_names":[],"name":"Alport syndrome","id":"13255","alternate_symbols":["ATS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS301050\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"63\"}","{\"db\":\"OMIM\",\"id\":\"301050\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ATS\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"alport-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS301050\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5785\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"alport-syndrome\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Perrault syndrome is a rare condition that causes different patterns of signs and symptoms in affected males and females. A key feature of this condition is hearing loss, which occurs in both males and females. Affected females also have abnormalities of the ovaries. Neurological problems occur in some affected males and females.In Perrault syndrome, the problems with hearing are caused by changes in the inner ear, which is known as sensorineural hearing loss. The impairment usually affects both ears and can be present at birth or begin in early childhood. Unless hearing is completely impaired at birth, the hearing problems worsen over time.Females with Perrault syndrome have abnormal or missing ovaries (ovarian dysgenesis), although their external genitalia are normal. Severely affected girls do not begin menstruation by age 16 (primary amenorrhea), and most never have a menstrual period. Less severely affected women have an early loss of ovarian function (primary ovarian insufficiency); their menstrual periods begin in adolescence, but they become less frequent and eventually stop before age 40. Women with Perrault syndrome may have difficulty conceiving or be unable to have biological children (infertile).Neurological problems in individuals with Perrault syndrome can include intellectual disability, difficulty with balance and coordinating movements (ataxia), and loss of sensation and weakness in the limbs (peripheral neuropathy). However, not everyone with this condition has neurological problems.","medgen_id":"C0685838","alternate_names":["Gonadal dysgenesis with auditory dysfunction, autosomal recessive inheritance"],"name":"Perrault syndrome","id":"36656","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS233400\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2855\"}","{\"db\":\"SNOMED CT\",\"id\":\"93466004\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Gonadal dysgenesis with auditory dysfunction, autosomal recessive inheritance\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"perrault-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS233400\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"2855\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"perrault-syndrome\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Microphthalmia is an eye abnormality that arises before birth. In this condition, one or both eyeballs are abnormally small. In some affected individuals, the eyeball may appear to be completely missing; however, even in these cases some remaining eye tissue is generally present. Such severe microphthalmia should be distinguished from another condition called anophthalmia, in which no eyeball forms at all. However, the terms anophthalmia and severe microphthalmia are often used interchangeably. Microphthalmia may or may not result in significant vision loss.People with microphthalmia may also have a condition called coloboma. Colobomas are missing pieces of tissue in structures that form the eye. They may appear as notches or gaps in the colored part of the eye called the iris; the retina, which is the specialized light-sensitive tissue that lines the back of the eye; the blood vessel layer under the retina called the choroid; or in the optic nerves, which carry information from the eyes to the brain. Colobomas may be present in one or both eyes and, depending on their size and location, can affect a person's vision.People with microphthalmia may also have other eye abnormalities, including clouding of the lens of the eye (cataract) and a narrowed opening of the eye (narrowed palpebral fissure). Additionally, affected individuals may have an abnormality called microcornea, in which the clear front covering of the eye (cornea) is small and abnormally curved.Between one-third and one-half of affected individuals have microphthalmia as part of a syndrome that affects other organs and tissues in the body. These forms of the condition are described as syndromic. When microphthalmia occurs by itself, it is described as nonsyndromic or isolated.","medgen_id":"C0026010","alternate_names":["Abnormally small eyeball","Abnormally small globe of eye","Decreased size of eyeball","Decreased size of globe of eye","Microphthalmos"],"name":"Microphthalmia","id":"17232","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000568\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007996\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000568\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormally small eyeball\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000568\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormally small globe of eye\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000568\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased size of eyeball\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000568\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased size of globe of eye\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000568\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Microphthalmos\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000568\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"microphthalmia\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MRX1","medgen_id":"C2931498","alternate_names":["MENTAL RETARDATION, X-LINKED 78","Mental retardation, X-linked, nonspecific"],"name":"Mental retardation, X-linked 1","id":"5487","alternate_symbols":["MRX","MRX18","MRX78"],"type":"Disease","xrefs":["{\"db\":\"Gene\",\"id\":\"170530\"}","{\"db\":\"OMIM\",\"id\":\"309530\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"777\"}","{\"db\":\"OMIM\",\"id\":\"300522.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED 78\"}","{\"db\":\"OMIM\",\"id\":\"309530\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED 78\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mental+retardation%2C+X-linked%2C+nonspecific/4665\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mental retardation, X-linked, nonspecific\"}","{\"db\":\"OMIM\",\"id\":\"309530\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRX\"}","{\"db\":\"OMIM\",\"id\":\"309530\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRX18\"}","{\"db\":\"OMIM\",\"id\":\"300551\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRX78\"}","{\"db\":\"OMIM\",\"id\":\"309530\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRX78\"}","{\"db\":\"OMIM\",\"id\":\"309530\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3542\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SIDBA1","medgen_id":"C4551511","alternate_names":["ANEMIA, HYPOCHROMIC","ANEMIA, SIDEROBLASTIC, 1, LATE-ONSET","ANEMIA, SIDEROBLASTIC, 1, PYRIDOXINE REFRACTORY","X-linked pyridoxine-refractory sideroblastic anemia"],"name":"Anemia, sideroblastic, 1","disease_mechanism":"loss of function","id":"4582","alternate_symbols":["ANH1","XLSA"],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"300751\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"75563\"}","{\"db\":\"OMIM\",\"id\":\"300751\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, HYPOCHROMIC\"}","{\"db\":\"OMIM\",\"id\":\"301300.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 1, LATE-ONSET\"}","{\"db\":\"OMIM\",\"id\":\"301300.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 1, LATE-ONSET\"}","{\"db\":\"OMIM\",\"id\":\"301300.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 1, PYRIDOXINE REFRACTORY\"}","{\"db\":\"OMIM\",\"id\":\"300751\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ANH1\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9456\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ANH1\"}","{\"db\":\"OMIM\",\"id\":\"300751\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XLSA\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9456\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XLSA\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530692\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558542\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000559503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"OMIM\",\"id\":\"300751\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4551493","alternate_names":["Situs ambiguus","situs oppositus","situs transversus"],"name":"Situs inversus totalis","id":"35637","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001696\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"157769\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001696\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"situs oppositus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001696\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"situs transversus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001696\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"IMF","medgen_id":"C0432284","alternate_names":["FIBROMATOSIS, CONGENITAL GENERALIZED"],"name":"Infantile myofibromatosis","id":"17972","alternate_symbols":["CGF"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS228550\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2591\"}","{\"db\":\"OMIM\",\"id\":\"228550\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FIBROMATOSIS, CONGENITAL GENERALIZED\"}","{\"db\":\"OMIM\",\"id\":\"228550\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CGF\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Infantile+myofibromatosis/3809\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS228550\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2998\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"254146000\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"CN238505","alternate_names":[],"name":"Oocyte maturation defect","id":"36157","alternate_symbols":["OOMD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS615774\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"615774\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"OOMD\"}","{\"db\":\"OMIM\",\"id\":\"PS615774\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PHOAR1","medgen_id":"C4551679","alternate_names":["PHO, AUTOSOMAL RECESSIVE"],"name":"Hypertrophic osteoarthropathy, primary, autosomal recessive, 1","id":"2379","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"259100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1525\"}","{\"db\":\"Orphanet\",\"id\":\"2796\"}","{\"db\":\"OMIM\",\"id\":\"259100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PHO, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"259100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0266432","alternate_names":["LEYDIG CELL HYPOPLASIA WITH MALE PSEUDOHERMAPHRODITISM","LEYDIG CELL HYPOPLASIA, COMPLETE","LEYDIG CELL HYPOPLASIA, TYPE I"],"name":"Leydig cell agenesis","id":"2687","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"238320\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"755\"}","{\"db\":\"OMIM\",\"id\":\"238320\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA WITH MALE PSEUDOHERMAPHRODITISM\"}","{\"db\":\"OMIM\",\"id\":\"238320\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, COMPLETE\"}","{\"db\":\"OMIM\",\"id\":\"152790.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"152790.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"152790.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"152790.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"152790.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"152790.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"152790.0025\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"152790.0026\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"152790.0027\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"152790.0028\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"238320\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEYDIG CELL HYPOPLASIA, TYPE I\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Leydig+cells+hypoplasia/4217\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"56212008\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PSORS14","medgen_id":"C0343055","alternate_names":["ACRODERMATITIS CONTINUA OF HALLOPEAU","INTERLEUKIN 36 RECEPTOR ANTAGONIST DEFICIENCY","PSORIASIS 14, PUSTULAR"],"name":"Pustular psoriasis, generalized","id":"16517","alternate_symbols":["DITRA","GPP","PSORP"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"614204\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"247353\"}","{\"db\":\"OMIM\",\"id\":\"614204\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ACRODERMATITIS CONTINUA OF HALLOPEAU\"}","{\"db\":\"OMIM\",\"id\":\"614204\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INTERLEUKIN 36 RECEPTOR ANTAGONIST DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"605507.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSORIASIS 14, PUSTULAR\"}","{\"db\":\"OMIM\",\"id\":\"605507.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSORIASIS 14, PUSTULAR\"}","{\"db\":\"OMIM\",\"id\":\"605507.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSORIASIS 14, PUSTULAR\"}","{\"db\":\"OMIM\",\"id\":\"605507.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSORIASIS 14, PUSTULAR\"}","{\"db\":\"OMIM\",\"id\":\"605507.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSORIASIS 14, PUSTULAR\"}","{\"db\":\"OMIM\",\"id\":\"605507.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSORIASIS 14, PUSTULAR\"}","{\"db\":\"OMIM\",\"id\":\"605507.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSORIASIS 14, PUSTULAR\"}","{\"db\":\"OMIM\",\"id\":\"605507.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSORIASIS 14, PUSTULAR\"}","{\"db\":\"OMIM\",\"id\":\"614204\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSORIASIS 14, PUSTULAR\"}","{\"db\":\"OMIM\",\"id\":\"614204\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DITRA\"}","{\"db\":\"OMIM\",\"id\":\"614204\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GPP\"}","{\"db\":\"OMIM\",\"id\":\"614204\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PSORP\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pustular+psoriasis%2C+generalized/9198\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614204\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0019555","alternate_names":["Congenital dislocation of the hip","Congenital dislocation of the hips","Congenital hip anomaly","Congenital hip dislocations","Developmental dysplasia of the hip","Dislocated hip since birth"],"name":"Dysplasia of acetabulum","id":"36162","alternate_symbols":["CDH","DDH"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS142700\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital dislocation of the hip\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital dislocation of the hips\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital hip anomaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital hip dislocations\"}","{\"db\":\"OMIM\",\"id\":\"PS142700\",\"type\":\"Phenotypic series\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Developmental dysplasia of the hip\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dislocated hip since birth\"}","{\"db\":\"OMIM\",\"id\":\"142700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDH\"}","{\"db\":\"OMIM\",\"id\":\"142700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DDH\"}","{\"db\":\"SNOMED CT\",\"id\":\"52781008\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BESC1","medgen_id":"C2749757","alternate_names":[],"name":"Bronchiectasis with or without elevated sweat chloride 1","id":"1065","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"211400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"60033\"}","{\"db\":\"OMIM\",\"id\":\"211400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SPGF1","medgen_id":"C0403810","alternate_names":["OLIGOCHIASMATIC INFERTILITY","SPERMATOGENIC FAILURE 1"],"name":"Oligosynaptic infertility","id":"3111","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"258150\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"258150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OLIGOCHIASMATIC INFERTILITY\"}","{\"db\":\"OMIM\",\"id\":\"258150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPERMATOGENIC FAILURE 1\"}","{\"db\":\"SNOMED CT\",\"id\":\"236803007\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"258150\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1708371","alternate_names":["Arachnocytosis of the myocardium","Foamy myocardial transformation","Focal lipid cardiomyopathy","Histiocytoid cardiomyopathy","Infantile cardiomyopathy with histiocytoid changes","Infantile xanthomatous cardiomyopathy","Isolated cardiac lipidosis","Myocardial or conduction system hamartoma","Oncocytic cardiomyopathy"],"name":"Infantile histiocytoid cardiomyopathy","id":"722","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005152\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"500000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"137675\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005152\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Arachnocytosis of the myocardium\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005152\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Foamy myocardial transformation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005152\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Focal lipid cardiomyopathy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005152\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Histiocytoid cardiomyopathy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005152\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Infantile cardiomyopathy with histiocytoid changes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005152\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Infantile xanthomatous cardiomyopathy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005152\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Isolated cardiac lipidosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005152\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Myocardial or conduction system hamartoma\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005152\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Oncocytic cardiomyopathy\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Infantile+histiocytoid+cardiomyopathy/3807\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9511\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0001079","alternate_names":[],"name":"Achondrogenesis","id":"13186","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS200600\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"932\"}","{\"db\":\"OMIM\",\"id\":\"PS200600\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2882\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PPCD1","medgen_id":"C1852555","alternate_names":["CONGENITAL HEREDITARY ENDOTHELIAL DYSTROPHY OF CORNEA","CORNEAL DYSTROPHY, CONGENITAL HEREDITARY ENDOTHELIAL","Corneal endothelial dystrophy 1, autosomal dominant","MAUMENEE CORNEAL DYSTROPHY"],"name":"Posterior polymorphous corneal dystrophy 1","id":"843","alternate_symbols":["CHED1"],"type":"Disease","xrefs":["{\"db\":\"Gene\",\"id\":\"8197\"}","{\"db\":\"OMIM\",\"id\":\"122000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98973\"}","{\"db\":\"OMIM\",\"id\":\"121700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONGENITAL HEREDITARY ENDOTHELIAL DYSTROPHY OF CORNEA\"}","{\"db\":\"OMIM\",\"id\":\"121700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CORNEAL DYSTROPHY, CONGENITAL HEREDITARY ENDOTHELIAL\"}","{\"db\":\"OMIM\",\"id\":\"121700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MAUMENEE CORNEAL DYSTROPHY\"}","{\"db\":\"OMIM\",\"id\":\"121700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CHED1\"}","{\"db\":\"OMIM\",\"id\":\"122000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CTRCT46","medgen_id":"C0220721","alternate_names":["CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY"],"name":"Cataract Hutterite type","id":"13489","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"212500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91492\"}","{\"db\":\"OMIM\",\"id\":\"212500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"616312.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 46, JUVENILE-ONSET, WITH OR WITHOUT ARRHYTHMIC CARDIOMYOPATHY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cataract+Hutterite+Type/1146\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1150\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"212500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"KC","public_definition":"Keratoconus is an eye condition that affects the shape of the cornea, which is the clear outer covering of the eye. In this condition, the cornea thins and bulges outward, eventually resembling a cone shape. These corneal abnormalities, which worsen over time, can lead to nearsightedness (myopia), blurred vision that cannot be improved with corrective lenses (irregular astigmatism), and vision loss.Other corneal changes typical of keratoconus that can be seen during an eye exam include iron deposits in the cornea that form a yellow-to-brownish ring, called the Fleischer ring, surrounding the colored part of the eye (iris). Affected individuals may also develop Vogt's striae, which are thin, vertical, white lines in the tissue at the back of the cornea.Keratoconus may affect only one eye at first, but eventually the corneas of both eyes become misshapen, although they might not be affected with the same severity. As keratoconus worsens, people with this condition can develop corneal scarring, often caused by exposure of the abnormally thin cornea to prolonged contact lens use or excessive eye rubbing.The eye changes characteristic of keratoconus typically begin in adolescence and slowly worsen until mid-adulthood at which point the shape of the cornea remains stable.","medgen_id":"C0022578","alternate_names":["Bulging cornea","Conical cornea"],"name":"Keratoconus","id":"6402","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000563\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS148300\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000563\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Bulging cornea\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000563\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Conical cornea\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000563\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS148300\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6824\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"65636009\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"keratoconus\",\"ref_field\":\"public_definition\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6824\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ASD","medgen_id":"C0018817","alternate_names":["Atria septal defect","Atrial septum defect","Defect in the atrial septum","Interatrial communication"],"name":"Atrial septal defect","id":"16498","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001630\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001631\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS108800\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"1478\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001631\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Atria septal defect\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001631\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Atrial septum defect\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001631\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Defect in the atrial septum\"}","{\"db\":\"Orphanet\",\"id\":\"1478\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Interatrial communication\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001631\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS108800\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001631\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Autism spectrum disorder (ASD) is a condition that appears very early in childhood development, varies in severity, and is characterized by impaired social skills, communication problems, and repetitive behaviors. These difficulties can interfere with affected individuals' ability to function in social, academic, and employment settings. People with ASD also have an increased risk of psychiatric problems such as anxiety, depression, obsessive-compulsive disorder, and eating disorders.From as early as 1 to 2 years of age, people with ASD have an impaired ability to interact with other people; they are often more comfortable dealing with objects. Affected individuals have difficulty understanding and using non-verbal social cues such as eye contact, facial expressions, gestures, and body language. Inability to recognize and use these cues makes it hard for affected individuals to understand the feelings of others or communicate their own feelings appropriately. Behavioral signs of ASD, such as reduced eye contact and social interaction, can sometimes be detected before age 2. However, the condition is usually diagnosed between ages 2 and 4, when more advanced communication and social skills, such as learning to play with others, typically begin to develop.Repetitive behaviors in ASD can include simple actions such as rocking, hand-flapping, or repetition of words or noises (echolalia). Affected individuals often dwell on or repeatedly express particular thoughts; this behavior is called perseveration. People with ASD tend to be rigid about their established routines and may strongly resist disruptions such as changes in schedule. They may also have difficulty tolerating sensory stimuli such as loud noises or bright lights.While social and communication difficulties and unusual behaviors define ASD, affected individuals can have a wide range of intellectual abilities and language skills. A majority of people with ASD have mild to moderate intellectual disability, while others have average to above-average intelligence. Some have particular cognitive abilities that greatly surpass their overall level of functioning, often in areas such as music, mathematics, or memory.Some people with ASD do not speak at all, while others use language fluently. However, fluent speakers with ASD often have problems associated with verbal communication. They might speak in a monotone voice, have unusual vocal mannerisms, or choose unusual topics of conversation.Several diagnoses that used to be classified as separate conditions are now grouped together under the diagnosis of ASD. For example, autistic disorder was a term that was used when affected individuals had limited or absent verbal communication, often in combination with intellectual disability. By contrast, Asperger syndrome was a diagnosis formerly applied to affected individuals of average or above-average intelligence who were not delayed in their language development. The broader diagnosis of ASD was established because many affected individuals fall outside of the strict definitions of the narrower diagnoses, and their intellectual and communication abilities may change over time. However, some individuals who were previously diagnosed with one of the subtypes now do not meet all the criteria of the new umbrella diagnosis.","medgen_id":"C0524528","alternate_names":[],"name":"Rare pervasive developmental disorder","id":"41337","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Orphanet\",\"id\":\"168778\"}","{\"db\":\"Orphanet\",\"id\":\"168778\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"autism-spectrum-disorder\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0027708","alternate_names":["Wilm's tumor","Wilms' tumor"],"name":"Nephroblastoma","id":"32458","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000115\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002667\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS194070\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"654\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002667\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Wilm's tumor\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002667\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"25081006\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Mosaic variegated aneuploidy (MVA) syndrome is a rare disorder in which some cells in the body have an abnormal number of chromosomes instead of the usual 46 chromosomes, a situation known as aneuploidy. Most commonly, cells have an extra chromosome, which is called trisomy, or are missing a chromosome, which is known as monosomy. In MVA syndrome, some cells are aneuploid and others have the normal number of chromosomes, which is a phenomenon known as mosaicism. Typically, at least one-quarter of cells in affected individuals have an abnormal number of chromosomes. Because the additional or missing chromosomes vary among the abnormal cells, the aneuploidy is described as variegated.In MVA syndrome, growth before birth is slow (intrauterine growth restriction). After birth, affected individuals continue to grow at a slow rate and are shorter than average. In addition, they typically have an unusually small head size (microcephaly). Another common feature of MVA syndrome is an increased risk of developing cancer in childhood. Cancers that occur most frequently in affected individuals include a cancer of muscle tissue called rhabdomyosarcoma, a form of kidney cancer known as Wilms tumor, and a cancer of the blood-forming tissue known as leukemia.Less commonly, people with MVA syndrome have eye abnormalities or distinctive facial features, such as a broad nasal bridge and low-set ears. Some affected individuals have brain abnormalities, the most common of which is called Dandy-Walker malformation. Intellectual disability, seizures, and other health problems can also occur in people with MVA syndrome.There are at least three types of MVA syndrome, each with a different genetic cause. Type 1 is the most common and displays the classic signs and symptoms described above. Type 2 appears to have slightly different signs and symptoms than type 1, although the small number of affected individuals makes it difficult to define its characteristic features. Individuals with MVA syndrome type 2 grow slowly before and after birth; however, their head size is typically normal. Some people with MVA syndrome type 2 have unusually short arms. Individuals with MVA syndrome type 2 do not seem to have an increased risk of cancer. Another form of MVA syndrome is characterized by a high risk of developing Wilms tumor. Individuals with this form may also have other signs and symptoms typical of MVA syndrome type 1.","medgen_id":"C1850343","alternate_names":[],"name":"Mosaic variegated aneuploidy syndrome","id":"37988","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS257300\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"1052\"}","{\"db\":\"OMIM\",\"id\":\"PS257300\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"1052\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"mosaic-variegated-aneuploidy-syndrome\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"TTD1","medgen_id":"C1866504","alternate_names":["TAY SYNDROME","TRICHOTHIODYSTROPHY WITH CONGENITAL ICHTHYOSIS","Trichothiodystrophy, complementation group A"],"name":"Trichothiodystrophy 1, photosensitive","id":"4296","alternate_symbols":["TTDP"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"601675\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"33364\"}","{\"db\":\"Orphanet\",\"id\":\"670\"}","{\"db\":\"OMIM\",\"id\":\"601675\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"TAY SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"601675\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"TRICHOTHIODYSTROPHY WITH CONGENITAL ICHTHYOSIS\"}","{\"db\":\"OMIM\",\"id\":\"601675\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TTDP\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5270\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TTDP\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5270\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601675\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"RSTS1","medgen_id":"C0035934","alternate_names":[],"name":"Rubinstein-Taybi syndrome","id":"41364","alternate_symbols":["RSTS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS180849\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"783\"}","{\"db\":\"OMIM\",\"id\":\"180849\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"RSTS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7593\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"RSTS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Rubinstein-Taybi+syndrome/6372\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS180849\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7593\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"45582004\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MLASA","medgen_id":"C1838103","alternate_names":[],"name":"Mitochondrial myopathy and sideroblastic anemia","id":"32104","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS600462\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2598\"}","{\"db\":\"Orphanet\",\"id\":\"2598\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3885\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CAON","medgen_id":"C1833683","alternate_names":["Calcium oxalate kidney stones","Calcium oxalate nephrolithiasis","Oxalate nephrolithiasis"],"name":"Calcium oxalate urolithiasis","id":"3443","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008672\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008700\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008725\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"167030\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008672\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Calcium oxalate kidney stones\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008672\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Calcium oxalate nephrolithiasis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008672\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Oxalate nephrolithiasis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008672\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"444717006\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"167030\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EA","medgen_id":"C1720189","alternate_names":["Hereditary episodic ataxia","Intermittent cerebellar ataxia","Paroxysmal ataxia"],"name":"Episodic ataxia","id":"14043","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002131\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006862\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007152\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007214\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS160120\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"211062\"}","{\"db\":\"Orphanet\",\"id\":\"211062\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hereditary episodic ataxia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002131\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Intermittent cerebellar ataxia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002131\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Paroxysmal ataxia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002131\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS160120\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9851\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CDCBM1","medgen_id":"C3808397","alternate_names":[],"name":"Cortical dysplasia, complex, with other brain malformations 1","id":"16030","alternate_symbols":["CDCBM"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"614039\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"300570\"}","{\"db\":\"OMIM\",\"id\":\"614039\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SCKL1","medgen_id":"C0265202","alternate_names":[],"name":"Seckel syndrome","id":"4130","alternate_symbols":["SCKL"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS210600\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"808\"}","{\"db\":\"OMIM\",\"id\":\"210600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SCKL\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8562\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SCKL\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Seckel+syndrome/6478\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS210600\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8562\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"57917004\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0004158","alternate_names":["Athetoid movements"],"name":"Athetosis","id":"22996","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002305\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007167\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007316\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002305\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Athetoid movements\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002305\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5863\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4072867","alternate_names":["Rarefaction of retinal pigmentation","Retinal pigment clumping"],"name":"Pigmentary retinopathy","id":"21761","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000580\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007702\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007821\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007869\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007961\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008010\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000580\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Retinal pigment clumping\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000580\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4357\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0026654","alternate_names":[],"name":"Moyamoya disease","id":"33368","alternate_symbols":["MYMY"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS252350\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2573\"}","{\"db\":\"OMIM\",\"id\":\"252350\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MYMY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Moyamoya+disease/9608\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS252350\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7064\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"69116000\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0338488","alternate_names":[],"name":"Alternating hemiplegia of childhood","id":"33344","alternate_symbols":["AHC"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS104290\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2131\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"11\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AHC\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Alternating+Hemiplegia+of+Childhood/342\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS104290\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"11\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"230466004\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SLEB11","public_definition":"Systemic lupus erythematosus (SLE) is a chronic disease that causes inflammation in connective tissues, such as cartilage and the lining of blood vessels, which provide strength and flexibility to structures throughout the body. The signs and symptoms of SLE vary among affected individuals, and can involve many organs and systems, including the skin, joints, kidneys, lungs, central nervous system, and blood-forming (hematopoietic) system. SLE is one of a large group of conditions called autoimmune disorders that occur when the immune system attacks the body's own tissues and organs.SLE may first appear as extreme tiredness (fatigue), a vague feeling of discomfort or illness (malaise), fever, loss of appetite, and weight loss. Most affected individuals also have joint pain, typically affecting the same joints on both sides of the body, and muscle pain and weakness. Skin problems are common in SLE. A characteristic feature is a flat red rash across the cheeks and bridge of the nose, called a \"butterfly rash\" because of its shape. The rash, which generally does not hurt or itch, often appears or becomes more pronounced when exposed to sunlight. Other skin problems that may occur in SLE include calcium deposits under the skin (calcinosis), damaged blood vessels (vasculitis) in the skin, and tiny red spots called petechiae. Petechiae are caused by a shortage of cells involved in clotting (platelets), which leads to bleeding under the skin. Affected individuals may also have hair loss (alopecia) and open sores (ulcerations) in the moist lining (mucosae) of the mouth, nose, or, less commonly, the genitals.About a third of people with SLE develop kidney disease (nephritis). Heart problems may also occur in SLE, including inflammation of the sac-like membrane around the heart (pericarditis) and abnormalities of the heart valves, which control blood flow in the heart. Heart disease caused by fatty buildup in the blood vessels (atherosclerosis), which is very common in the general population, is even more common in people with SLE. The inflammation characteristic of SLE can also damage the nervous system, and may result in abnormal sensation and weakness in the limbs (peripheral neuropathy); seizures; stroke; and difficulty processing, learning, and remembering information (cognitive impairment). Anxiety and depression are also common in SLE.People with SLE have episodes in which the condition gets worse (exacerbations) and other times when it gets better (remissions). Overall, SLE gradually gets worse over time, and damage to the major organs of the body can be life-threatening.","medgen_id":"C2677096","alternate_names":["SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11"],"name":"Systemic lupus erythematosus 11","id":"4237","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"612253\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"600558.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11\"}","{\"db\":\"OMIM\",\"id\":\"612253\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"systemic-lupus-erythematosus\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612253\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0520680","alternate_names":["Central sleep apnoea","SLEEP APNEA, LETHAL CENTRAL"],"name":"Central sleep apnea syndrome","id":"15883","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010536\",\"type\":\"primary\"}","{\"db\":\"MeSH\",\"id\":\"D020182\"}","{\"db\":\"OMIM\",\"id\":\"107640\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"207720\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010536\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Central sleep apnoea\"}","{\"db\":\"OMIM\",\"id\":\"207720\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SLEEP APNEA, LETHAL CENTRAL\"}","{\"db\":\"SNOMED CT\",\"id\":\"27405005\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Usher syndrome is a condition characterized by partial or total hearing loss and vision loss that worsens over time. The hearing loss is classified as sensorineural, which means that it is caused by abnormalities of the inner ear. The loss of vision is caused by an eye disease called retinitis pigmentosa (RP), which affects the layer of light-sensitive tissue at the back of the eye (the retina). Vision loss occurs as the light-sensing cells of the retina gradually deteriorate. Night vision loss begins first, followed by blind spots that develop in the side (peripheral) vision. Over time, these blind spots enlarge and merge to produce tunnel vision. In some cases, vision is further impaired by clouding of the lens of the eye (cataracts). However, many people with retinitis pigmentosa retain some central vision throughout their lives.Researchers have identified three major types of Usher syndrome, designated as types I, II, and III. These types are distinguished by the severity of hearing loss, the presence or absence of balance problems, and the age at which signs and symptoms appear. The types are further divided into subtypes based on their genetic cause.Most individuals with Usher syndrome type I are born with severe to profound hearing loss. Progressive vision loss caused by retinitis pigmentosa becomes apparent in childhood. This type of Usher syndrome also causes abnormalities of the vestibular system, which is the part of the inner ear that helps maintain the body's balance and orientation in space. As a result of the vestibular abnormalities, children with the condition have trouble with balance. They begin sitting independently and walking later than usual, and they may have difficulty riding a bicycle and playing certain sports.Usher syndrome type II is characterized by hearing loss from birth and progressive vision loss that begins in adolescence or adulthood. The hearing loss associated with this form of Usher syndrome ranges from mild to severe and mainly affects the ability to hear high-frequency sounds. For example, it is difficult for affected individuals to hear high, soft speech sounds, such as those of the letters d and t. The degree of hearing loss varies within and among families with this condition, and it may become more severe over time. Unlike the other forms of Usher syndrome, type II is not associated with vestibular abnormalities that cause difficulties with balance.People with Usher syndrome type III experience hearing loss and vision loss beginning somewhat later in life. Unlike the other forms of Usher syndrome, type III is usually associated with normal hearing at birth. Hearing loss typically begins during late childhood or adolescence, after the development of speech, and becomes more severe over time. By middle age, most affected individuals have profound hearing loss. Vision loss caused by retinitis pigmentosa also develops in late childhood or adolescence. Some people with Usher syndrome type III develop vestibular abnormalities that cause problems with balance.","medgen_id":"C0271097","alternate_names":["Usher Syndromes"],"name":"Usher syndrome","disease_mechanism":"loss of function","id":"38085","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"MeSH\",\"id\":\"D052245\"}","{\"db\":\"OMIM\",\"id\":\"PS276900\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"886\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561956\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"usher-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS276900\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"886\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"usher-syndrome\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0018798","alternate_names":[],"name":"Heart, malformation of","id":"15882","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"140500\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"234750\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"88991\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Oculocutaneous albinism is a group of conditions that affect coloring (pigmentation) of the skin, hair, and eyes. Affected individuals typically have very fair skin and white or light-colored hair. Long-term sun exposure greatly increases the risk of skin damage and skin cancers, including an aggressive form of skin cancer called melanoma, in people with this condition. Oculocutaneous albinism also reduces pigmentation of the colored part of the eye (the iris) and the light-sensitive tissue at the back of the eye (the retina). People with this condition usually have vision problems such as reduced sharpness; rapid, involuntary eye movements (nystagmus); and increased sensitivity to light (photophobia).Researchers have identified multiple types of oculocutaneous albinism, which are distinguished by their specific skin, hair, and eye color changes and by their genetic cause. Oculocutaneous albinism type 1 is characterized by white hair, very pale skin, and light-colored irises. Type 2 is typically less severe than type 1; the skin is usually a creamy white color and hair may be light yellow, blond, or light brown. Type 3 includes a form of albinism called rufous oculocutaneous albinism, which usually affects dark-skinned people. Affected individuals have reddish-brown skin, ginger or red hair, and hazel or brown irises. Type 3 is often associated with milder vision abnormalities than the other forms of oculocutaneous albinism. Type 4 has signs and symptoms similar to those seen with type 2.Several additional types of this disorder have been proposed, each affecting one or a few families.","medgen_id":"C0078918","alternate_names":[],"name":"Oculocutaneous albinism","id":"17998","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS203100\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"55\"}","{\"db\":\"OMIM\",\"id\":\"PS203100\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"63844009\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"oculocutaneous-albinism\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"GHIP","medgen_id":"C1858656","alternate_names":["GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL","GROWTH HORMONE INSENSITIVITY, PARTIAL"],"name":"Short stature, idiopathic, autosomal","id":"4141","alternate_symbols":["GHDP","SS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"604271\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"314811\"}","{\"db\":\"OMIM\",\"id\":\"601898.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL\"}","{\"db\":\"OMIM\",\"id\":\"601898.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL\"}","{\"db\":\"OMIM\",\"id\":\"601898.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL\"}","{\"db\":\"OMIM\",\"id\":\"615925\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL\"}","{\"db\":\"OMIM\",\"id\":\"600946.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GROWTH HORMONE INSENSITIVITY, PARTIAL\"}","{\"db\":\"OMIM\",\"id\":\"600946.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GROWTH HORMONE INSENSITIVITY, PARTIAL\"}","{\"db\":\"OMIM\",\"id\":\"600946.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GROWTH HORMONE INSENSITIVITY, PARTIAL\"}","{\"db\":\"OMIM\",\"id\":\"600946.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GROWTH HORMONE INSENSITIVITY, PARTIAL\"}","{\"db\":\"OMIM\",\"id\":\"600946.0020\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GROWTH HORMONE INSENSITIVITY, PARTIAL\"}","{\"db\":\"OMIM\",\"id\":\"604271\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GROWTH HORMONE INSENSITIVITY, PARTIAL\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Short+stature%2C+idiopathic%2C+autosomal/9295\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604271\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CPSKF1B","medgen_id":"CN259076","alternate_names":[],"name":"CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B","id":"41916","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"618469\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618469\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618469\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"CN228424","alternate_names":[],"name":"Lymphoproliferative syndrome","id":"32997","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS308240\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"238510\"}","{\"db\":\"OMIM\",\"id\":\"PS308240\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Mitochondrial complex I deficiency is a shortage (deficiency) of a protein complex called complex I or a loss of its function. Complex I is found in cell structures called mitochondria, which convert the energy from food into a form that cells can use. Complex I is the first of five mitochondrial complexes that carry out a multi-step process called oxidative phosphorylation, through which cells derive much of their energy.Mitochondrial complex I deficiency can cause a wide variety of signs and symptoms affecting many organs and systems of the body, particularly the nervous system, the heart, and the muscles used for movement (skeletal muscles). These signs and symptoms can appear at any time from birth to adulthood.People with mitochondrial complex I deficiency typically have neurological problems, such as abnormal brain function (encephalopathy), recurrent seizures (epilepsy), intellectual disability, difficulty coordinating movements (ataxia), or involuntary movements (dystonia). Affected individuals may have low muscle tone (hypotonia), muscle pain (myalgia), and extreme fatigue in response to physical activity (exercise intolerance). They tend to develop elevated levels of lactic acid in the blood (lactic acidosis), which can cause nausea, vomiting, weakness, and rapid breathing. In severe cases, lactic acidosis can be life-threatening.People with mitochondrial complex I deficiency sometimes have heart, liver, or kidney problems. Vision problems due to abnormal eye movement or breakdown (degeneration) of the nerves that carry signals from the eyes to the brain (optic nerves) can also occur.Some people with mitochondrial complex I deficiency have groups of signs and symptoms that are classified as a specific syndrome. For example, a condition called Leigh syndrome is most commonly caused by mitochondrial complex I deficiency. Leigh syndrome is characterized by progressive loss of mental and movement abilities (developmental or psychomotor regression) and typically results in death within 2 to 3 years from the onset of symptoms. Another condition that can be caused by mitochondrial complex I deficiency, Leber hereditary optic neuropathy, is associated mainly with vision problems due to optic nerve degeneration. These syndromes can also have other causes.","medgen_id":"C2936907","alternate_names":[],"name":"Mitochondrial complex I deficiency","id":"3208","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Orphanet\",\"id\":\"2609\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mitochondrial+complex+I+deficiency/4823\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3908\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"mitochondrial-complex-i-deficiency\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"GCCR","medgen_id":"C1841972","alternate_names":["GCCR DEFICIENCY"],"name":"Glucocorticoid resistance, generalized","id":"12486","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"615962\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"786\"}","{\"db\":\"OMIM\",\"id\":\"615962\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GCCR DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"615962\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1955934","alternate_names":[],"name":"Trichothiodystrophy","id":"38310","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS601675\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"33364\"}","{\"db\":\"OMIM\",\"id\":\"PS601675\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CORD21","public_definition":"Cone-rod dystrophy is a group of related eye disorders that causes vision loss, which becomes more severe over time. These disorders affect the retina, which is the layer of light-sensitive tissue at the back of the eye. In people with cone-rod dystrophy, vision loss occurs as the light-sensing cells of the retina gradually deteriorate.The first signs and symptoms of cone-rod dystrophy, which often occur in childhood, are usually decreased sharpness of vision (visual acuity) and increased sensitivity to light (photophobia). These features are typically followed by impaired color vision (dyschromatopsia), blind spots (scotomas) in the center of the visual field, and partial side (peripheral) vision loss. Over time, affected individuals develop night blindness and a worsening of their peripheral vision, which can limit independent mobility. Decreasing visual acuity makes reading increasingly difficult and most affected individuals are legally blind by mid-adulthood. As the condition progresses, individuals may develop involuntary eye movements (nystagmus).There are more than 30 types of cone-rod dystrophy, which are distinguished by their genetic cause and their pattern of inheritance: autosomal recessive, autosomal dominant, and X-linked. Additionally, cone-rod dystrophy can occur alone without any other signs and symptoms or it can occur as part of a syndrome that affects multiple parts of the body.","medgen_id":"CN231743","alternate_names":[],"name":"Cone-rod dystrophy 21","id":"33616","alternate_symbols":["DRAM2"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"616502\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1872\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"cone-rod-dystrophy\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"616502\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EIG","medgen_id":"C0270850","alternate_names":[],"name":"Idiopathic generalized epilepsy","id":"1168","alternate_symbols":["IGE"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"600669\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"PS600669\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"600669\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IGE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Idiopathic+generalized+epilepsy/8637\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"36803009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600669\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"VUR","medgen_id":"C0042580","alternate_names":["Familial vesicoureteral reflux","Ureteral reflux","Ureteric reflux","Vesico-Ureteral Reflux","Vesicoureteric reflux"],"name":"Vesicoureteral reflux","id":"21404","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000076\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005998\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006002\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008667\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS193000\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"289365\"}","{\"db\":\"Orphanet\",\"id\":\"289365\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Familial vesicoureteral reflux\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000076\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ureteral reflux\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000076\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ureteric reflux\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000076\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Vesicoureteric reflux\"}","{\"db\":\"SNOMED CT\",\"id\":\"197811007\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Vesicoureteric reflux\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000076\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS193000\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"193000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0264886","alternate_names":[],"name":"Conduction disorder of the heart","id":"664","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"115080\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"871\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Conduction+disorder+of+the+heart/8034\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"44808001\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Mucopolysaccharidosis type III (MPS III), also known as Sanfilippo syndrome, is a progressive disorder that primarily affects the brain and spinal cord (central nervous system). It is characterized by deterioration of neurological function (neurodegeneration), resulting in many of the features of the condition. Other body systems can also be involved, although the physical features are usually mild in the early stages.People with MPS III generally do not display any features of the condition at birth, but they begin to show signs and symptoms of the disorder during early childhood. Affected children often initially have delayed speech and behavior problems. They may become restless, destructive, anxious, or aggressive, and some display features of autism spectrum disorder, which is a condition characterized by difficulty with social interactions and communication. Sleep disturbances are also very common in children with MPS III. This condition causes progressive intellectual disability and the loss of previously acquired skills (developmental regression). In later stages of the disorder, people with MPS III may develop seizures and movement disorders.The physical features of MPS III are less pronounced than those of other types of mucopolysaccharidosis. Individuals with MPS III typically have mildly \"coarse\" facial features, a large head (macrocephaly), a slightly enlarged liver (mild hepatomegaly), and a soft out-pouching around the belly-button (umbilical hernia) or lower abdomen (inguinal hernia). Some people with MPS III have short stature, joint stiffness, or mild dysostosis multiplex, which refers to multiple skeletal abnormalities seen on x-ray. Affected individuals often experience chronic diarrhea and recurrent upper respiratory and ear infections. People with MPS III may also have hearing loss and vision problems.MPS III is divided into types IIIA, IIIB, IIIC, and IIID, which are distinguished by their genetic cause. The different types of MPS III have similar signs and symptoms, although the features of MPS IIIA typically appear earlier in life and progress more rapidly. People with MPS III usually live into adolescence or early adulthood.","medgen_id":"C0026706","alternate_names":[],"name":"Sanfilippo syndrome","id":"6283","alternate_symbols":["MPS III"],"type":"Disease","xrefs":["{\"db\":\"Orphanet\",\"id\":\"581\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3807\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"88393000\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"mucopolysaccharidosis-type-iii\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"NMIHBA","medgen_id":"C4479566","alternate_names":[],"name":"Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies","id":"37814","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"617481\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"544469\"}","{\"db\":\"OMIM\",\"id\":\"617481\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AUTSX2","medgen_id":"C1845539","alternate_names":[],"name":"Autism, susceptibility to, X-linked 2","id":"366","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"300495\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"AUTISM%2C+SUSCEPTIBILITY+TO%2C+X-LINKED+2/7769\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300495\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CVID13","medgen_id":"C4225173","alternate_names":[],"name":"Immunodeficiency, common variable, 13","id":"34886","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"616873\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"616873\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"CN262194","alternate_names":["HIGH DENSITY LIPOPROTEIN DEFICIENCY"],"name":"HYPOALPHALIPOPROTEINEMIA, PRIMARY, 2","id":"42319","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"618463\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618463\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIGH DENSITY LIPOPROTEIN DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"107680.0023\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618463\",\"type\":\"MIM\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BCYM4","medgen_id":"C2748515","alternate_names":["BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES","SEMD, PAKISTANI TYPE"],"name":"Spondyloepimetaphyseal dysplasia, pakistani type","id":"6840","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"612847\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"93282\"}","{\"db\":\"OMIM\",\"id\":\"603005.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"603005.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"612847\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES\"}","{\"db\":\"OMIM\",\"id\":\"612847\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SEMD, PAKISTANI TYPE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spondyloepimetaphyseal+dysplasia%2C+pakistani+type/9350\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"612847\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CHNG2","medgen_id":"C1869118","alternate_names":["Thyroid dysplasia"],"name":"Thyroid dysgenesis","id":"5311","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008188\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"218700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"95712\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008188\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thyroid dysplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008188\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8426\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"218700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0029124","alternate_names":["Optic nerve atrophy","Optic-nerve degeneration"],"name":"Optic atrophy","id":"17224","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000648\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007751\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007855\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS165500\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000648\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Optic nerve atrophy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000648\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Optic-nerve degeneration\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000648\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS165500\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ECYT8","medgen_id":"C1291620","alternate_names":["BISPHOSPHOGLYCERATE MUTASE DEFICIENCY","BPGM DEFICIENCY","DPGM DEFICIENCY"],"name":"Deficiency of bisphosphoglycerate mutase","id":"16032","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"222800\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"222800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BISPHOSPHOGLYCERATE MUTASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"222800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BPGM DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"222800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DPGM DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Diphosphoglycerate+Mutase+Deficiency+of+Erythrocyte/2291\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"124678007\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"222800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BESC3","medgen_id":"C2751324","alternate_names":[],"name":"Bronchiectasis with or without elevated sweat chloride 3","id":"6687","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"613071\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"60033\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Bronchiectasis+with+or+without+elevated+sweat+chloride+3/7872\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613071\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"RCDP","medgen_id":"C0282529","alternate_names":[],"name":"Rhizomelic chondrodysplasia punctata","id":"9563","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS215100\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"177\"}","{\"db\":\"OMIM\",\"id\":\"PS215100\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"56692003\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Crohn disease is a complex, long-lasting (chronic) disorder that primarily affects the digestive system. This condition involves an abnormal immune response that causes excess inflammation. It most often affects the intestinal walls, particularly in the lower part of the small intestine (the ileum) and portions of the large intestine (the colon). However, inflammation can occur in any part of the digestive system, from the mouth to the anus. The inflamed tissues become thick and swollen, and the inner surfaces of the digestive system may develop open sores (ulcers).Crohn disease most commonly appears in a person's late teens or twenties, although the disease can begin at any age. Signs and symptoms tend to flare up multiple times throughout life. The most common features of this condition are persistent diarrhea, abdominal pain and cramping, loss of appetite, weight loss, and fever. Some people with Crohn disease have blood in the stool from inflamed tissues in the intestine; over time, chronic bleeding can lead to a low number of red blood cells (anemia). In some cases, Crohn disease can also cause inflammation affecting the joints, eyes, or skin.Intestinal blockage is a common complication of Crohn disease. Blockages are caused by swelling or a buildup of scar tissue in the intestinal walls. Some affected individuals also develop fistulae, which are abnormal connections between the intestine and other tissues. Fistulae occur when ulcers break through the intestinal wall and passages form between loops of the intestine or between the intestine and nearby structures (such as the bladder, vagina, or skin).Crohn disease is one common form of inflammatory bowel disease (IBD). Another type of IBD, ulcerative colitis, also causes chronic inflammation of the intestinal lining. Unlike Crohn disease, which can affect any part of the digestive system, ulcerative colitis typically causes inflammation only in the colon.","medgen_id":"CN043071","alternate_names":[],"name":"Crohn disease","id":"8962","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Genetics Home Reference\",\"id\":\"crohn-disease\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"crohn-disease\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MGORS1","public_definition":"Meier-Gorlin syndrome is a condition primarily characterized by short stature. It is considered a form of primordial dwarfism because the growth problems begin before birth (intrauterine growth retardation). After birth, affected individuals continue to grow at a slow rate. Other characteristic features of this condition are underdeveloped or missing kneecaps (patellae), small ears, and, often, an abnormally small head (microcephaly). Despite a small head size, most people with Meier-Gorlin syndrome have normal intellect.Some people with Meier-Gorlin syndrome have other skeletal abnormalities, such as unusually narrow long bones in the arms and legs, a deformity of the knee joint that allows the knee to bend backwards (genu recurvatum), and slowed mineralization of bones (delayed bone age).Most people with Meier-Gorlin syndrome have distinctive facial features. In addition to being abnormally small, the ears may be low-set or rotated backward. Additional features can include a small mouth (microstomia), an underdeveloped lower jaw (micrognathia), full lips, and a narrow nose with a high nasal bridge.Abnormalities in sexual development may also occur in Meier-Gorlin syndrome. In some males with this condition, the testes are small or undescended (cryptorchidism). Affected females may have unusually small external genital folds (hypoplasia of the labia majora) and small breasts. Both males and females with this condition can have sparse or absent underarm (axillary) hair.Additional features of Meier-Gorlin syndrome can include difficulty feeding and a lung condition known as pulmonary emphysema or other breathing problems.","medgen_id":"C1868684","alternate_names":[],"name":"Meier-Gorlin syndrome","disease_mechanism":"gain of function","id":"33107","alternate_symbols":["MGORS - GMNN"],"type":"Disease","disease_mechanism_id":"274","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS224690\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2554\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529599\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGORS - GMNN\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529599\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Meier-Gorlin+syndrome/4571\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"meier-gorlin-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS224690\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2033\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"meier-gorlin-syndrome\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AAPC","medgen_id":"C1868019","alternate_names":[],"name":"Adenomatous polyposis coli, attenuated","disease_mechanism":"loss of function","id":"8652","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500599\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"OMIM\",\"id\":\"175100\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EDAID2","medgen_id":"C2677481","alternate_names":["ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY 2","ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNODEFICIENCY 2","Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, autosomal dominant"],"name":"Ectodermal dysplasia and immunodeficiency 2","id":"4992","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"612132\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"238468\"}","{\"db\":\"Orphanet\",\"id\":\"98813\"}","{\"db\":\"OMIM\",\"id\":\"612132\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY 2\"}","{\"db\":\"OMIM\",\"id\":\"612132\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNODEFICIENCY 2\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Ectodermal+dysplasia%2C+anhidrotic%2C+with+T-cell+immunodeficiency%2C+autosomal+dominant/8291\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, autosomal dominant\"}","{\"db\":\"OMIM\",\"id\":\"612132\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SIDBA3","medgen_id":"C4225155","alternate_names":["ANEMIA, SIDEROBLASTIC, 3"],"name":"Sideroblastic anemia 3, pyridoxine-refractory","id":"34841","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"616860\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"255132\"}","{\"db\":\"OMIM\",\"id\":\"609588.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 3\"}","{\"db\":\"OMIM\",\"id\":\"609588.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 3\"}","{\"db\":\"OMIM\",\"id\":\"609588.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, SIDEROBLASTIC, 3\"}","{\"db\":\"OMIM\",\"id\":\"616860\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0027889","alternate_names":[],"name":"Hereditary sensory and autonomic neuropathy","id":"38768","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS162400\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"140471\"}","{\"db\":\"OMIM\",\"id\":\"PS162400\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"140471\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1868598","alternate_names":["CATLIN MARKS","CRANIUM BIFIDUM, HEREDITARY","Cranium bifidum occultum","FORAMINA PARIETALIA PERMAGNA","PARIETAL FORAMINA, SYMMETRIC"],"name":"Enlarged parietal foramina","id":"38536","alternate_symbols":["PFM"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004423\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS168500\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"60015\"}","{\"db\":\"OMIM\",\"id\":\"168500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATLIN MARKS\"}","{\"db\":\"OMIM\",\"id\":\"168500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CRANIUM BIFIDUM, HEREDITARY\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004423\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cranium bifidum occultum\"}","{\"db\":\"OMIM\",\"id\":\"168500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FORAMINA PARIETALIA PERMAGNA\"}","{\"db\":\"OMIM\",\"id\":\"168500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PARIETAL FORAMINA, SYMMETRIC\"}","{\"db\":\"OMIM\",\"id\":\"168500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PFM\"}","{\"db\":\"Orphanet\",\"id\":\"60015\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AOVD2","medgen_id":"C3542024","alternate_names":[],"name":"Aortic valve disease 2","id":"17368","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"614823\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"614823\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"POF","medgen_id":"C0085215","alternate_names":["PRIMARY OVARIAN INSUFFICIENCY, FRAGILE X-ASSOCIATED"],"name":"Premature ovarian failure","id":"16835","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS311360\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"311360\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PRIMARY OVARIAN INSUFFICIENCY, FRAGILE X-ASSOCIATED\"}","{\"db\":\"Genetic Alliance\",\"id\":\"premature+ovarian+failure/5929\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS311360\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"237788002\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"311360\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HPP","medgen_id":"C0520739","alternate_names":[],"name":"Hereditary pyropoikilocytosis","disease_mechanism":"loss of function","id":"5841","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004805\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004839\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"266140\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98867\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522279\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522331\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528390\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pyropoikilocytosis+hereditary/6118\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"9434008\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"266140\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CMC","medgen_id":"C0340803","alternate_names":["CAPILLARY MALFORMATIONS","CAPILLARY MALFORMATIONS, CONGENITAL, 1, SOMATIC, MOSAIC","Capillary malformations, congenital","PORT-WINE STAIN"],"name":"Capillary malformation","id":"653","alternate_symbols":["CMAL"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0025104\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"163000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"211247\"}","{\"db\":\"Orphanet\",\"id\":\"624\"}","{\"db\":\"OMIM\",\"id\":\"163000\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CAPILLARY MALFORMATIONS\"}","{\"db\":\"OMIM\",\"id\":\"600998.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CAPILLARY MALFORMATIONS, CONGENITAL, 1, SOMATIC, MOSAIC\"}","{\"db\":\"OMIM\",\"id\":\"163000\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PORT-WINE STAIN\"}","{\"db\":\"OMIM\",\"id\":\"163000\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMAL\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0025104\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"163000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"VAMAS1","medgen_id":"C1847835","alternate_names":["SYSTEMIC LUPUS ERYTHEMATOSUS, VITILIGO-RELATED"],"name":"Vitiligo-associated multiple autoimmune disease susceptibility 1","id":"3954","alternate_symbols":["SLEV1","VTLG"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"606579\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"247871\"}","{\"db\":\"OMIM\",\"id\":\"606579\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SYSTEMIC LUPUS ERYTHEMATOSUS, VITILIGO-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"606579\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SLEV1\"}","{\"db\":\"OMIM\",\"id\":\"606579\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"VTLG\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Vitiligo-associated+multiple+autoimmune+disease+susceptibility+1/9458\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606579\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C3696376","alternate_names":[],"name":"3-Methylglutaconic aciduria","id":"23849","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003535\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS250950\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"289902\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003535\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS250950\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"237950009\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":["Neoplasm"],"symbol":"CAKUT2","medgen_id":"C1840451","alternate_names":[],"name":"Multicystic renal dysplasia, bilateral","id":"2975","alternate_symbols":["MRD","PUJO","UPJO"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"143400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2190\"}","{\"db\":\"Orphanet\",\"id\":\"97364\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9517\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRD\"}","{\"db\":\"OMIM\",\"id\":\"143400\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PUJO\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9517\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PUJO\"}","{\"db\":\"OMIM\",\"id\":\"143400\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"UPJO\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Multicystic+renal+dysplasia%2C+bilateral/4939\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9517\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"143400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HFE5","medgen_id":"CN181217","alternate_names":[],"name":"Hemochromatosis type 5","id":"18365","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"615517\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"247790\"}","{\"db\":\"OMIM\",\"id\":\"615517\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ISS","medgen_id":"C1845118","alternate_names":[],"name":"Short stature, idiopathic, X-linked","disease_mechanism":"loss of function","id":"4142","alternate_symbols":["SS"],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"300582\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"314795\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508920\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511912\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529040\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"SHORT+STATURE%2C+IDIOPATHIC%2C+X-LINKED/9296\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300582\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AVSD","medgen_id":"C1389018","alternate_names":["AVC DEFECT","Atrioventricular canal defect","Endocardial cushion defect"],"name":"Atrioventricular septal defect","id":"360","alternate_symbols":["AVCD","ECD"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005139\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005298\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006695\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010439\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"606215\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"PS606215\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"98722\"}","{\"db\":\"OMIM\",\"id\":\"606215\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AVC DEFECT\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006695\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Atrioventricular canal defect\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006695\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Endocardial cushion defect\"}","{\"db\":\"OMIM\",\"id\":\"606215\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AVCD\"}","{\"db\":\"OMIM\",\"id\":\"606215\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ECD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Atrioventricular+Septal+Defect/656\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006695\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS606215\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"606215\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"IDDBCS","medgen_id":"CN263095","alternate_names":[],"name":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES","id":"43202","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"618725\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"608325.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618725\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618725\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1704375","alternate_names":[],"name":"Hypophosphatemic rickets","id":"24705","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004912\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS193100\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"437\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004912\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS193100\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0006267","alternate_names":[],"name":"Bronchiectasis","id":"36325","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002110\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS211400\",\"type\":\"Phenotypic series\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Bronchiectasis/7870\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002110\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS211400\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"12295008\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CMTDID","public_definition":"Charcot-Marie-Tooth disease encompasses a group of disorders called hereditary sensory and motor neuropathies that damage the peripheral nerves. Peripheral nerves connect the brain and spinal cord to muscles and to sensory cells that detect sensations such as touch, pain, heat, and sound. Damage to the peripheral nerves that worsens over time can result in alteration or loss of sensation and wasting (atrophy) of muscles in the feet, legs, and hands.Charcot-Marie-Tooth disease usually becomes apparent in adolescence or early adulthood, but onset may occur anytime from early childhood through late adulthood. Symptoms of Charcot-Marie-Tooth disease vary in severity and age of onset even among members of the same family. Some people never realize they have the disorder because their symptoms are so mild, but most have a moderate amount of physical disability. A small percentage of people experience severe weakness or other problems which, in very rare cases, can be life-threatening. In most affected individuals, however, Charcot-Marie-Tooth disease does not affect life expectancy.Typically, the earliest symptoms of Charcot-Marie-Tooth disease result from muscle atrophy in the feet. Affected individuals may have foot abnormalities such as high arches (pes cavus), flat feet (pes planus), or curled toes (hammer toes). They often have difficulty flexing the foot or walking on the heel of the foot. These difficulties may cause a higher than normal step (steppage gait) and increase the risk of ankle injuries and tripping. As the disease worsens, muscles in the lower legs usually weaken, but leg and foot problems rarely require the use of a wheelchair.Affected individuals may also develop weakness in the hands, causing difficulty with daily activities such as writing, fastening buttons, and turning doorknobs. People with Charcot-Marie-Tooth disease typically experience a decreased sensitivity to touch, heat, and cold in the feet and lower legs, but occasionally feel aching or burning sensations. In rare cases, affected individuals have loss of vision or gradual hearing loss that sometimes leads to deafness.There are several types of Charcot-Marie-Tooth disease, which are differentiated by their effects on nerve cells and patterns of inheritance. Type 1 (CMT1) is characterized by abnormalities in myelin, the fatty substance that covers nerve cells, protecting them and helping to transmit nerve impulses. These abnormalities slow the transmission of nerve impulses and can affect the health of the nerve fiber. Type 2 (CMT2) is characterized by abnormalities in the fiber, or axon, that extends from a nerve cell body to muscles or to sense organs. These abnormalities reduce the strength of the nerve impulse. In forms of Charcot-Marie-Tooth disease classified as intermediate type, the nerve impulses are both slowed and reduced in strength, probably due to abnormalities in both myelin and axons. Type 4 (CMT4) is distinguished from the other types by its pattern of inheritance; it can affect either the axons or the myelin. Type X Charcot-Marie-Tooth disease (CMTX) is caused by mutations in genes on the X chromosome, one of the two sex chromosomes. Within the various types of Charcot-Marie-Tooth disease, subtypes (such as CMT1A, CMT1B, CMT2A, CMT4A, and CMTX1) indicate different genetic causes.Sometimes other, historical names are used to refer to particular forms of Charcot-Marie-Tooth disease. For example, Roussy-Levy syndrome is a form of CMT11 with the additional feature of rhythmic shaking (tremors). Dejerine-Sottas syndrome is a term sometimes used to describe a severe, early childhood form of Charcot-Marie-Tooth disease; it is also sometimes called type 3 (CMT3). Depending on the specific gene that is altered, this severe, early-onset form of the disorder may also be classified as CMT1 or CMT4. CMTX5 is also known as Rosenberg-Chutorian syndrome.","medgen_id":"C1843075","alternate_names":["CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D","CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE D"],"name":"Charcot-Marie-Tooth disease dominant intermediate 3","id":"1419","alternate_symbols":["CMT2I","CMT2J","DI-CMTD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"607791\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"159440.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D\"}","{\"db\":\"OMIM\",\"id\":\"607791\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D\"}","{\"db\":\"OMIM\",\"id\":\"607791\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE D\"}","{\"db\":\"OMIM\",\"id\":\"607791\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DI-CMTD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Charcot-Marie-Tooth+Disease+Dominant+Intermediate+3/1280\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9207\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"charcot-marie-tooth-disease\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"607791\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0013274","alternate_names":["Ductus arteriosus","Patent arterial duct","Persistent arterial duct","Persistent ductus arteriosus"],"name":"Patent ductus arteriosus","id":"36274","alternate_symbols":["PDA"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001643\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS607411\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"706\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001643\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ductus arteriosus\"}","{\"db\":\"Orphanet\",\"id\":\"706\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Patent arterial duct\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001643\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Persistent arterial duct\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001643\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Persistent ductus arteriosus\"}","{\"db\":\"OMIM\",\"id\":\"607411\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PDA\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7342\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PDA\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Patent+ductus+arteriosus/5628\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001643\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS607411\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7342\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"83330001\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EO Obesity","medgen_id":"C0028754","alternate_names":["OBESITY, SUSCEPTIBILITY TO"],"name":"Obesity","id":"5660","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001513\",\"type\":\"primary\"}","{\"db\":\"MeSH\",\"id\":\"D009765\"}","{\"db\":\"OMIM\",\"id\":\"601665\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"71529\"}","{\"db\":\"OMIM\",\"id\":\"109691.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OBESITY, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"173335.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OBESITY, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"173335.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OBESITY, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"173335.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OBESITY, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"516020.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OBESITY, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"605353.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OBESITY, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"605353.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OBESITY, SUSCEPTIBILITY TO\"}","{\"db\":\"GeneTests\",\"id\":\"319194\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Obesity/9028\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"414916001\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0730290","alternate_names":["Cone dystrophy","Cone-rod retinal dystrophy"],"name":"Cone/cone-rod dystrophy","id":"21734","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000548\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008157\",\"type\":\"secondary\"}","{\"db\":\"Orphanet\",\"id\":\"1871\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000548\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cone dystrophy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000548\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cone-rod retinal dystrophy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000548\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SAO","medgen_id":"C1862322","alternate_names":["HE, STOMATOCYTIC","Ovalocytosis, Malaysian-Melanesian-Filipino type","Stomatocytic elliptocytosis, hereditary"],"name":"Ovalocytosis, southeast Asian","id":"3251","alternate_symbols":["EL4"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"166900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98868\"}","{\"db\":\"OMIM\",\"id\":\"166900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HE, STOMATOCYTIC\"}","{\"db\":\"OMIM\",\"id\":\"166900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EL4\"}","{\"db\":\"OMIM\",\"id\":\"166900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EDSARTH2","medgen_id":"CN706304","alternate_names":["EHLERS-DANLOS SYNDROME, TYPE VIIB, AUTOSOMAL DOMINANT"],"name":"EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2","id":"38475","alternate_symbols":["EDS7B"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"617821\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"617821\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, TYPE VIIB, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"617821\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EDS7B\"}","{\"db\":\"OMIM\",\"id\":\"120160.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"120160.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"120160.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"120160.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"120160.0027\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"120160.0042\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617821\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"617821\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HSD10MD","medgen_id":"C3266731","alternate_names":["17-beta-hydroxysteroid dehydrogenase X deficiency","2-methyl-3-hydroxybutyric aciduria","CHORIOATHETOSIS WITH MENTAL RETARDATION AND ABNORMAL BEHAVIOR","HSD10 MITOCHONDRIAL DISEASE","HSD17B10 DEFICIENCY"],"name":"HSD10 disease","disease_mechanism":"loss of function","id":"53","alternate_symbols":["CAMR","MRXS10"],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"300438\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"391417\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Beta+Ketothiolase+Deficiency/812\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"2-methyl-3-hydroxybutyric aciduria\"}","{\"db\":\"OMIM\",\"id\":\"300438\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHORIOATHETOSIS WITH MENTAL RETARDATION AND ABNORMAL BEHAVIOR\"}","{\"db\":\"OMIM\",\"id\":\"300256.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSD10 MITOCHONDRIAL DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"300256.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSD10 MITOCHONDRIAL DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"300256.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSD10 MITOCHONDRIAL DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"300256.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSD10 MITOCHONDRIAL DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"300256.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSD10 MITOCHONDRIAL DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"300256.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSD10 MITOCHONDRIAL DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"300256.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSD10 MITOCHONDRIAL DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"300256.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSD10 MITOCHONDRIAL DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"300438\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSD10 MITOCHONDRIAL DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"300438\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSD17B10 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"300438\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CAMR\"}","{\"db\":\"OMIM\",\"id\":\"300438\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MRXS10\"}","{\"db\":\"Orphanet\",\"id\":\"391417\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"300438\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"OSA","medgen_id":"C0520679","alternate_names":["Obstructive sleep apnoea","SLEEP APNEA/HYPOPNEA SYNDROME"],"name":"Obstructive sleep apnea syndrome","id":"4605","alternate_symbols":["OSAHS","OSAS","SAHS"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002870\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"107650\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002870\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Obstructive sleep apnoea\"}","{\"db\":\"OMIM\",\"id\":\"107650\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SLEEP APNEA/HYPOPNEA SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"107650\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"OSAHS\"}","{\"db\":\"OMIM\",\"id\":\"107650\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"OSAS\"}","{\"db\":\"OMIM\",\"id\":\"107650\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SAHS\"}","{\"db\":\"SNOMED CT\",\"id\":\"78275009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"107650\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0010495","alternate_names":["Chalazoderma","Cutaneous laxity","Dermatochalasia","Dermatomegaly","Elastolysis","Generalized elastolysis","Hanging skin","Hypoelastic skin","Inelastic skin","Lax skin","Loose skin","Skin laxity"],"name":"Cutis laxa","id":"22070","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS123700\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"209\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Chalazoderma\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cutaneous laxity\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dermatochalasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dermatomegaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Elastolysis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Generalized elastolysis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hanging skin\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypoelastic skin\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Inelastic skin\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lax skin\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Loose skin\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Skin laxity\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000973\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS123700\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6227\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"58588007\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C2243051","alternate_names":["Big calvaria","Big cranium","Big head","Big skull","Increased size of cranium","Increased size of head","Increased size of skull","Large calvaria","Large cranium","Large head circumference","Large skull","Macrocephaly","Macrocrania","Megacephaly"],"name":"Macrocephalus","id":"21542","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005491\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005496\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0200135\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Big calvaria\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Big cranium\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Big head\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Big skull\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased size of cranium\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased size of head\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased size of skull\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Large calvaria\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Large cranium\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Large head circumference\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Large skull\"}","{\"db\":\"Developmental Genetics Unit,King Faisal Specialist Hospital \u0026 Research Centre\",\"id\":\"13DG1472\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macrocephaly\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Macrocephaly/4387\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macrocephaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macrocephaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macrocrania\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000256\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Megacephaly\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0027662","alternate_names":[],"name":"Multiple endocrine neoplasia","id":"33367","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS131100\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"276161\"}","{\"db\":\"OMIM\",\"id\":\"PS131100\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"46724008\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C3266076","alternate_names":[],"name":"Orofacial cleft","id":"16696","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS119530\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"PS119530\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Olmsted syndrome is a rare congenital disorder characterized by bilateral mutilating palmoplantar keratoderma (PPK) and periorificial keratotic plaques with severe pruritus of lesions. Diffuse alopecia, constriction of digits, and onychodystrophy have also been reported. Infections and squamous cell carcinomas can arise on the keratotic areas (summary by Lin et al., 2012). The digital constriction ('pseudoainhum') may progress to autoamputation of fingers and toes (Olmsted, 1927).","medgen_id":"C2609071","alternate_names":[],"name":"Palmoplantar keratoderma, mutilating, with periorificial keratotic plaques","id":"16887","alternate_symbols":["OLMS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"614594\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"659\"}","{\"db\":\"OMIM\",\"id\":\"614594\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"OLMS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Olmsted+syndrome/5353\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614594\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SIDBA2","medgen_id":"C4225425","alternate_names":["Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive"],"name":"Anemia, sideroblastic, 2, pyridoxine-refractory","id":"309","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"205950\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"260305\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Sideroblastic+anemia+pyridoxine-refractory+autosomal+recessive/6596\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive\"}","{\"db\":\"OMIM\",\"id\":\"205950\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Baraitser-Winter syndrome is a condition that affects the development of many parts of the body, particularly the face and the brain.An unusual facial appearance is the most common characteristic of Baraitser-Winter syndrome. Distinctive facial features can include widely spaced eyes (hypertelorism), large eyelid openings, droopy eyelids (ptosis), high-arched eyebrows, a broad nasal bridge and tip of the nose, a long space between the nose and upper lip (philtrum), full cheeks, and a pointed chin.Structural brain abnormalities are also present in most people with Baraitser-Winter syndrome. These abnormalities are related to impaired neuronal migration, a process by which nerve cells (neurons) move to their proper positions in the developing brain. The most frequent brain abnormality associated with Baraitser-Winter syndrome is pachygyria, which is an area of the brain that has an abnormally smooth surface with fewer folds and grooves. Less commonly, affected individuals have lissencephaly, which is similar to pachygyria but involves the entire brain surface. These structural changes can cause mild to severe intellectual disability, developmental delay, and seizures.Other features of Baraitser-Winter syndrome can include short stature, ear abnormalities and hearing loss, heart defects, presence of an extra (duplicated) thumb, and abnormalities of the kidneys and urinary system. Some affected individuals have limited movement of large joints, such as the elbows and knees, which may be present at birth or develop over time. Rarely, people with Baraitser-Winter syndrome have involuntary muscle tensing (dystonia).","medgen_id":"C1853623","alternate_names":["CEREBROOCULOFACIAL LYMPHATIC SYNDROME","CHROMOSOME 7p22 DELETION SYNDROME","COFL SYNDROME","Fryns-Aftimos syndrome","MENTAL RETARDATION WITH EPILEPSY AND CHARACTERISTIC FACIES","PACHYGYRIA, MENTAL RETARDATION, EPILEPSY, AND CHARACTERISTIC FACIES"],"name":"Baraitser-Winter syndrome","id":"40721","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS243310\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2995\"}","{\"db\":\"OMIM\",\"id\":\"606155\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBROOCULOFACIAL LYMPHATIC SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"243310\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHROMOSOME 7p22 DELETION SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"606155\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COFL SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"606155\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION WITH EPILEPSY AND CHARACTERISTIC FACIES\"}","{\"db\":\"OMIM\",\"id\":\"606155\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PACHYGYRIA, MENTAL RETARDATION, EPILEPSY, AND CHARACTERISTIC FACIES\"}","{\"db\":\"OMIM\",\"id\":\"PS243310\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"702410002\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"baraitser-winter-syndrome\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1861063","alternate_names":["CIGARETTE HABITUATION, SUSCEPTIBILITY TO","NICOTINE DEPENDENCE, SUSCEPTIBILITY TO"],"name":"Tobacco addiction, susceptibility to","id":"6058","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"188890\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"188890\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CIGARETTE HABITUATION, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"188890\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NICOTINE DEPENDENCE, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"607340.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NICOTINE DEPENDENCE, SUSCEPTIBILITY TO\"}","{\"db\":\"OMIM\",\"id\":\"607340.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NICOTINE DEPENDENCE, SUSCEPTIBILITY TO\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Tobacco+addiction%2C+susceptibility+to/9410\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0020502","alternate_names":["Elevated blood parathyroid hormone level"],"name":"Hyperparathyroidism","id":"32370","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000843\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS145000\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"181408\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000843\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Elevated blood parathyroid hormone level\"}","{\"db\":\"CSER _CC_NCGL, University of Washington\",\"id\":\"UWMG_3863240\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000843\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS145000\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C3665333","alternate_names":["Keratitis-Ichthyosis-Deafness Syndrome"],"name":"Keratitis ichthyosis and deafness syndrome","id":"36542","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS148210\",\"type\":\"Phenotypic series\"}","{\"db\":\"SNOMED CT\",\"id\":\"239059004\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"GACR","medgen_id":"C0599035","alternate_names":["Gyrate atrophy of choroid and retina","High blood ornithine levels"],"name":"Ornithine aminotransferase deficiency","id":"1408","alternate_symbols":["HOGA"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012026\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"258870\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"414\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6556\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Gyrate atrophy of choroid and retina\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012026\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"High blood ornithine levels\"}","{\"db\":\"OMIM\",\"id\":\"258870\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HOGA\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6556\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HOGA\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Ornithine+aminotransferase+deficiency/5411\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6556\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"276426004\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"258870\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"STHAG4","medgen_id":"C1835492","alternate_names":["LATERAL INCISORS, ABSENCE OF","LATERAL INCISORS, PEGGED OR MISSING","TOOTH AGENESIS, SELECTIVE, 4, WITH OR WITHOUT ECTODERMAL DYSPLASIA"],"name":"Tooth agenesis, selective, 4","disease_mechanism":"loss of function","id":"6064","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"150400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"99798\"}","{\"db\":\"OMIM\",\"id\":\"150400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LATERAL INCISORS, ABSENCE OF\"}","{\"db\":\"OMIM\",\"id\":\"150400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LATERAL INCISORS, PEGGED OR MISSING\"}","{\"db\":\"OMIM\",\"id\":\"150400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"TOOTH AGENESIS, SELECTIVE, 4, WITH OR WITHOUT ECTODERMAL DYSPLASIA\"}","{\"db\":\"OMIM\",\"id\":\"606268.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"TOOTH AGENESIS, SELECTIVE, 4, WITH OR WITHOUT ECTODERMAL DYSPLASIA\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332541\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Tooth+agenesis%2C+selective%2C+4/9413\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"150400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SLSN","medgen_id":"C0403553","alternate_names":["Senior-Loken syndrome"],"name":"Renal dysplasia and retinal aplasia","id":"16589","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS266900\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"3156\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"322\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Senior-Loken syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Senior+Loken+Syndrome/6501\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"236531005\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PAGEN1","public_definition":"Permanent neonatal diabetes mellitus is a type of diabetes that first appears within the first 6 months of life and persists throughout the lifespan. This form of diabetes is characterized by high blood sugar levels (hyperglycemia) resulting from a shortage of the hormone insulin. Insulin controls how much glucose (a type of sugar) is passed from the blood into cells for conversion to energy.Individuals with permanent neonatal diabetes mellitus experience slow growth before birth (intrauterine growth retardation). Affected infants have hyperglycemia and an excessive loss of fluids (dehydration) and are unable to gain weight and grow at the expected rate (failure to thrive).In some cases, people with permanent neonatal diabetes mellitus also have certain neurological problems, including developmental delay and recurrent seizures (epilepsy). This combination of developmental delay, epilepsy, and neonatal diabetes is called DEND syndrome. Intermediate DEND syndrome is a similar combination but with milder developmental delay and without epilepsy.A small number of individuals with permanent neonatal diabetes mellitus have an underdeveloped pancreas. Because the pancreas produces digestive enzymes as well as secreting insulin and other hormones, affected individuals experience digestive problems such as fatty stools and an inability to absorb fat-soluble vitamins.","medgen_id":"C3891828","alternate_names":["PANCREATIC HYPOPLASIA, CONGENITAL","Pancreatic agenesis, congenital"],"name":"Pancreatic agenesis 1","id":"3259","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"260370\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2805\"}","{\"db\":\"OMIM\",\"id\":\"260370\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PANCREATIC HYPOPLASIA, CONGENITAL\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pancreatic+agenesis%2C+congenital/9067\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pancreatic agenesis, congenital\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"permanent-neonatal-diabetes-mellitus\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"260370\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0032461","alternate_names":["Abnormally shaped erythrocytes","Polycythaemia","Polyglobulia"],"name":"Polycythemia","id":"32378","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001893\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001901\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"98427\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001901\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormally shaped erythrocytes\"}","{\"db\":\"CSER _CC_NCGL, University of Washington\",\"id\":\"UWMG_3693758\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Polycythaemia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001901\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Polyglobulia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001901\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Anauxetic dysplasia is a disorder characterized by extremely short stature (dwarfism) and other skeletal abnormalities, an unusually large range of joint movement (hypermobility), dental problems, and distinctive facial features. Mild intellectual disability can also occur in this disorder.People with anauxetic dysplasia have dwarfism with unusually short limbs for their height (disproportionate short stature) beginning before birth. Dislocation of the bones at the top of the spine (atlantoaxial subluxation) can also occur in this disorder, and may cause pinching (compression) of the spinal cord. As a result, affected individuals may experience neurological symptoms including pain, tingling, numbness, coordination problems, weakness, and paralysis. In severe cases, the spinal cord compression may lead to paralysis of the muscles needed for breathing, which can be life-threatening during early childhood.Other skeletal abnormalities in anauxetic dysplasia include a barrel-shaped chest and a rounded upper back that also curves to the side (kyphoscoliosis). Without surgical correction, the kyphoscoliosis can constrict the lungs and cause difficulty breathing. People with anauxetic dysplasia can also have an exaggerated curvature of the lower back (hyperlordosis), dislocation of the hips, and soles of the feet that are rounded outward (rocker-bottom feet).Typical facial features in anauxetic dysplasia include closely spaced eyes (hypotelorism), a flat or sunken appearance of the middle of the face (midface hypoplasia), an unusually large tongue (macroglossia), and a protruding chin (prognathism). Affected individuals can also have fewer teeth than normal (hypodontia).","medgen_id":"C1846796","alternate_names":["SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ANAUXETIC TYPE","SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE"],"name":"Anauxetic dysplasia","id":"37896","alternate_symbols":["ANXD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS607095\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"93347\"}","{\"db\":\"OMIM\",\"id\":\"607095\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, ANAUXETIC TYPE\"}","{\"db\":\"OMIM\",\"id\":\"607095\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE\"}","{\"db\":\"OMIM\",\"id\":\"607095\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ANXD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Anauxetic+Dysplasia/425\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS607095\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9657\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"anauxetic-dysplasia\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LORD","medgen_id":"C1854065","alternate_names":["RETINAL DEGENERATION, LATE-ONSET, AUTOSOMAL DOMINANT"],"name":"Late-onset retinal degeneration","disease_mechanism":"loss of function","id":"2540","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"605670\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"67042\"}","{\"db\":\"OMIM\",\"id\":\"605670\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RETINAL DEGENERATION, LATE-ONSET, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"608752.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RETINAL DEGENERATION, LATE-ONSET, AUTOSOMAL DOMINANT\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515794\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000553865\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Late-onset+retinal+degeneration/8718\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"605670\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":["Neoplasm"],"symbol":"NTD","medgen_id":"C3891448","alternate_names":["Abnormality of neural tube closure","Neural tube defects"],"name":"Neural tube defect","id":"3168","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0045005\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"182940\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3388\"}","{\"db\":\"Orphanet\",\"id\":\"823\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0045005\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormality of neural tube closure\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Neural+tube+defects/8992\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0045005\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"253098009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"182940\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1862839","alternate_names":["Anterior chamber cleavage defect","Anterior chamber cleavage disorder","Anterior chamber malformation","Anterior chamber mesodermal anomalies","Anterior segment mesencyhmal dysgenesis","Anterior segment ocular dysgenesis"],"name":"Anterior segment dysgenesis","id":"26347","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007696\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007699\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008040\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS107250\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"88632\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior chamber cleavage defect\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior chamber cleavage disorder\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior chamber malformation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior chamber mesodermal anomalies\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior segment mesencyhmal dysgenesis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anterior segment ocular dysgenesis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007700\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS107250\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Bartter syndrome is a group of very similar kidney disorders that cause an imbalance of potassium, sodium, chloride, and related molecules in the body.In some cases, Bartter syndrome becomes apparent before birth. The disorder can cause polyhydramnios, which is an increased volume of fluid surrounding the fetus (amniotic fluid). Polyhydramnios increases the risk of premature birth.Beginning in infancy, affected individuals often fail to grow and gain weight at the expected rate (failure to thrive). They lose excess amounts of salt (sodium chloride) in their urine, which leads to dehydration, constipation, and increased urine production (polyuria). In addition, large amounts of calcium are lost through the urine (hypercalciuria), which can cause weakening of the bones (osteopenia). Some of the calcium is deposited in the kidneys as they are concentrating urine, leading to hardening of the kidney tissue (nephrocalcinosis). Bartter syndrome is also characterized by low levels of potassium in the blood (hypokalemia), which can result in muscle weakness, cramping, and fatigue. Rarely, affected children develop hearing loss caused by abnormalities in the inner ear (sensorineural deafness).Two major forms of Bartter syndrome are distinguished by their age of onset and severity. One form begins before birth (antenatal) and is often life-threatening. The other form, often called the classical form, begins in early childhood and tends to be less severe. Once the genetic causes of Bartter syndrome were identified, researchers also split the disorder into different types based on the genes involved. Types I, II, and IV have the features of antenatal Bartter syndrome. Because type IV is also associated with hearing loss, it is sometimes called antenatal Bartter syndrome with sensorineural deafness. Type III usually has the features of classical Bartter syndrome.","medgen_id":"C0004775","alternate_names":["Bartter's syndrome"],"name":"Bartter syndrome","id":"6253","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS601678\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"112\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Bartter%27s+Syndrome/750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Bartter's syndrome\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"bartter-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS601678\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5893\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"bartter-syndrome\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"TTP","medgen_id":"C1268935","alternate_names":["Congenital Thrombotic Thrombocytopenic Purpura","Moschkowitz Disease"],"name":"Upshaw-Schulman syndrome","id":"4264","alternate_symbols":["USS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"274150\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"93583\"}","{\"db\":\"OMIM\",\"id\":\"274150\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"USS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9430\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"USS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Thrombotic+thrombocytopenic+purpura%2C+congenital/7089\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9430\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"373420004\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"274150\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":["Neoplasm"],"symbol":"MASTC","medgen_id":"C0024899","alternate_names":["MASTOCYTOSIS, CUTANEOUS","MASTOCYTOSIS, DIFFUSE CUTANEOUS","MASTOCYTOSIS, MACULOPAPULAR CUTANEOUS"],"name":"Mastocytosis","id":"2826","alternate_symbols":["KIT","SMCD"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100495\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"154800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98292\"}","{\"db\":\"OMIM\",\"id\":\"154800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MASTOCYTOSIS, CUTANEOUS\"}","{\"db\":\"OMIM\",\"id\":\"154800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MASTOCYTOSIS, DIFFUSE CUTANEOUS\"}","{\"db\":\"OMIM\",\"id\":\"154800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MASTOCYTOSIS, MACULOPAPULAR CUTANEOUS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mast+cell+disease/4494\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100495\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6987\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"154800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CHNG1","medgen_id":"C3493776","alternate_names":["HYPOTHYROIDISM DUE TO UNRESPONSIVENESS TO THYROTROPIN","HYPOTHYROIDISM, CONGENITAL, DUE TO TSH RESISTANCE","HYPOTHYROIDISM, NONAUTOIMMUNE","THYROID-STIMULATING HORMONE, RESISTANCE TO","THYROTROPIN RESISTANCE","TSH RESISTANCE"],"name":"Hypothyroidism, congenital, nongoitrous, 1","id":"15913","alternate_symbols":["RTSH"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"275200\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"90673\"}","{\"db\":\"OMIM\",\"id\":\"275200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM DUE TO UNRESPONSIVENESS TO THYROTROPIN\"}","{\"db\":\"OMIM\",\"id\":\"275200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM, CONGENITAL, DUE TO TSH RESISTANCE\"}","{\"db\":\"OMIM\",\"id\":\"275200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTHYROIDISM, NONAUTOIMMUNE\"}","{\"db\":\"OMIM\",\"id\":\"275200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THYROID-STIMULATING HORMONE, RESISTANCE TO\"}","{\"db\":\"OMIM\",\"id\":\"275200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THYROTROPIN RESISTANCE\"}","{\"db\":\"OMIM\",\"id\":\"275200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"TSH RESISTANCE\"}","{\"db\":\"OMIM\",\"id\":\"275200\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"RTSH\"}","{\"db\":\"OMIM\",\"id\":\"275200\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"CN160484","alternate_names":[],"name":"Auriculocondylar syndrome","id":"17461","alternate_symbols":["ACS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS602483\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"137888\"}","{\"db\":\"OMIM\",\"id\":\"PS602483\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CVD1","medgen_id":"C0268341","alternate_names":["EDS V","EHLERS-DANLOS SYNDROME, TYPE V","Ehlers-Danlos syndrome, type 5"],"name":"Cardiac valvular dysplasia, X-linked","id":"711","alternate_symbols":["EDS5","XMVD"],"ghr_links":"Ehlers-Danlos syndrome","type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"314400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1864\"}","{\"db\":\"Orphanet\",\"id\":\"75497\"}","{\"db\":\"OMIM\",\"id\":\"305200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EDS V\"}","{\"db\":\"OMIM\",\"id\":\"305200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, TYPE V\"}","{\"db\":\"OMIM\",\"id\":\"314400\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EHLERS-DANLOS SYNDROME, TYPE V\"}","{\"db\":\"SNOMED CT\",\"id\":\"67202007\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ehlers-Danlos syndrome, type 5\"}","{\"db\":\"OMIM\",\"id\":\"305200\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EDS5\"}","{\"db\":\"OMIM\",\"id\":\"314400\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EDS5\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8505\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EDS5\"}","{\"db\":\"OMIM\",\"id\":\"314400\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XMVD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1096\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XMVD\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"ehlers-danlos-syndrome\",\"ref_field\":\"ghr_links\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cardiac+Valvular+Dysplasia%2C+X-Linked/1082\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1096\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"314400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1096\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PDHC","medgen_id":"C0034345","alternate_names":["PDH DEFICIENCY","Pyruvate Dehydrogenase Complex Deficiency Disease"],"name":"Pyruvate dehydrogenase complex deficiency","id":"3569","alternate_symbols":["PDHAD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS312170\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"765\"}","{\"db\":\"Orphanet\",\"id\":\"79243\"}","{\"db\":\"OMIM\",\"id\":\"312170\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PDH DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"312170\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PDHAD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pyruvate+dehydrogenase+deficiency/6122\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS312170\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7513\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"46683007\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7513\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0158683","alternate_names":["Congenital cystic disease of liver"],"name":"Polycystic liver disease","id":"25675","alternate_symbols":["PCLD"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006557\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS174050\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2924\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Congenital+cystic+disease+of+liver/8049\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital cystic disease of liver\"}","{\"db\":\"SNOMED CT\",\"id\":\"72925005\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital cystic disease of liver\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9457\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PCLD\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006557\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS174050\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0410179","alternate_names":["MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 22","Ullrich muscular dystrophy"],"name":"Ullrich congenital muscular dystrophy","id":"36275","alternate_symbols":["LGMDR22","UCMD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS254090\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"75840\"}","{\"db\":\"OMIM\",\"id\":\"254090\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 22\"}","{\"db\":\"OMIM\",\"id\":\"254090\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LGMDR22\"}","{\"db\":\"OMIM\",\"id\":\"254090\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"UCMD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4769\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"UCMD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Scleroatonic+muscular+dystrophy/6457\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS254090\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4769\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"240062007\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"CN240835","alternate_names":[],"name":"Mental retardation, autosomal dominant","id":"37032","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS156200\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"PS156200\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"OCA6","medgen_id":"C3805375","alternate_names":["SKIN/HAIR/EYE PIGMENTATION 4, FAIR/DARK SKIN"],"name":"Skin/hair/eye pigmentation, variation in, 4","id":"5922","alternate_symbols":["SHEP4"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"113750\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"370097\"}","{\"db\":\"OMIM\",\"id\":\"113750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SKIN/HAIR/EYE PIGMENTATION 4, FAIR/DARK SKIN\"}","{\"db\":\"OMIM\",\"id\":\"609802.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SKIN/HAIR/EYE PIGMENTATION 4, FAIR/DARK SKIN\"}","{\"db\":\"OMIM\",\"id\":\"113750\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SHEP4\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Skin-hair-eye+pigmentation%2C+variation+in%2C+4/9308\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"113750\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MGA1","medgen_id":"C4551825","alternate_names":["MEGALOBLASTIC ANEMIA 1"],"name":"Megaloblastic anemia due to inborn errors of metabolism","id":"2837","alternate_symbols":["IGS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"261100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"35858\"}","{\"db\":\"OMIM\",\"id\":\"261100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEGALOBLASTIC ANEMIA 1\"}","{\"db\":\"OMIM\",\"id\":\"605799.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MEGALOBLASTIC ANEMIA 1\"}","{\"db\":\"OMIM\",\"id\":\"261100\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IGS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Megaloblastic+anemia+due+to+inborn+errors+of+metabolism/8803\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"34925000\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"250950\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"OMIM\",\"id\":\"261100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7006\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"IMD25","medgen_id":"C1857798","alternate_names":["IMMUNODEFICIENCY 25","Immunodeficiency due to defect in cd3-zeta, somatic"],"name":"Immunodeficiency due to defect in cd3-zeta","id":"5325","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"610163\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"610163\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"IMMUNODEFICIENCY 25\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Immunodeficiency+due+to+defect+in+cd3-zeta/8643\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"610163\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"FADS1","medgen_id":"C1276035","alternate_names":["FETAL AKINESIA DEFORMATION SEQUENCE 1"],"name":"Pena-Shokeir syndrome type I","id":"1806","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"208150\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"994\"}","{\"db\":\"OMIM\",\"id\":\"208150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FETAL AKINESIA DEFORMATION SEQUENCE 1\"}","{\"db\":\"OMIM\",\"id\":\"601296.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FETAL AKINESIA DEFORMATION SEQUENCE 1\"}","{\"db\":\"OMIM\",\"id\":\"601296.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FETAL AKINESIA DEFORMATION SEQUENCE 1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pena+Shokeir+syndrome%2C+type+1/5655\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"401138005\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"208150\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SCD","medgen_id":"C0085298","alternate_names":["Premature sudden cardiac death","Sudden adult death syndrome"],"name":"Sudden cardiac death","id":"16308","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"EFO\",\"id\":\"EFO_0004278\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001645\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005161\",\"type\":\"secondary\"}","{\"db\":\"MeSH\",\"id\":\"D016757\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001645\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Premature sudden cardiac death\"}","{\"db\":\"EFO\",\"id\":\"EFO_0004278\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Sudden adult death syndrome\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001645\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"95281009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115080\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Centronuclear myopathy is a condition characterized by muscle weakness (myopathy) and wasting (atrophy) in the skeletal muscles, which are the muscles used for movement. The severity of centronuclear myopathy varies among affected individuals, even among members of the same family.People with centronuclear myopathy begin experiencing muscle weakness at any time from birth to early adulthood. The muscle weakness slowly worsens over time and can lead to delayed development of motor skills, such as crawling or walking; muscle pain during exercise; and difficulty walking. Some affected individuals may need wheelchair assistance as the muscles atrophy and weakness becomes more severe. In rare instances, the muscle weakness improves over time.Some people with centronuclear myopathy experience mild to severe breathing problems related to the weakness of muscles needed for breathing. People with centronuclear myopathy may have droopy eyelids (ptosis) and weakness in other facial muscles, including the muscles that control eye movement. People with this condition may also have foot abnormalities, a high arch in the roof of the mouth (high-arched palate), and abnormal side-to-side curvature of the spine (scoliosis). Rarely, individuals with centronuclear myopathy have a weakened heart muscle (cardiomyopathy), disturbances in nerve function (neuropathy), or intellectual disability.A key feature of centronuclear myopathy is the displacement of the nucleus in muscle cells, which can be viewed under a microscope. Normally the nucleus is found at the edges of the rod-shaped muscle cells, but in people with centronuclear myopathy the nucleus is located in the center of these cells. How the change in location of the nucleus affects muscle cell function is unknown.","medgen_id":"CN221282","alternate_names":[],"name":"Myopathy, centronuclear","id":"32291","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS160150\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"PS160150\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"centronuclear-myopathy\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1956257","alternate_names":["Narrowing of pulmonic valve","Pulmonary stenosis","Pulmonic valve stenosis"],"name":"Pulmonic stenosis","id":"4067","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001642\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"265500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3189\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001642\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Narrowing of pulmonic valve\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001642\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pulmonary stenosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001642\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pulmonic valve stenosis\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pulmonic+stenosis/6100\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001642\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10071\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SOTOS","public_definition":"Sotos syndrome is a disorder characterized by a distinctive facial appearance, overgrowth in childhood, and learning disabilities or delayed development of mental and movement abilities. Characteristic facial features include a long, narrow face; a high forehead; flushed (reddened) cheeks; and a small, pointed chin. In addition, the outside corners of the eyes may point downward (down-slanting palpebral fissures). This facial appearance is most notable in early childhood. Affected infants and children tend to grow quickly; they are significantly taller than their siblings and peers and have an unusually large head. However, adult height is usually in the normal range.People with Sotos syndrome often have intellectual disability, and most also have behavioral problems. Frequent behavioral issues include attention-deficit/hyperactivity disorder (ADHD), phobias, obsessions and compulsions, tantrums, and impulsive behaviors. Problems with speech and language are also common. Affected individuals often have a stutter, a monotone voice, and problems with sound production. Additionally, weak muscle tone (hypotonia) may delay other aspects of early development, particularly motor skills such as sitting and crawling.Other signs and symptoms of Sotos syndrome can include an abnormal side-to-side curvature of the spine (scoliosis), seizures, heart or kidney defects, hearing loss, and problems with vision. Some infants with this disorder experience yellowing of the skin and whites of the eyes (jaundice) and poor feeding.A small percentage of people with Sotos syndrome have developed cancer, most often in childhood, but no single form of cancer occurs most frequently with this condition. It remains uncertain whether Sotos syndrome increases the risk of specific types of cancer. If people with this disorder have an increased cancer risk, it is only slightly greater than that of the general population.","medgen_id":"C0175695","alternate_names":["Sotos' syndrome"],"name":"Sotos syndrome","id":"36672","alternate_symbols":["SOTOS1"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS117550\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"821\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Sotos+syndrome/6665\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Sotos' syndrome\"}","{\"db\":\"SNOMED CT\",\"id\":\"75968004\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Sotos' syndrome\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000525320\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SOTOS1\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"sotos-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS117550\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10091\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"sotos-syndrome\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CTRCT21","medgen_id":"C3888097","alternate_names":["CATARACT 21, CERULEAN, WITH OR WITHOUT MICROCORNEA","CATARACT 21, MULTIPLE TYPES, WITH MICROCORNEA","CATARACT 21, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA","Cataract, pulverulent, juvenile-onset"],"name":"Cataract 21, multiple types","id":"4752","alternate_symbols":["CCA4"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"610202\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91492\"}","{\"db\":\"OMIM\",\"id\":\"177075.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 21, CERULEAN, WITH OR WITHOUT MICROCORNEA\"}","{\"db\":\"OMIM\",\"id\":\"177075.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 21, MULTIPLE TYPES, WITH MICROCORNEA\"}","{\"db\":\"OMIM\",\"id\":\"177075.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 21, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA\"}","{\"db\":\"OMIM\",\"id\":\"177075.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 21, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA\"}","{\"db\":\"OMIM\",\"id\":\"610202\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 21, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cataract%2C+pulverulent%2C+juvenile-onset/7925\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cataract, pulverulent, juvenile-onset\"}","{\"db\":\"OMIM\",\"id\":\"610202\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CCA4\"}","{\"db\":\"OMIM\",\"id\":\"610202\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SPD1","medgen_id":"C2699746","alternate_names":["Syndactyly type 2","Syndactyly, type II"],"name":"Synpolydactyly 1","id":"6307","alternate_symbols":["SDTY2","SPD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"186000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"93403\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Syndactyly+type+2/6957\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Syndactyly type 2\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5087\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SPD\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CAKUT","public_definition":"Congenital anomalies of kidney and urinary tract (CAKUT) is a group of abnormalities affecting the kidneys or other structures of the urinary tract. The additional parts of the urinary tract that may be affected include the bladder, the tubes that carry urine from each kidney to the bladder (the ureters), and the tube that carries urine from the bladder out of the body (the urethra). CAKUT results from abnormal development of the urinary system and is present from birth (congenital), although the abnormality may not become apparent until later in life.Individuals with CAKUT have one or more kidney or urinary tract abnormalities. For paired structures, like the kidneys and ureters, one or both may be affected. Many different developmental abnormalities are classified as CAKUT, including underdevelopment or absence of a kidney (renal hypodysplasia or agenesis), a kidney formed of fluid-filled sacs called cysts (multicystic dysplastic kidney), buildup of urine in the kidneys (hydronephrosis), an extra ureter leading to the kidney (duplex kidney or duplicated collecting system), a blockage in a ureter where it joins the kidney (ureteropelvic junction obstruction), an abnormally wide ureter (megaureter), backflow of urine from the bladder into the ureter (vesicoureteral reflux), and an abnormal membrane in the urethra that blocks the flow of urine out of the bladder (posterior urethral valve).CAKUT varies in severity. The abnormalities can result in recurrent urinary tract infections or a buildup of urine in the urinary tract, which may damage the kidneys or other structures. Severe CAKUT can result in life-threatening kidney failure and end-stage renal disease.CAKUT is often one of several features of a condition that affects multiple body systems (syndromic CAKUT). For example, renal coloboma syndrome, 17q12 deletion syndrome, renal cysts and diabetes (RCAD) syndrome, Fraser syndrome, Townes-Brocks syndrome, and branchio-oto-renal syndrome can cause kidney or urinary tract abnormalities in addition to other problems. However, urinary system abnormalities sometimes occur without other signs and symptoms, which is known as nonsyndromic or isolated CAKUT.","medgen_id":"C1968949","alternate_names":[],"name":"Congenital anomalies of kidney and urinary tract","id":"34805","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS610805\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"93545\"}","{\"db\":\"OMIM\",\"id\":\"PS610805\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"congenital-anomalies-of-kidney-and-urinary-tract\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Heterotaxy syndrome is a condition in which the internal organs are abnormally arranged in the chest and abdomen. The term \"heterotaxy\" is from the Greek words \"heteros,\" meaning \"other than,\" and \"taxis,\" meaning \"arrangement.\" Individuals with this condition have complex birth defects affecting the heart, lungs, liver, spleen, intestines, and other organs.In the normal body, most of the organs in the chest and abdomen have a particular location on the right or left side. For example, the heart, spleen, and pancreas are on the left side of the body, and most of the liver is on the right. This normal arrangement of the organs is known as \"situs solitus.\" Rarely, the orientation of the internal organs is completely flipped from right to left, a situation known as \"situs inversus.\" This mirror-image orientation usually does not cause any health problems, unless it occurs as part of a syndrome affecting other parts of the body. Heterotaxy syndrome is an arrangement of internal organs somewhere between situs solitus and situs inversus; this condition is also known as \"situs ambiguus.\" Unlike situs inversus, the abnormal arrangement of organs in heterotaxy syndrome often causes serious health problems.Heterotaxy syndrome can alter the structure of the heart, including the attachment of the large blood vessels that carry blood to and from the rest of the body. It can also affect the structure of the lungs, such as the number of lobes in each lung and the length of the tubes (called bronchi) that lead from the windpipe to the lungs. In the abdomen, the condition can cause a person to have no spleen (asplenia) or multiple small, poorly functioning spleens (polysplenia). The liver may lie across the middle of the body instead of being in its normal position to the right of the stomach. Some affected individuals also have intestinal malrotation, which is an abnormal twisting of the intestines that occurs in the early stages of development before birth.Depending on the organs involved, signs and symptoms of heterotaxy syndrome can include a bluish appearance of the skin or lips (cyanosis, which is due to a shortage of oxygen), breathing difficulties, an increased risk of infections, and problems with digesting food. The most serious complications are generally caused by critical congenital heart disease, a group of complex heart defects that are present from birth. Biliary atresia, a problem with the bile ducts in the liver, can also cause severe health problems in infancy.The severity of heterotaxy syndrome varies depending on the specific abnormalities involved. Some affected individuals have only mild health problems related to the condition. At the other end of the spectrum, heterotaxy syndrome can be life-threatening in infancy or childhood, even with treatment.","medgen_id":"C3178805","alternate_names":["Heterotaxy syndrome"],"name":"Heterotaxia","id":"16650","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030853\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"450\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030853\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"450\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"heterotaxy-syndrome\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"POBINDS","medgen_id":"CN263151","alternate_names":[],"name":"POIRIER-BIENVENU NEURODEVELOPMENTAL SYNDROME","id":"43281","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"618732\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"115441.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"115441.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618732\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618732\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":["Hereditary cancer syndrome","Neoplasm"],"symbol":"CVID2","public_definition":"Common variable immune deficiency (CVID) is a disorder that impairs the immune system. People with CVID are highly susceptible to infection from foreign invaders such as bacteria, or more rarely, viruses and often develop recurrent infections, particularly in the lungs, sinuses, and ears. Pneumonia is common in people with CVID. Over time, recurrent infections can lead to chronic lung disease. Affected individuals may also experience infection or inflammation of the gastrointestinal tract, which can cause diarrhea and weight loss. Abnormal accumulation of immune cells causes enlarged lymph nodes (lymphadenopathy) or an enlarged spleen (splenomegaly) in some people with CVID. Immune cells can accumulate in other organs, forming small lumps called granulomas.Approximately 25 percent of people with CVID have an autoimmune disorder, which occurs when the immune system malfunctions and attacks the body's tissues and organs. The blood cells are most frequently affected by autoimmune attacks in CVID; the most commonly occurring autoimmune disorders are immune thrombocytopenia, which is an abnormal bleeding disorder caused by a decrease in cells involved in blood clotting called platelets, and autoimmune hemolytic anemia, which results in premature destruction of red blood cells. Other autoimmune disorders such as rheumatoid arthritis can occur. Individuals with CVID also have a greater than normal risk of developing certain types of cancer, including a cancer of immune system cells called non-Hodgkin lymphoma and less frequently, stomach (gastric) cancer.People with CVID may start experiencing signs and symptoms of the disorder anytime between childhood and adulthood; most people with CVID are diagnosed in their twenties or thirties. The life expectancy of individuals with CVID varies depending on the severity and frequency of illnesses they experience. Most people with CVID live into adulthood.There are many different types of CVID that are distinguished by genetic cause. People with the same type of CVID may have varying signs and symptoms.","medgen_id":"C3150354","alternate_names":["ANTIBODY DEFICIENCY DUE TO TACI DEFECT","HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY"],"name":"Common variable immunodeficiency 2","id":"5329","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"240500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1572\"}","{\"db\":\"OMIM\",\"id\":\"240500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANTIBODY DEFICIENCY DUE TO TACI DEFECT\"}","{\"db\":\"OMIM\",\"id\":\"240500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOGAMMAGLOBULINEMIA DUE TO TACI DEFICIENCY\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"common-variable-immune-deficiency\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"240500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CNM","mode_of_inheritance":"All","medgen_id":"C0175709","alternate_names":[],"name":"Myotubular myopathy","id":"14948","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Orphanet\",\"id\":\"595\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000016534\",\"ref_field\":\"mode_of_inheritance\"}","{\"db\":\"SNOMED CT\",\"id\":\"82077006\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000016534\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Narcolepsy is a chronic sleep disorder that disrupts the normal sleep-wake cycle. Although this condition can appear at any age, it most often begins in adolescence.Narcolepsy is characterized by excessive daytime sleepiness. Affected individuals feel tired during the day, and several times a day they may experience an overwhelming urge to sleep. \"Sleep attacks\" can occur at unusual times, such as during a meal or in the middle of a conversation. They last from a few seconds to a few minutes and often lead to a longer nap, after which affected individuals wake up feeling refreshed.Another common feature of narcolepsy is cataplexy, which is a sudden loss of muscle tone in response to strong emotion (such as laughing, surprise, or anger). These episodes of muscle weakness can cause an affected person to slump over or fall, which occasionally leads to injury. Episodes of cataplexy usually last just a few seconds, and they may occur from several times a day to a few times a year. Most people diagnosed with narcolepsy also have cataplexy. However, some do not, which has led researchers to distinguish two major forms of the condition: narcolepsy with cataplexy and narcolepsy without cataplexy.Narcolepsy also affects nighttime sleep. Most affected individuals have trouble sleeping for more than a few hours at night. They often experience vivid hallucinations while falling asleep (hypnogogic hallucinations) or while waking up (hypnopompic hallucinations). Affected individuals often have realistic and distressing dreams, and they may act out their dreams by moving excessively or talking in their sleep. Many people with narcolepsy also experience sleep paralysis, which is an inability to move or speak for a short period while falling asleep or awakening. The combination of hallucinations, vivid dreams, and sleep paralysis is often frightening and unpleasant for affected individuals.Some people with narcolepsy have all of the major features of the disorder, while others have only one or two. Most of the signs and symptoms persist throughout life, although episodes of cataplexy may become less frequent with age and treatment.","medgen_id":"C0751362","alternate_names":[],"name":"Cataplexy and narcolepsy","id":"32725","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS161400\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2073\"}","{\"db\":\"SNOMED CT\",\"id\":\"193042000\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"narcolepsy\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0026760","alternate_names":[],"name":"Multiple epiphyseal dysplasia","id":"23227","alternate_symbols":["EDM","MED"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002654\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS132400\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"251\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10756\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EDM\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10756\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MED\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002654\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10756\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ACRDYS1","medgen_id":"C0220659","alternate_names":[],"name":"Acrodysostosis","id":"33120","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS101800\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"950\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Acrodysostosis/145\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS101800\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5724\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"66758006\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0013575","alternate_names":[],"name":"Ectodermal dysplasia","id":"32994","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000968\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007615\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS305100\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"79373\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Ectodermal+Dysplasia/2437\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000968\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6317\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"8654005\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SEMDJL3","medgen_id":"C5193073","alternate_names":[],"name":"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3","id":"41592","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"618395\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"607880.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607880.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618395\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618395\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CPHD","public_definition":"Combined pituitary hormone deficiency is a condition that causes a shortage (deficiency) of several hormones produced by the pituitary gland, which is located at the base of the brain. A lack of these hormones may affect the development of many parts of the body. The first signs of this condition include a failure to grow at the expected rate and short stature that usually becomes apparent in early childhood.People with combined pituitary hormone deficiency may have hypothyroidism, which is underactivity of the butterfly-shaped thyroid gland in the lower neck. Hypothyroidism can cause many symptoms, including weight gain and fatigue. Other features of combined pituitary hormone deficiency include delayed or absent puberty and lack the ability to have biological children (infertility). The condition can also be associated with a deficiency of the hormone cortisol. Cortisol deficiency can impair the body's immune system, causing individuals to be more susceptible to infection.Rarely, people with combined pituitary hormone deficiency have intellectual disability; a short, stiff neck; or underdeveloped optic nerves, which carry visual information from the eyes to the brain.","medgen_id":"CN078207","alternate_names":[],"name":"Pituitary hormone deficiency, combined","id":"16503","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS613038\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"95494\"}","{\"db\":\"OMIM\",\"id\":\"PS613038\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"combined-pituitary-hormone-deficiency\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ATOD","medgen_id":"C0011615","alternate_names":["Atopic dermatitis, chronic","Baby eczema"],"name":"Dermatitis, atopic","id":"1956","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001047\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007533\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007564\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"603165\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"PS603165\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001047\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Atopic dermatitis, chronic\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001047\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Baby eczema\"}","{\"db\":\"OMIM\",\"id\":\"PS603165\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"603165\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1852271","alternate_names":[],"name":"Auditory neuropathy","id":"6403","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS609129\",\"type\":\"Phenotypic series\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Auditory+Neuropathy/667\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS609129\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9274\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CPI","medgen_id":"C1837218","alternate_names":[],"name":"Cleft palate, isolated","id":"4813","alternate_symbols":["CP"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"119540\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2014\"}","{\"db\":\"OMIM\",\"id\":\"119540\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CP\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cleft+Palate/1672\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"119540\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ICH","medgen_id":"C3281105","alternate_names":[],"name":"Hemorrhage, intracerebral, susceptibility to","id":"16854","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"614519\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"614519\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CRMCC","medgen_id":"C2677299","alternate_names":["Coats plus syndrome"],"name":"Cerebroretinal microangiopathy with calcifications and cysts","id":"37893","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS612199\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"313838\"}","{\"db\":\"Orphanet\",\"id\":\"313838\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Coats plus syndrome\"}","{\"db\":\"OMIM\",\"id\":\"612199\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LCDD","medgen_id":"C1835612","alternate_names":[],"name":"Lacrimal duct defect","id":"2661","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"149700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"451612\"}","{\"db\":\"OMIM\",\"id\":\"149700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EDSFS","medgen_id":"C1858302","alternate_names":[],"name":"Ectodermal dysplasia skin fragility syndrome","id":"4997","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"604536\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"158668\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Ectodermal+Dysplasia+Skin+Fragility+Syndrome/2453\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9705\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604536\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CMD1S","medgen_id":"C1834481","alternate_names":[],"name":"Dilated cardiomyopathy 1S","id":"6663","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"613426\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"154\"}","{\"db\":\"Orphanet\",\"id\":\"54260\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Dilated+cardiomyopathy+1S/8260\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613426\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":["Neoplasm"],"symbol":"SEMDJL1","medgen_id":"C4017377","alternate_names":["SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1"],"name":"Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures","id":"4195","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"271640\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"93359\"}","{\"db\":\"OMIM\",\"id\":\"615291.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"615291.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"615291.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"615291.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"615291.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"615291.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1\"}","{\"db\":\"OMIM\",\"id\":\"271640\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LPFS3","medgen_id":"C4748863","alternate_names":["CD70 DEFICIENCY"],"name":"LYMPHOPROLIFERATIVE SYNDROME 3","id":"40939","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"618261\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"538958\"}","{\"db\":\"OMIM\",\"id\":\"618261\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CD70 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"602840.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602840.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"602840.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618261\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618261\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C3489726","alternate_names":[],"name":"Geleophysic dysplasia","id":"34565","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS231050\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2623\"}","{\"db\":\"OMIM\",\"id\":\"PS231050\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0022596","alternate_names":["Hyperkeratosis of palms and soles","Hyperkeratosis of the palms and soles","Palmoplantar hyperkeratosis","Palmoplantar keratoses","Palmoplantar keratosis","Thick palms and soles","Thickened palms and soles"],"name":"Hereditary palmoplantar keratoderma","id":"6577","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000972\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000972\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hyperkeratosis of palms and soles\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000972\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hyperkeratosis of the palms and soles\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000972\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Palmoplantar hyperkeratosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000972\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Palmoplantar keratoses\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000972\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Palmoplantar keratosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000972\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thick palms and soles\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000972\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thickened palms and soles\"}","{\"db\":\"SNOMED CT\",\"id\":\"239066003\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"alternate_names":[],"name":"Diencephalic-mesencephalic junction dysplasia syndrome","id":"42507","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS251280\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"PS251280\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Mandibuloacral dysplasia is a condition that causes a variety of abnormalities involving bone development, skin coloring (pigmentation), and fat distribution. People with this condition may grow slowly after birth. Most affected individuals are born with an underdeveloped lower jaw bone (mandible) and small collar bones (clavicles), leading to the characteristic features of a small chin and sloped shoulders. Other bone problems include loss of bone from the tips of the fingers (acroosteolysis), which causes bulbous finger tips; delayed closure of certain skull bones; and joint deformities (contractures).People with mandibuloacral dysplasia can have mottled or patchy skin pigmentation or other skin abnormalities. Some people with this condition have features of premature aging (a condition called progeria), such as thin skin, loss of teeth, loss of hair, and a beaked nose. Some individuals with mandibuloacral dysplasia have metabolic problems, such as diabetes.A common feature of mandibuloacral dysplasia is a lack of fatty tissue under the skin (lipodystrophy) in certain regions of the body. The two types of this disorder, mandibuloacral dysplasia with type A lipodystrophy (MADA) and mandibuloacral dysplasia with type B lipodystrophy (MADB) are distinguished by the pattern of fat distribution throughout the body. Type A is described as partial lipodystrophy; affected individuals have a loss of fatty tissue from the torso and limbs, but it may build up around the neck and shoulders. Type B is a generalized lipodystrophy, with loss of fatty tissue in the face, torso, and limbs.MADA usually begins in adulthood, although children can be affected. MADB begins earlier, often just after birth. Many babies with MADB are born prematurely.","medgen_id":"C0432291","alternate_names":["Mandibuloacral dysostosis"],"name":"Mandibuloacral dysplasia","id":"16643","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS248370\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2457\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mandibuloacral+dysostosis/8786\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mandibuloacral dysostosis\"}","{\"db\":\"SNOMED CT\",\"id\":\"109419009\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mandibuloacral dysostosis\"}","{\"db\":\"CSER _CC_NCGL, University of Washington\",\"id\":\"UWMG_2593822\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"mandibuloacral-dysplasia\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EDAID1","medgen_id":"C1846006","alternate_names":["ECTODERMAL DYSPLASIA AND IMMUNE DEFICIENCY 1","ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNE DEFICIENCY","Hypohidrotic ectodermal dysplasia with immune deficiency"],"name":"Ectodermal dysplasia and immunodeficiency 1","id":"1582","alternate_symbols":["HED-ID","HEDID","XHMED"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"300291\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"238468\"}","{\"db\":\"Orphanet\",\"id\":\"98813\"}","{\"db\":\"OMIM\",\"id\":\"300248.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ECTODERMAL DYSPLASIA AND IMMUNE DEFICIENCY 1\"}","{\"db\":\"OMIM\",\"id\":\"300291\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNE DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hypohidrotic+ectodermal+dysplasia+with+immune+deficiency/3657\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypohidrotic ectodermal dysplasia with immune deficiency\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9936\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HED-ID\"}","{\"db\":\"OMIM\",\"id\":\"300291\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HEDID\"}","{\"db\":\"OMIM\",\"id\":\"300291\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XHMED\"}","{\"db\":\"OMIM\",\"id\":\"300291\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"FHBL1","medgen_id":"C4551990","alternate_names":["HYPOBETALIPOPROTEINEMIA, FAMILIAL"],"name":"Hypobetalipoproteinemia, familial, 1","id":"18459","alternate_symbols":["FHBL"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"615558\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"615558\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOBETALIPOPROTEINEMIA, FAMILIAL\"}","{\"db\":\"OMIM\",\"id\":\"615558\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FHBL\"}","{\"db\":\"OMIM\",\"id\":\"615558\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CHNG7","medgen_id":"CN262229","alternate_names":[],"name":"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7","id":"42896","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"618573\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"188545.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"188545.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"188545.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"188545.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618573\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618573\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SEMDJL2","medgen_id":"C1863732","alternate_names":["SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, HALL TYPE","SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, LEPTODACTYLIC TYPE","Spondyloepimetaphyseal dysplasia with multiple dislocations"],"name":"Spondyloepimetaphyseal dysplasia with joint laxity, type 2","id":"5981","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"603546\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"93360\"}","{\"db\":\"OMIM\",\"id\":\"603546\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, HALL TYPE\"}","{\"db\":\"OMIM\",\"id\":\"603546\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, LEPTODACTYLIC TYPE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spondyloepimetaphyseal+dysplasia+with+multiple+dislocations/6816\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Spondyloepimetaphyseal dysplasia with multiple dislocations\"}","{\"db\":\"OMIM\",\"id\":\"603546\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4021866","alternate_names":["Abnormality of cardiac morphology","Abnormality of the heart","Abnormally shaped heart","Cardiac abnormality","Cardiac anomalies"],"name":"Abnormal heart morphology","id":"17052","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001627\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:3000001\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001627\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormality of cardiac morphology\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001627\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormality of the heart\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001627\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormally shaped heart\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001627\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cardiac abnormality\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001627\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cardiac anomalies\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001627\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CATIFA","medgen_id":"CN263223","alternate_names":["CLEFT LIP, CATARACT, TOOTH ABNORMALITY, IMPAIRED INTELLECTUAL DEVELOPMENT, FACIAL DYSMORPHISM, AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER"],"name":"CATIFA SYNDROME","id":"43460","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"618761\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618761\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CLEFT LIP, CATARACT, TOOTH ABNORMALITY, IMPAIRED INTELLECTUAL DEVELOPMENT, FACIAL DYSMORPHISM, AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER\"}","{\"db\":\"OMIM\",\"id\":\"610354.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618761\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618761\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AI","medgen_id":"C0002452","alternate_names":["Congenital enamel hypoplasia"],"name":"Amelogenesis imperfecta","id":"13262","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000705\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006284\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006310\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006325\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006327\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006331\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS104500\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"88661\"}","{\"db\":\"SNOMED CT\",\"id\":\"78494001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital enamel hypoplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000705\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS104500\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5791\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0022680","alternate_names":["Enlarged polycystic kidneys","Polycystic kidneys"],"name":"Polycystic kidney dysplasia","id":"17137","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000113\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004716\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004739\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004740\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008645\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008673\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008699\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS173900\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000113\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Enlarged polycystic kidneys\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000113\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Polycystic kidneys\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000113\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CPSFS1A","medgen_id":"C1867440","alternate_names":["CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A","Distal arthrogryposis type 8","MULTIPLE PTERYGIUM SYNDROME, AUTOSOMAL DOMINANT"],"name":"Contractures, pterygia, and variable skeletal fusions syndrome 1A","id":"2979","alternate_symbols":["CPSKF1A","CPSKF1A MULTIPLE PTERYGIUM SYNDROME, AUTOSOMAL DOMINANT","DA8"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"178110\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"65743\"}","{\"db\":\"OMIM\",\"id\":\"160720.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A\"}","{\"db\":\"OMIM\",\"id\":\"160720.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A\"}","{\"db\":\"OMIM\",\"id\":\"160720.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A\"}","{\"db\":\"OMIM\",\"id\":\"160720.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A\"}","{\"db\":\"OMIM\",\"id\":\"160720.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A\"}","{\"db\":\"OMIM\",\"id\":\"160720.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A\"}","{\"db\":\"OMIM\",\"id\":\"160720.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A\"}","{\"db\":\"OMIM\",\"id\":\"178110\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CONTRACTURES, PTERYGIA, AND SPONDYLOCARPOTARSAL FUSION SYNDROME 1A\"}","{\"db\":\"OMIM\",\"id\":\"178110\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CPSKF1A MULTIPLE PTERYGIUM SYNDROME, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"178110\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DA8\"}","{\"db\":\"OMIM\",\"id\":\"178110\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"FHH","medgen_id":"C1809471","alternate_names":["Familial benign hypercalcemia"],"name":"Familial hypocalciuric hypercalcemia","id":"14459","alternate_symbols":["HHC1"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS145980\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"405\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+benign+hypercalcemia/8374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Familial benign hypercalcemia\"}","{\"db\":\"SNOMED CT\",\"id\":\"190868007\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Familial benign hypercalcemia\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2796\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HHC1\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2796\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HLS","medgen_id":"C2931104","alternate_names":[],"name":"Hydrolethalus syndrome","id":"7046","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS236680\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2189\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hydrolethalus+syndrome/3522\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS236680\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6683\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6683\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CFDS","medgen_id":"C4015495","alternate_names":[],"name":"Cerebellofaciodental syndrome","id":"32630","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"616202\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"444072\"}","{\"db\":\"OMIM\",\"id\":\"616202\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0018818","alternate_names":["Ventriculoseptal defect"],"name":"Ventricular septal defect","id":"32771","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001629\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001652\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS614429\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"1480\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001629\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ventriculoseptal defect\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001629\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS614429\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"30288003\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Primary coenzyme Q10 deficiency is a disorder that can affect many parts of the body, especially the brain, muscles, and kidneys. As its name suggests, the disorder involves a shortage (deficiency) of a substance called coenzyme Q10.The severity, combination of signs and symptoms, and age of onset of primary coenzyme Q10 deficiency vary widely. In the most severe cases, the condition becomes apparent in infancy and causes severe brain dysfunction combined with muscle weakness (encephalomyopathy) and the failure of other body systems. These problems can be life-threatening. The mildest cases of primary coenzyme Q10 deficiency can begin as late as a person's sixties and often cause cerebellar ataxia, which refers to problems with coordination and balance due to defects in the part of the brain that is involved in coordinating movement (cerebellum). Other neurological abnormalities that can occur in primary coenzyme Q10 deficiency include seizures, intellectual disability, poor muscle tone (hypotonia), involuntary muscle contractions (dystonia), progressive muscle stiffness (spasticity), abnormal eye movements (nystagmus), vision loss caused by degeneration (atrophy) of the optic nerves or breakdown of the light-sensing tissue at the back of the eyes (retinopathy), and sensorineural hearing loss (which is caused by abnormalities in the inner ear). The neurological problems gradually get worse unless treated with coenzyme Q10 supplementation.A type of kidney dysfunction called nephrotic syndrome is another common feature of primary coenzyme Q10 deficiency. It can occur with or without neurological abnormalities. Nephrotic syndrome occurs when damage to the kidneys impairs their function, which allows protein from the blood to pass into the urine (proteinuria). Other signs and symptoms of nephrotic syndrome include increased cholesterol in the blood (hypercholesterolemia), an abnormal buildup of fluid in the abdominal cavity (ascites), and swelling (edema). Affected individuals may also have blood in the urine (hematuria), which can lead to a reduced number of red blood cells in the body (anemia), abnormal blood clotting, or reduced amounts of certain white blood cells. Low white blood cell counts can lead to a weakened immune system and frequent infections in people with nephrotic syndrome. If not treated with coenzyme Q10 supplementation, affected individuals eventually develop irreversible kidney failure (end-stage renal disease).A type of heart disease that enlarges and weakens the heart muscle (hypertrophic cardiomyopathy) can also occur in primary coenzyme Q10 deficiency.","medgen_id":"CN229570","alternate_names":["Coenzyme Q10 deficiency"],"name":"Coenzyme Q10 deficiency, primary","id":"33110","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS607426\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"35656\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Coenzyme+Q10+Deficiency/1707\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Coenzyme Q10 deficiency\"}","{\"db\":\"OMIM\",\"id\":\"PS607426\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"primary-coenzyme-q10-deficiency\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BESC2","medgen_id":"C2751666","alternate_names":[],"name":"Bronchiectasis with or without elevated sweat chloride 2","id":"6875","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"613021\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"60033\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Bronchiectasis+with+or+without+elevated+sweat+chloride+2/7871\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613021\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EDS","public_definition":"Ehlers-Danlos syndrome is a group of disorders that affect connective tissues supporting the skin, bones, blood vessels, and many other organs and tissues. Defects in connective tissues cause the signs and symptoms of these conditions, which range from mildly loose joints to life-threatening complications.The various forms of Ehlers-Danlos syndrome have been classified in several different ways. Originally, 11 forms of Ehlers-Danlos syndrome were named using Roman numerals to indicate the types (type I, type II, and so on). In 1997, researchers proposed a simpler classification (the Villefranche nomenclature) that reduced the number of types to six and gave them descriptive names based on their major features. In 2017, the classification was updated to include rare forms of Ehlers-Danlos syndrome that were discovered more recently. The 2017 classification describes 13 types of Ehlers-Danlos syndrome.An unusually large range of joint movement (hypermobility) occurs in most forms of Ehlers-Danlos syndrome, and it is a hallmark feature of the hypermobile type. Infants and children with hypermobility often have weak muscle tone (hypotonia), which can delay the development of motor skills such as sitting, standing, and walking. The loose joints are unstable and prone to dislocation and chronic pain. In the arthrochalasia type of Ehlers-Danlos syndrome, infants have hypermobility and dislocations of both hips at birth.Many people with the Ehlers-Danlos syndromes have soft, velvety skin that is highly stretchy (elastic) and fragile. Affected individuals tend to bruise easily, and some types of the condition also cause abnormal scarring. People with the classical form of Ehlers-Danlos syndrome experience wounds that split open with little bleeding and leave scars that widen over time to create characteristic \"cigarette paper\" scars. The dermatosparaxis type of the disorder is characterized by loose skin that sags and wrinkles, and extra (redundant) folds of skin may be present.Some forms of Ehlers-Danlos syndrome, notably the vascular type and to a lesser extent the kyphoscoliotic, classical, and classical-like types, can cause unpredictable tearing (rupture) of blood vessels, leading to internal bleeding and other potentially life-threatening complications. The vascular type of Ehlers-Danlos syndrome is also associated with an increased risk of organ rupture, including tearing of the intestine and rupture of the uterus during pregnancy.Other types of Ehlers-Danlos syndrome have additional signs and symptoms. The cardiac-valvular type causes severe problems with the valves that control the movement of blood through the heart. People with the kyphoscoliotic type experience severe curvature of the spine that worsens over time and can interfere with breathing by restricting lung expansion. A type of Ehlers-Danlos syndrome called brittle cornea syndrome is characterized by thinness of the clear covering of the eye (the cornea) and other eye abnormalities. The spondylodysplastic type features short stature and skeletal abnormalities such as abnormally curved (bowed) limbs. Abnormalities of muscles, including hypotonia and permanently bent joints (contractures), are among the characteristic signs of the musculocontractural and myopathic forms of Ehlers-Danlos syndrome. The periodontal type causes abnormalities of the teeth and gums.","medgen_id":"C0013720","alternate_names":[],"name":"Ehlers-Danlos syndrome","id":"6501","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS130000\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"98249\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"ehlers-danlos-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS130000\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6322\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"398114001\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"ehlers-danlos-syndrome\",\"ref_field\":\"public_definition\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6322\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"JBS","public_definition":"Jacobsen syndrome is a condition caused by a loss of genetic material from chromosome 11. Because this deletion occurs at the end (terminus) of the long (q) arm of chromosome 11, Jacobsen syndrome is also known as 11q terminal deletion disorder.The signs and symptoms of Jacobsen syndrome vary considerably. Most affected individuals have delayed development, including the development of speech and motor skills (such as sitting, standing, and walking). Most also have cognitive impairment and learning difficulties. Behavioral problems have been reported, including compulsive behavior (such as shredding paper), a short attention span, and easy distractibility. Many people with Jacobsen syndrome have been diagnosed with attention-deficit/hyperactivity disorder (ADHD). Jacobsen syndrome is also associated with an increased likelihood of autism spectrum disorders, which are characterized by impaired communication and socialization skills.Jacobsen syndrome is also characterized by distinctive facial features. These include small and low-set ears, widely set eyes (hypertelorism) with droopy eyelids (ptosis), skin folds covering the inner corner of the eyes (epicanthal folds), a broad nasal bridge, downturned corners of the mouth, a thin upper lip, and a small lower jaw. Affected individuals often have a large head size (macrocephaly) and a skull abnormality called trigonocephaly, which gives the forehead a pointed appearance.More than 90 percent of people with Jacobsen syndrome have a bleeding disorder called Paris-Trousseau syndrome. This condition causes a lifelong risk of abnormal bleeding and easy bruising. Paris-Trousseau syndrome is a disorder of platelets, which are blood cells that are necessary for blood clotting.Other features of Jacobsen syndrome can include heart defects, feeding difficulties in infancy, short stature, frequent ear and sinus infections, and skeletal abnormalities. The disorder can also affect the digestive system, kidneys, and genitalia. The life expectancy of people with Jacobsen syndrome is unknown, although affected individuals have lived into adulthood.","medgen_id":"C0795841","alternate_names":["Jacobsen Distal 11q Deletion Syndrome"],"name":"11q partial monosomy syndrome","id":"2431","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"147791\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2308\"}","{\"db\":\"SNOMED CT\",\"id\":\"4325000\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"jacobsen-syndrome\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"147791\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"307\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HBFQTL6","medgen_id":"C3150805","alternate_names":[],"name":"Fetal hemoglobin quantitative trait locus 6","id":"15769","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"613566\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"251380\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Fetal+hemoglobin+quantitative+trait+locus+6/8428\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613566\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C2699510","alternate_names":[],"name":"Split-hand/foot malformation","id":"36564","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS183600\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"PS183600\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0037052","alternate_names":["Familial sick sinus syndrome"],"name":"Sick sinus syndrome","id":"18759","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011704\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS608567\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"166282\"}","{\"db\":\"Orphanet\",\"id\":\"166282\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Familial sick sinus syndrome\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011704\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS608567\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"36083008\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HSAN1C","medgen_id":"C3150896","alternate_names":["HSAN IC","HSN IC"],"name":"Hereditary sensory and autonomic neuropathy type IC","id":"15789","alternate_symbols":["HSN1C"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"613640\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"36386\"}","{\"db\":\"OMIM\",\"id\":\"613640\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSAN IC\"}","{\"db\":\"OMIM\",\"id\":\"613640\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSN IC\"}","{\"db\":\"OMIM\",\"id\":\"613640\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HSN1C\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hereditary+sensory+and+autonomic+neuropathy+type+IC/8532\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"613640\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"IDDM","medgen_id":"C0011854","alternate_names":["DIABETES MELLITUS, INSULIN-DEPENDENT, 1","Insulin-dependent diabetes mellitus","Juvenile diabetes mellitus","Type I diabetes","Type I diabetes mellitus"],"name":"Diabetes mellitus type 1","id":"1089","alternate_symbols":["IDDM1"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"222100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"181371\"}","{\"db\":\"OMIM\",\"id\":\"222100\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIABETES MELLITUS, INSULIN-DEPENDENT, 1\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Insulin-dependent diabetes mellitus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Juvenile diabetes mellitus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Type I diabetes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100651\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Type I diabetes mellitus\"}","{\"db\":\"OMIM\",\"id\":\"222100\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IDDM1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Diabetes+mellitus+type+1/8214\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"46635009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"222100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SS1","medgen_id":"C2697310","alternate_names":["BOECK SARCOID","SARCOIDOSIS, SUSCEPTIBILITY TO, 1"],"name":"Sarcoidosis 1","id":"5886","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"181000\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"797\"}","{\"db\":\"OMIM\",\"id\":\"181000\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BOECK SARCOID\"}","{\"db\":\"OMIM\",\"id\":\"142857.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SARCOIDOSIS, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"181000\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SARCOIDOSIS, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Sarcoidosis+1/9261\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"181000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"public_definition":"Critical congenital heart disease (CCHD) is a term that refers to a group of serious heart defects that are present from birth. These abnormalities result from problems with the formation of one or more parts of the heart during the early stages of embryonic development. CCHD prevents the heart from pumping blood effectively or reduces the amount of oxygen in the blood. As a result, organs and tissues throughout the body do not receive enough oxygen, which can lead to organ damage and life-threatening complications. Individuals with CCHD usually require surgery soon after birth.Although babies with CCHD may appear healthy for the first few hours or days of life, signs and symptoms soon become apparent. These can include an abnormal heart sound during a heartbeat (heart murmur), rapid breathing (tachypnea), low blood pressure (hypotension), low levels of oxygen in the blood (hypoxemia), and a blue or purple tint to the skin caused by a shortage of oxygen (cyanosis). If untreated, CCHD can lead to shock, coma, and death. However, most people with CCHD now survive past infancy due to improvements in early detection, diagnosis, and treatment.Some people with treated CCHD have few related health problems later in life. However, long-term effects of CCHD can include delayed development and reduced stamina during exercise. Adults with these heart defects have an increased risk of abnormal heart rhythms, heart failure, sudden cardiac arrest, stroke, and premature death.Each of the heart defects associated with CCHD affects the flow of blood into, out of, or through the heart. Some of the heart defects involve structures within the heart itself, such as the two lower chambers of the heart (the ventricles) or the valves that control blood flow through the heart. Others affect the structure of the large blood vessels leading into and out of the heart (including the aorta and pulmonary artery). Still others involve a combination of these structural abnormalities.People with CCHD have one or more specific heart defects. The heart defects classified as CCHD include coarctation of the aorta, double-outlet right ventricle, D-transposition of the great arteries, Ebstein anomaly, hypoplastic left heart syndrome, interrupted aortic arch, pulmonary atresia with intact septum, single ventricle, total anomalous pulmonary venous connection, tetralogy of Fallot, tricuspid atresia, and truncus arteriosus.","medgen_id":"C0040761","alternate_names":["Transposition of great vessels","Transposition of the great arteries, dextro-looped"],"name":"Transposition of the great arteries","id":"17177","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001669\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS608808\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"216694\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001669\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Transposition of great vessels\"}","{\"db\":\"OMIM\",\"id\":\"PS608808 \",\"type\":\"Phenotypic series\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Transposition of the great arteries, dextro-looped\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"critical-congenital-heart-disease\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0086543","alternate_names":["Cataracts","Cloudy lens","Lens opacities","Lens opacity"],"name":"Cataract","id":"17111","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000518\",\"type\":\"primary\"}","{\"db\":\"MeSH\",\"id\":\"D002386\"}","{\"db\":\"OMIM\",\"id\":\"PS116200\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"98640\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000518\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cataracts\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000518\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cloudy lens\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000518\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lens opacities\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000518\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lens opacity\"}","{\"db\":\"OMIM\",\"id\":\"PS116200\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C3151619","alternate_names":["Ataxia, spastic, childhood-onset, autosomal recessive, with optic atrophy and mental retardation"],"name":"Spastic ataxia","id":"4156","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002497\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"270500\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"PS108600\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"316226\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002497\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS108600\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AUTS1","medgen_id":"C1968924","alternate_names":["AUTISM, SUSCEPTIBILITY TO, 1"],"name":"Autism 1","id":"8887","alternate_symbols":["ASD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"209850\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AUTISM, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"209850\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"RAI","medgen_id":"C0175707","alternate_names":[],"name":"Bilateral right-sidedness sequence","id":"553","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"208530\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"97548\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6795\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"17604001\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"208530\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"CN163181","alternate_names":[],"name":"Atelosteogenesis","id":"17520","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS108720\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\"PS108720\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"43814000\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0265552","alternate_names":["Megalodactyly"],"name":"Congenital macrodactylia","id":"2839","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"155500\",\"type\":\"MIM\"}","{\"db\":\"SNOMED CT\",\"id\":\"48449000\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PSHK2","medgen_id":"C1836705","alternate_names":["CRYOHYDROCYTOSIS, MILD","PSEUDOHYPERKALEMIA EAST LONDON","PSEUDOHYPERKALEMIA LILLE","Pseudohyperkalemia Chiswick","Pseudohyperkalemia Falkirk"],"name":"Pseudohyperkalemia, familial, 2, due to red cell leak","id":"4055","alternate_symbols":["ABCB6"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"609153\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"90044\"}","{\"db\":\"OMIM\",\"id\":\"609153\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CRYOHYDROCYTOSIS, MILD\"}","{\"db\":\"OMIM\",\"id\":\"609153\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSEUDOHYPERKALEMIA EAST LONDON\"}","{\"db\":\"OMIM\",\"id\":\"609153\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PSEUDOHYPERKALEMIA LILLE\"}","{\"db\":\"OMIM\",\"id\":\"609153\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HYPT7","public_definition":"Autosomal recessive hypotrichosis is a condition that affects hair growth. People with this condition have sparse hair (hypotrichosis) on the scalp beginning in infancy. This hair is usually coarse, dry, and tightly curled (often described as woolly hair). Scalp hair may also be lighter in color than expected and is fragile and easily broken. Affected individuals often cannot grow hair longer than a few inches. The eyebrows, eyelashes, and other body hair may be sparse as well. Over time, the hair problems can remain stable or progress to complete scalp hair loss (alopecia) and a decrease in body hair.Rarely, people with autosomal recessive hypotrichosis have skin problems affecting areas with sparse hair, such as redness (erythema), itchiness (pruritus), or missing patches of skin (erosions) on the scalp. In areas of poor hair growth, they may also develop bumps called hyperkeratotic follicular papules that develop around hair follicles, which are specialized structures in the skin where hair growth occurs.","medgen_id":"C1836672","alternate_names":["HYPOTRICHOSIS, AUTOSOMAL RECESSIVE","HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 2","Total Hypotrichosis, Mari type"],"name":"Hypotrichosis 7","id":"5313","alternate_symbols":["AH","ARWH2","LAH2"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"604379\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"55654\"}","{\"db\":\"OMIM\",\"id\":\"604379\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTRICHOSIS, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"604379\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 2\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Total+Hypotrichosis%2C+Mari+type/7142\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Total Hypotrichosis, Mari type\"}","{\"db\":\"OMIM\",\"id\":\"604379\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AH\"}","{\"db\":\"OMIM\",\"id\":\"604379\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ARWH2\"}","{\"db\":\"OMIM\",\"id\":\"604379\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LAH2\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"autosomal-recessive-hypotrichosis\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"604379\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HALP1","medgen_id":"C3149462","alternate_names":["CETP DEFICIENCY"],"name":"Hyperalphalipoproteinemia 1","id":"1669","alternate_symbols":["HDLCQ10"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"143470\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"143470\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CETP DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"143470\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HDLCQ10\"}","{\"db\":\"OMIM\",\"id\":\"143470\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0265338","alternate_names":["HYPERTRICHOSIS, HYPERKERATOSIS, MENTAL RETARDATION, AND DISTINCTIVE FACIAL FEATURES"],"name":"Coffin-Siris syndrome","id":"36159","alternate_symbols":["CSS","HHID"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS135900\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"1465\"}","{\"db\":\"OMIM\",\"id\":\"135900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HYPERTRICHOSIS, HYPERKERATOSIS, MENTAL RETARDATION, AND DISTINCTIVE FACIAL FEATURES\"}","{\"db\":\"OMIM\",\"id\":\"135900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CSS\"}","{\"db\":\"OMIM\",\"id\":\"135900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HHID\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Coffin-Siris+Syndrome/1710\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"coffin-siris-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS135900\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6124\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"10007009\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SCID","mode_of_inheritance":"X-Linked or Autosomal recessive","medgen_id":"C0085110","alternate_names":[],"name":"Severe combined immunodeficiency disease","id":"6210","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004430\",\"type\":\"primary\"}","{\"db\":\"MeSH\",\"id\":\"D016511\"}","{\"db\":\"Orphanet\",\"id\":\"183660\"}","{\"db\":\"SNOMED CT\",\"id\":\"31323000\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7628\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CHED","medgen_id":"C1857569","alternate_names":[],"name":"Corneal endothelial dystrophy type 2","id":"1568","alternate_symbols":["CHED2"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"217700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"293603\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6196\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CHED2\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Corneal+Endothelial+Dystrophy+Type+2/1915\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6196\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"217700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"VOWNKL","medgen_id":"C0265964","alternate_names":[],"name":"Mutilating keratoderma","id":"1723","alternate_symbols":["KHM"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"124500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"494\"}","{\"db\":\"OMIM\",\"id\":\"124500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"KHM\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3092\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"KHM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Vohwinkel+syndrome/7413\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3092\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"24559001\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"124500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"NS/LAH","medgen_id":"C1843181","alternate_names":["Noonan-like syndrome with loose anagen hair"],"name":"Noonan syndrome-like disorder with loose anagen hair","id":"38380","alternate_symbols":["NSLH"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS607721\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2701\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Noonan-like+syndrome+with+loose+anagen+hair/5266\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Noonan-like syndrome with loose anagen hair\"}","{\"db\":\"OMIM\",\"id\":\"607721\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NSLH\"}","{\"db\":\"OMIM\",\"id\":\"PS607721\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"2701\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"2701\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0027126","alternate_names":[],"name":"Myotonic dystrophy","id":"10123","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS160900\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"206647\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Myotonic+dystrophy/5076\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS160900\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10419\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0795690","alternate_names":["CHROMOSOME 1p31 DUPLICATION SYNDROME","OMPHALOCELE, AUTOSOMAL","OMPHALOCELE, X-LINKED","Omphalocoele"],"name":"Congenital omphalocele","id":"15852","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001539\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"164750\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"310980\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"660\"}","{\"db\":\"OMIM\",\"id\":\"164750\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHROMOSOME 1p31 DUPLICATION SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"164750\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OMPHALOCELE, AUTOSOMAL\"}","{\"db\":\"OMIM\",\"id\":\"310980\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OMPHALOCELE, X-LINKED\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001539\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Omphalocoele\"}","{\"db\":\"SNOMED CT\",\"id\":\"18735004\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0456070","alternate_names":["Delayed growth","Growth deficiency","Growth retardation","Poor growth","Retarded growth","Very poor growth"],"name":"Growth delay","id":"17153","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001434\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001510\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001512\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001514\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001517\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001532\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008847\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008870\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008886\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008893\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008926\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001510\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed growth\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001510\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Growth deficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001510\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Growth retardation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001510\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Poor growth\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001510\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Retarded growth\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001510\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Very poor growth\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ODG1","medgen_id":"C0949595","alternate_names":["OVARIAN DYSGENESIS, HYPERGONADOTROPIC, AUTOSOMAL RECESSIVE","OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH NORMAL KARYOTYPE","OVARIAN FAILURE, HYPERGONADOTROPIC"],"name":"Ovarian dysgenesis 1","id":"15833","alternate_symbols":["XXGD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"233300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"243\"}","{\"db\":\"OMIM\",\"id\":\"233300\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN DYSGENESIS, HYPERGONADOTROPIC, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"233300\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH NORMAL KARYOTYPE\"}","{\"db\":\"OMIM\",\"id\":\"233300\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OVARIAN FAILURE, HYPERGONADOTROPIC\"}","{\"db\":\"OMIM\",\"id\":\"233300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"XXGD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Gonadal+Dysgenesis%2C+XX+Type/3151\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"233300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1956346","alternate_names":[],"name":"Coronary artery disease","id":"22530","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001677\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005138\",\"type\":\"secondary\"}","{\"db\":\"MeSH\",\"id\":\"D003324\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001677\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CZP3","medgen_id":"C1866078","alternate_names":["CATARACT 14, COPPOCK-LIKE","CATARACT 14, EMBRYONAL NUCLEAR","CATARACT 14, NUCLEAR CORALLIFORM","CATARACT 14, NUCLEAR PULVERULENT","CATARACT 14, NUCLEAR PULVERULENT AND POSTERIOR POLAR","CATARACT 14, ZONULAR PULVERULENT"],"name":"Zonular pulverulent cataract 3","id":"1329","alternate_symbols":["CAE3","CTRCT14"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"601885\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91492\"}","{\"db\":\"OMIM\",\"id\":\"121015.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 14, COPPOCK-LIKE\"}","{\"db\":\"OMIM\",\"id\":\"121015.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 14, EMBRYONAL NUCLEAR\"}","{\"db\":\"OMIM\",\"id\":\"121015.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 14, NUCLEAR CORALLIFORM\"}","{\"db\":\"OMIM\",\"id\":\"121015.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 14, NUCLEAR PULVERULENT\"}","{\"db\":\"OMIM\",\"id\":\"121015.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 14, NUCLEAR PULVERULENT AND POSTERIOR POLAR\"}","{\"db\":\"OMIM\",\"id\":\"121015.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 14, ZONULAR PULVERULENT\"}","{\"db\":\"OMIM\",\"id\":\"121015.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 14, ZONULAR PULVERULENT\"}","{\"db\":\"OMIM\",\"id\":\"121015.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 14, ZONULAR PULVERULENT\"}","{\"db\":\"OMIM\",\"id\":\"121015.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CATARACT 14, ZONULAR PULVERULENT\"}","{\"db\":\"OMIM\",\"id\":\"601885\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CAE3\"}","{\"db\":\"OMIM\",\"id\":\"601885\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CTRCT14\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Zonular+pulverulent+cataract+3/9528\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601885\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"RHNR","medgen_id":"C1849387","alternate_names":["RH-NULL DISEASE, REGULATOR TYPE"],"name":"Rh-null, regulator type","id":"4103","alternate_symbols":["RHN"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"268150\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"268150\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RH-NULL DISEASE, REGULATOR TYPE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Rh-null%2C+regulator+type/9250\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"268150\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SMC1","medgen_id":"C1846431","alternate_names":[],"name":"Smith-McCort dysplasia","id":"36155","alternate_symbols":["SMC"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS607326\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"178355\"}","{\"db\":\"OMIM\",\"id\":\"607326\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SMC\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Smith+McCort+dysplasia/6647\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS607326\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10620\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CHBL","medgen_id":"C4551515","alternate_names":[],"name":"Chilblain lupus erythematosus","id":"33007","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS610448\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"90280\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Chilblain+lupus+erythematosus/7966\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"238928005\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0026650","alternate_names":["Movement disorder","Unusual movement"],"name":"Abnormality of movement","id":"36754","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001294\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100022\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"102003\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100022\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Movement disorder\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100022\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Unusual movement\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100022\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ATLD","medgen_id":"C1858391","alternate_names":[],"name":"Ataxia-telangiectasia-like disorder","id":"36734","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS604391\",\"type\":\"Phenotypic series\"}","{\"db\":\"OMIM\",\"id\":\" PS604391\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS604391\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604391\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1857276","alternate_names":["Syndromic diarrhea","THE SYNDROME"],"name":"Trichohepatoenteric syndrome","id":"36272","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS222470\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"84064\"}","{\"db\":\"Orphanet\",\"id\":\"84064\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Syndromic diarrhea\"}","{\"db\":\"OMIM\",\"id\":\"222470\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THE SYNDROME\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Tricho-hepato-enteric+syndrome/7191\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS222470\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0853087","alternate_names":[],"name":"Abnormality of the nail","id":"22473","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001597\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001597\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1836996","alternate_names":["Dolichostenomelia","Marfanoid body habitus","Reduced upper-lower segment ratio"],"name":"Disproportionate tall stature","id":"18107","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001519\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003511\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008864\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001519\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dolichostenomelia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001519\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Marfanoid body habitus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001519\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Reduced upper-lower segment ratio\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001519\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0025322","alternate_names":["Climacterium praecox","Early menopause","Hypergonadotropic amenorrhea","Menopause praecox","Premature menopause"],"name":"Premature ovarian insufficiency","id":"26671","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001587\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008209\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100805\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008209\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Climacterium praecox\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008209\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Early menopause\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008209\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypergonadotropic amenorrhea\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008209\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Menopause praecox\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008209\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Premature menopause\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008209\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0399526","alternate_names":["Big lower jaw","Big mandible","Enlarged mandible","Enlargement of mandible","Hyperplasia of lower jaw","Hypertrophy of lower jaw","Hypertrophy of mandible","Increased projection of lower jaw","Increased projection of mandible","Increased size of lower jaw","Increased size of mandible","Large lower jaw","Large mandible","Lower jaw excess","Lower jaw hyperplasia","Macromandible","Mandible prognathism","Mandibular excess","Mandibular hyperplasia","Mandibular macrognathia","Prognathia","Prognathism","Prominent chin","Prominent jaw","Prominent lower jaw","Prominent mandible","Relative mandibular prognathism"],"name":"Mandibular prognathia","id":"18035","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000251\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000279\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000328\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002051\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004648\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004656\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008514\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Big lower jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Big mandible\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Enlarged mandible\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Enlargement of mandible\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hyperplasia of lower jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypertrophy of lower jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypertrophy of mandible\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased projection of lower jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased projection of mandible\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased size of lower jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased size of mandible\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Large lower jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Large mandible\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lower jaw excess\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lower jaw hyperplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macromandible\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mandible prognathism\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mandibular excess\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mandibular hyperplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mandibular macrognathia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prognathia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prognathism\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prominent chin\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prominent jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prominent lower jaw\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prominent mandible\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Relative mandibular prognathism\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000303\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1740801","alternate_names":["Exaggerated acoustic startle response","Increased startle response"],"name":"Exaggerated startle response","id":"22971","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002267\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002267\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Exaggerated acoustic startle response\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002267\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased startle response\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002267\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0001623","alternate_names":[],"name":"Adrenal insufficiency","id":"18061","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000846\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000865\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008218\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000846\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0008519","alternate_names":["Heterotopias"],"name":"Heterotopia","id":"17197","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002282\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002282\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Heterotopias\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002282\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0007789","alternate_names":["Cerebral paralysis"],"name":"Cerebral palsy","id":"17064","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100021\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100021\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cerebral paralysis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100021\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0005586","alternate_names":[],"name":"Bipolar affective disorder","id":"17237","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000755\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007302\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007302\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1846267","alternate_names":["Congenital retinal septum","Persistent fetal vasculature","Persistent hyperplasia of primary vitreous","Persistent hypertrophic primary vitreous","Persistent posterior fetal fibrovascular sheath of the lens","Persistent tunica vasculosa lentis"],"name":"Remnants of the hyaloid vascular system","id":"26518","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007968\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007968\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital retinal septum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007968\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Persistent fetal vasculature\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007968\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Persistent hyperplasia of primary vitreous\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007968\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Persistent hypertrophic primary vitreous\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007968\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Persistent posterior fetal fibrovascular sheath of the lens\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007968\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Persistent tunica vasculosa lentis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007968\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1860819","alternate_names":["Metopic suture craniosynostosis"],"name":"Metopic synostosis","id":"29232","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011330\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011330\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Metopic suture craniosynostosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011330\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0265740","alternate_names":["Absent nose","Failure of development of nose","Missing nose","Nasal underdevelopment","Underdevelopment of nose"],"name":"Aplasia of the nose","id":"27888","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009927\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"1134\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009927\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Absent nose\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009927\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Failure of development of nose\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009927\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Missing nose\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009927\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Nasal underdevelopment\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009927\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Underdevelopment of nose\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009927\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"FSGS","medgen_id":"C0017668","alternate_names":["Focal and segmental glomerular sclerosis","Focal and segmental glomerulosclerosis"],"name":"Focal segmental glomerulosclerosis","disease_mechanism":"loss of function","id":"21418","alternate_symbols":[],"type":"Finding","disease_mechanism_id":"273","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000097\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004747\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS603278\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000097\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Focal and segmental glomerular sclerosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000097\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Focal and segmental glomerulosclerosis\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500214\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515530\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522221\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000523187\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528276\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529072\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552013\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000553522\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558125\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558132\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558473\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"ADAM\",\"id\":\"CN037700\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000097\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS603278\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6517\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6517\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4025871","alternate_names":["Abnormal face","Abnormality of the countenance","Abnormality of the physiognomy","Abnormality of the visage","Anomaly of face","Anomaly of the face","Disorder of face","Disorder of the face","Facial anomaly"],"name":"Abnormality of the face","id":"21551","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormal face\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormality of the countenance\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormality of the physiognomy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormality of the visage\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anomaly of face\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Anomaly of the face\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Disorder of face\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Disorder of the face\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial anomaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000271\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0266292","alternate_names":["Abnormal kidney","Renal anomalies","Renal anomaly"],"name":"Abnormality of the kidney","id":"17193","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000077\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000077\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormal kidney\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000077\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renal anomalies\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000077\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renal anomaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000077\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0431371","alternate_names":["Absence of the septum pellucidum","Agenesis of the septum pellucidum"],"name":"Absent septum pellucidum","id":"22313","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001331\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006969\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001331\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Absence of the septum pellucidum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001331\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Agenesis of the septum pellucidum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001331\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0431890","alternate_names":["Hypoplastic thumbs","Hypoplastic/small thumb","Short thumbs","Small thumbs","Thumb brachydactyly","Thumb hypoplasia"],"name":"Short thumb","id":"27764","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001183\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001186\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001589\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005699\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006151\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009628\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009778\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009778\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypoplastic thumbs\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009778\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypoplastic/small thumb\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009778\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Short thumbs\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009778\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Small thumbs\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009778\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thumb brachydactyly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009778\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thumb hypoplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009778\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0392525","alternate_names":["Renal calculi","Renal stones"],"name":"Nephrolithiasis","id":"21922","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000102\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000787\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000787\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renal calculi\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000787\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Renal stones\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000787\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"CN005851","alternate_names":["Acute lymphatic leukemia","Acute lymphocytic leukemia"],"name":"Acute lymphoblastic leukemia","id":"25799","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004803\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005555\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006721\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006721\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Acute lymphatic leukemia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006721\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Acute lymphocytic leukemia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006721\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4021813","alternate_names":["Cleft lip, cleft palate","Cleft of the mouth","Oral clefting"],"name":"Oral cleft","id":"21503","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000202\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000202\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cleft lip, cleft palate\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000202\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cleft of the mouth\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000202\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Oral clefting\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000202\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0424503","alternate_names":["Abnormal morphology of the face","Craniofacial dysmorphism","Deformity of face","Distinctive facies","Distortion of face","Dysmorphic facial features","Dysmorphic facies","Funny looking face","Malformation of face","Unusual facial appearance","Unusual facies"],"name":"Abnormal facial shape","id":"18041","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002004\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002260\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004643\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004649\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004652\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004655\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004675\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005124\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormal morphology of the face\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Deformity of face\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Distinctive facies\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Distortion of face\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dysmorphic facial features\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dysmorphic facies\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Funny looking face\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Malformation of face\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Unusual facial appearance\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Unusual facies\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001999\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4025284","alternate_names":[],"name":"Reduced protein S activity","id":"24669","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004855\",\"type\":\"primary\"}","{\"db\":\"MeSH\",\"id\":\"D018455\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004855\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C2911643","alternate_names":[],"name":"Osteoporosis","id":"22045","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000939\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002774\",\"type\":\"secondary\"}","{\"db\":\"GeneTests\",\"id\":\"14468\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000939\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0043094","alternate_names":[],"name":"Increased body weight","id":"24360","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004324\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0045083\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004324\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C2673410","alternate_names":["Decreased projection of midface","Decreased size of midface","Hypoplasia of midface","Hypotrophic midface","Midface deficiency","Retrusive midface","Small midface","Underdevelopment of midface"],"name":"Midface retrusion","id":"29693","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011800\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0040199\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011800\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased projection of midface\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011800\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased size of midface\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011800\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypoplasia of midface\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011800\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypotrophic midface\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011800\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Midface deficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011800\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Retrusive midface\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011800\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Small midface\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011800\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Underdevelopment of midface\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011800\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C2112942","alternate_names":["Partial/complete duplication of the phalanges of the big toe","Polydactyly affecting the hallux","Preaxial polydactyly of feet","Preaxial polydactyly of foot","Preaxial polydactyly of the feet","Preaxial polydactyly, feet"],"name":"Preaxial foot polydactyly","id":"18143","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001841\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009607\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010050\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001841\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Partial/complete duplication of the phalanges of the big toe\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001841\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Polydactyly affecting the hallux\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001841\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Preaxial polydactyly of feet\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001841\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Preaxial polydactyly of foot\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001841\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Preaxial polydactyly of the feet\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001841\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Preaxial polydactyly, feet\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001841\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1879362","alternate_names":["Increased tyrosine in blood"],"name":"Hypertyrosinemia","id":"23639","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003231\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003231\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased tyrosine in blood\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003231\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1291611","alternate_names":["Phosphohexose isomerase deficiency"],"name":"Decreased glucosephosphate isomerase activity","id":"23876","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003290\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003568\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003568\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Phosphohexose isomerase deficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003568\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1858120","alternate_names":["Decreased muscle tone","Generalized muscular hypotonia","Low muscle tone"],"name":"Generalized hypotonia","id":"22290","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001290\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001290\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased muscle tone\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001290\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Generalized muscular hypotonia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001290\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Low muscle tone\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001290\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4476529","alternate_names":[],"name":"Primary ovarian failure","id":"22468","alternate_symbols":[],"type":"Finding","xrefs":[]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0206698","alternate_names":[],"name":"Cholangiocarcinoma","id":"32384","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030153\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"70567\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030153\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0036572","alternate_names":[],"name":"Seizures","id":"17066","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001250\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001275\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001303\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002125\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002182\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002279\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002306\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002348\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002391\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002417\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002430\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002431\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002432\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002434\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002437\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002466\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002479\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002794\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006997\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010520\",\"type\":\"secondary\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Seizures/6489\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001250\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0025160","alternate_names":["Congenital megacolon","Hirschsprung megacolon","Megacolon"],"name":"Aganglionic megacolon","id":"22963","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002029\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002030\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002251\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002606\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004391\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002251\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital megacolon\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002251\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hirschsprung megacolon\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002251\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Megacolon\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002251\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0151878","alternate_names":["Long Q-T syndrome","Prolong qt interval on ekg"],"name":"Prolonged QT interval","id":"17187","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001657\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001657\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Long Q-T syndrome\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001657\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prolong qt interval on ekg\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001657\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0578878","alternate_names":[],"name":"Inflammation of the large intestine","id":"22797","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002037\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002037\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0011581","alternate_names":["Depression"],"name":"Depressivity","id":"17233","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000716\",\"type\":\"primary\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Depression/2199\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Depression\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000716\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Depression\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000716\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1848395","alternate_names":["Birth weight \u003e 90th percentile","Birthweight \u003e 90th percentile","Macrosomia","Macrosomia, neonatal"],"name":"Large for gestational age","id":"22433","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001520\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001825\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001520\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Birth weight \u003e 90th percentile\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001520\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Birthweight \u003e 90th percentile\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001520\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macrosomia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001520\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Macrosomia, neonatal\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001520\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0041206","alternate_names":["Common arterial trunk","Persistant truncus arteriosus"],"name":"Truncus arteriosus","id":"17183","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001660\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001660\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Common arterial trunk\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001660\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Persistant truncus arteriosus\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001660\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0542035","alternate_names":["Erythroid hypoplasia in the bone marrow"],"name":"Erythroid hypoplasia","id":"30019","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012133\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012133\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Erythroid hypoplasia in the bone marrow\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012133\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1846474","alternate_names":["Hypoplastic thenar eminences","Thenar muscle hypoplasia"],"name":"Small thenar eminence","id":"22259","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001245\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006188\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001245\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypoplastic thenar eminences\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001245\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thenar muscle hypoplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001245\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0162835","alternate_names":["Hypopigmented skin","Patchy lightened skin","Skin hypopigmentation"],"name":"Hypopigmentation of the skin","id":"22099","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001010\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005589\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007604\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007622\",\"type\":\"secondary\"}","{\"db\":\"Orphanet\",\"id\":\"79376\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001010\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypopigmented skin\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001010\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Patchy lightened skin\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001010\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Skin hypopigmentation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001010\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0027066","alternate_names":["Jerking","Myoclonic jerks"],"name":"Myoclonus","id":"22317","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001336\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002535\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007087\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001336\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Jerking\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001336\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Myoclonic jerks\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001336\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4476540","alternate_names":["Cerebral artery aneurysm","Intracranial aneurysm"],"name":"Dilatation of the cerebral artery","id":"24734","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002618\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004944\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006816\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004944\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cerebral artery aneurysm\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004944\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Intracranial aneurysm\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004944\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0162678","alternate_names":["Neurofibromata","multiple neurofibromas"],"name":"Neurofibromas","id":"22147","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001067\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006746\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007386\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007612\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001067\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Neurofibromata\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001067\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"multiple neurofibromas\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001067\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0240543","alternate_names":["Bulbous nasal tip"],"name":"Bulbous nose","id":"18087","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000414\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000443\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000414\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Bulbous nasal tip\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000414\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4023009","alternate_names":[],"name":"Constrictive median neuropathy","id":"30070","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012185\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012185\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1527366","alternate_names":["Salaam convulsions","Salaam seizures"],"name":"Epileptic spasms","id":"29005","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011097\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011097\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Salaam convulsions\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011097\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Salaam seizures\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011097\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1857278","alternate_names":["Partial corpus callosum agenesis","Partial or complete agenesis of corpus callosum","Partial or complete agenesis of the corpus callosum","Partial to complete agenesis of corpus callosum","Partial-total agenesis of corpus callosum"],"name":"Partial agenesis of the corpus callosum","id":"18134","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001338\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006982\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007090\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007128\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001338\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Partial corpus callosum agenesis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001338\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Partial or complete agenesis of corpus callosum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001338\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Partial or complete agenesis of the corpus callosum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001338\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Partial to complete agenesis of corpus callosum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001338\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Partial-total agenesis of corpus callosum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001338\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4317146","alternate_names":["Acid reflux","Acid reflux disease","Heartburn"],"name":"Gastroesophageal reflux","id":"22785","alternate_symbols":["GERD"],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002020\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004793\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002020\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Acid reflux\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002020\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Acid reflux disease\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002020\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Heartburn\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002020\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GERD\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002020\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0018802","alternate_names":["CHF","Cardiac failure","Cardiac failures","Cardiac insufficiency","Chronic heart failure"],"name":"Congestive heart failure","id":"17228","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001635\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006686\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001635\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHF\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001635\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cardiac failure\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001635\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cardiac failures\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001635\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cardiac insufficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001635\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Chronic heart failure\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001635\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4021536","alternate_names":["Mild conductive hearing loss"],"name":"Mild conductive hearing impairment","id":"26894","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008598\",\"type\":\"primary\"}","{\"db\":\"Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine\",\"id\":\"SIX2_c.C707T\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mild conductive hearing loss\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008598\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0042063","alternate_names":["Genitourinary abnormality","Genitourinary disease","Genitourinary dysplasia","Genitourinary tract malformation","Urogenital abnormalities","Urogenital anomalies"],"name":"Abnormality of the genitourinary system","id":"21433","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000119\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008658\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008688\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008704\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008713\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000119\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Genitourinary abnormality\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000119\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Genitourinary disease\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000119\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Genitourinary dysplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000119\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Genitourinary tract malformation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000119\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Urogenital abnormalities\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000119\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Urogenital anomalies\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000119\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C2973725","alternate_names":["Pulmonary artery hypertension","Pulmonary hypertension"],"name":"Pulmonary arterial hypertension","id":"17082","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002092\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006546\",\"type\":\"secondary\"}","{\"db\":\"Orphanet\",\"id\":\"182090\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002092\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pulmonary artery hypertension\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pulmonary+Hypertension/6088\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pulmonary hypertension\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002092\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0004368","alternate_names":["Autoimmune condition","Autoimmune disorder"],"name":"Autoimmunity","id":"23449","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002960\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002960\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Autoimmune condition\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002960\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Autoimmune disorder\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002960\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4024202","alternate_names":["Decreased number of teeth","Decreased tooth count","Failure of development of some teeth","Fewer teeth than normal","Missing some teeth"],"name":"Reduced number of teeth","id":"27789","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009804\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009804\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased number of teeth\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009804\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased tooth count\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009804\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Failure of development of some teeth\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009804\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fewer teeth than normal\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009804\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Missing some teeth\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009804\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1860834","alternate_names":["Decreased muscle tone in infant","Hypotonia early","Hypotonia in infancy"],"name":"Infantile muscular hypotonia","id":"27061","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002449\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002523\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008947\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010572\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008947\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased muscle tone in infant\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008947\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypotonia early\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008947\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypotonia in infancy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008947\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0311468","alternate_names":["High blood bilirubin levels"],"name":"Hyperbilirubinemia","id":"18013","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002904\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS237450\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002904\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"High blood bilirubin levels\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002904\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS237450\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"CN217169","alternate_names":[],"name":"Neonatal asphyxia","id":"30648","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012768\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012768\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AMC","medgen_id":"C0003886","alternate_names":["Arthrogryposis","Arthrogryposis multiplex","Arthrogryposis, congenital"],"name":"Arthrogryposis multiplex congenita","id":"23332","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001389\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001390\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002759\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002804\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005188\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005663\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005809\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005859\",\"type\":\"secondary\"}","{\"db\":\"MeSH\",\"id\":\"D001176\"}","{\"db\":\"Orphanet\",\"id\":\"1037\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002804\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Arthrogryposis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002804\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Arthrogryposis multiplex\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002804\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Arthrogryposis, congenital\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Arthrogryposis+Multiplex+Congenita/602\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002804\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"777\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0332878","alternate_names":["Congenital joint contractures"],"name":"Congenital contracture","id":"23331","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002803\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002803\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital joint contractures\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002803\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0678222","alternate_names":[],"name":"Breast carcinoma","id":"23475","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003002\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"180257\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003002\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0086437","alternate_names":["Joint ligamentous laxity","Lax joints","Loose-jointedness","Loosejointedness"],"name":"Joint laxity","id":"22350","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001380\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001383\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001388\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002771\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001388\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Joint ligamentous laxity\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001388\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lax joints\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001388\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Loose-jointedness\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001388\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Loosejointedness\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001388\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C4510897","alternate_names":[],"name":"Omodysplasia","id":"36685","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS258315\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2733\"}","{\"db\":\"Illumina Clinical Services Laboratory,Illumina\",\"id\":\"12476\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS258315\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0016049","alternate_names":["Gingival fibroma","Gingival fibrous nodules","Idiopathic gingival hyperplasia"],"name":"Gingival fibromatosis","id":"21477","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000169\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000169\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Gingival fibroma\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000169\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Gingival fibrous nodules\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000169\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Idiopathic gingival hyperplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000169\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1847523","alternate_names":[],"name":"Abducens palsy","id":"29250","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011349\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011349\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C2937365","alternate_names":["Buccal aphthous ulcers","Canker sore","aphthous ulcers"],"name":"Recurrent aphthous stomatitis","id":"29014","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011107\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011107\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Buccal aphthous ulcers\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011107\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Canker sore\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011107\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"aphthous ulcers\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011107\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0023465","alternate_names":[],"name":"Acute monocytic leukemia","id":"24662","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004833\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004845\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004845\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0427480","alternate_names":["Ovalocytosis"],"name":"Elliptocytosis","id":"24464","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004445\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004837\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004445\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ovalocytosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004445\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0080218","alternate_names":[],"name":"Tethered cord","id":"18174","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002144\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002144\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0600104","alternate_names":["OCD"],"name":"Obsessive-compulsive behavior","id":"21875","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000722\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000722\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OCD\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000722\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0240063","alternate_names":["Cat eye","Coloboma of the iris","Keyhole iris"],"name":"Iris coloboma","id":"17203","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000612\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000612\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cat eye\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000612\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Coloboma of the iris\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000612\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Keyhole iris\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000612\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0078981","alternate_names":[],"name":"Arachnoid cyst","id":"18072","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100702\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"2356\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0100702\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0454644","alternate_names":["Deficiency of speech development","Delayed language development","Delayed speech","Delayed speech acquisition","Delayed speech development","Impaired speech and language development","Impaired speech development","Language delay","Language delayed","Language development deficit","Late-onset speech development","Poor language development","Poor speech acquisition","Poor speech development","Speech and language delay","Speech and language difficulties"],"name":"Delayed speech and language development","id":"18105","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002116\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002117\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002336\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002399\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002498\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006936\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007004\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007127\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007170\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007172\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Deficiency of speech development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed language development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed speech\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed speech acquisition\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed speech development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Impaired speech and language development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Impaired speech development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Language delay\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Language delayed\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Language development deficit\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Late-onset speech development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Poor language development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Poor speech acquisition\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Poor speech development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Speech and language delay\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Speech and language difficulties\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000750\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0855329","alternate_names":["Abnormal electrocardiogram","Abnormal heart rate","Abnormality of cardiac conduction","Arrhythmias","Cardiac arrhythmias","Cardiac conduction defects","Cardiac rhythm disturbances","ECG abnormality","EKG abnormality","Ekg abnormalities","Electrocardiographic changes","Heart rhythm disorders","Irregular heart beat","Irregular heartbeat"],"name":"Arrhythmia","id":"18612","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"EFO\",\"id\":\"EFO_0004269\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001656\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001661\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001665\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001666\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001687\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001721\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004351\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005158\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormal electrocardiogram\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormal heart rate\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abnormality of cardiac conduction\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Arrhythmias\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cardiac arrhythmias\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cardiac conduction defects\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cardiac rhythm disturbances\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ECG abnormality\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"EKG abnormality\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ekg abnormalities\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Electrocardiographic changes\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Heart rhythm disorders\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Irregular heart beat\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Irregular heartbeat\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011675\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"248650006\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0332563","alternate_names":["Papules"],"name":"Papule","id":"31730","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0200034\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0200034\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Papules\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0200034\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1691215","alternate_names":["Hypospadia"],"name":"Hypospadias, penile","id":"21376","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000047\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000047\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypospadia\"}","{\"db\":\"SNOMED CT\",\"id\":\"204888000\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0856975","alternate_names":["Autism spectrum disorders","Autistic behaviors","Autistic behaviour","Pervasive developmental disorder"],"name":"Autistic behavior","id":"17060","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000729\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000729\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Autism spectrum disorders\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000729\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Autistic behaviors\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000729\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Autistic behaviour\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000729\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Pervasive developmental disorder\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000729\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0040822","alternate_names":[],"name":"Tremor","id":"22318","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001295\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001309\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001337\",\"type\":\"primary\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Tremor/7178\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001337\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1839888","alternate_names":["Decreased activity of the PDH complex"],"name":"Decreased activity of the pyruvate dehydrogenase complex","id":"23428","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002928\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002928\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Decreased activity of the PDH complex\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002928\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C0240635","alternate_names":["Elevated palate","Increased palatal height"],"name":"High palate","id":"17140","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000156\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000218\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009080\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009082\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009097\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000218\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Elevated palate\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000218\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased palatal height\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000218\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C2265792","alternate_names":["Hypertrophic muscles","Increased skeletal muscle cells","Muscular hypertrophy"],"name":"Skeletal muscle hypertrophy","id":"23944","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003712\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003712\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypertrophic muscles\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003712\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Increased skeletal muscle cells\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003712\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Muscular hypertrophy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003712\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1849943","alternate_names":["Cranial suture synostosis","Craniostenosis","Craniosyostosis","Deformity of the skull","Early fusion of cranial sutures","Premature closure of cranial sutures","Premature fontanel closure","Premature suture closure"],"name":"Craniosynostosis","id":"22335","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001363\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001365\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004494\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005448\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005457\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005467\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008492\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS123100\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001363\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cranial suture synostosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001363\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Craniostenosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001363\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Craniosyostosis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001363\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Deformity of the skull\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001363\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Early fusion of cranial sutures\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001363\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Premature closure of cranial sutures\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001363\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Premature fontanel closure\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001363\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Premature suture closure\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001363\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS123100\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"medgen_id":"C1858719","alternate_names":["Cranial nerve VII palsy","Facial muscle weakness","Facial muscle weakness of muscles innervated by CN VII","Facial nerve palsy","Facial nerve paralysis","Facial palsy, unilateral or bilateral","Facial weakness","Seventh cranial nerve palsy","VII th cranial nerve palsy"],"name":"Facial palsy","id":"28559","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000296\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000302\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000344\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000353\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002008\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002259\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002517\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004670\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007212\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0200004\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cranial nerve VII palsy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial muscle weakness\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial muscle weakness of muscles innervated by CN VII\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial nerve palsy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial nerve paralysis\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial palsy, unilateral or bilateral\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Facial weakness\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Seventh cranial nerve palsy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"VII th cranial nerve palsy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0010628\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":["Hereditary cancer syndrome","Neoplasm"],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301715\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1548\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ES, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24893135\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NANETS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3419007\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"KCRNC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24319509\",\"@Source\":\"PubMed\"}}]}","public_definition":"Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas cause catecholamine excess; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base and neck (referred to as head and neck PGL [HNPGL]) and sometimes in the upper mediastinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically lead to catecholamine excess. Symptoms of PGL/PCC result from either mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for developing metastatic disease is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas.","medgen_id":"C0031511","alternate_names":["Chromaffin tumors","MAX-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome","Pheochromocytoma, somatic"],"name":"Pheochromocytoma","id":"3796","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002666\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"171300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"29072\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002666\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Chromaffin tumors\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Pheochromocytoma/5718\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002666\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7385\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1548\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LQT9","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301308\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1129\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301559\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1385\",\"@Source\":\"BookShelf\"}]}]}","public_definition":"Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the ECG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.","medgen_id":"C2678485","alternate_names":[],"name":"Long QT syndrome 9","id":"2567","alternate_symbols":["LQT2/9, DIGENIC"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"611818\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"101016\"}","{\"db\":\"Orphanet\",\"id\":\"768\"}","{\"db\":\"OMIM\",\"id\":\"611818\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LQT2/9, DIGENIC\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Long+QT+syndrome+9/4306\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10435\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1129\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"611818\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10435\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CWS1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301661\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1488\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111012\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG/NSGC, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25394175\",\"@Source\":\"PubMed\"}}]}","public_definition":"The PTEN hamartoma tumor syndrome (PHTS) includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), PTEN-related Proteus syndrome (PS), and Proteus-like syndrome. CS is a multiple hamartoma syndrome with a high risk for benign and malignant tumors of the thyroid, breast, and endometrium. Affected individuals usually have macrocephaly, trichilemmomas, and papillomatous papules, and present by the late 20s. The lifetime risk of developing breast cancer is 85%, with an average age of diagnosis between 38 and 46 years. The lifetime risk for thyroid cancer (usually follicular, rarely papillary, but never medullary thyroid cancer) is approximately 35%. The risk for endometrial cancer may approach 28%. BRRS is a congenital disorder characterized by macrocephaly, intestinal hamartomatous polyposis, lipomas, and pigmented macules of the glans penis. PS is a complex, highly variable disorder involving congenital malformations and hamartomatous overgrowth of multiple tissues, as well as connective tissue nevi, epidermal nevi, and hyperostoses. Proteus-like syndrome is undefined but refers to individuals with significant clinical features of PS who do not meet the diagnostic criteria for PS.","medgen_id":"CN072330","alternate_names":[],"name":"Cowden syndrome 1","disease_mechanism":"gain of function","id":"13756","alternate_symbols":["MHAM"],"type":"Disease","disease_mechanism_id":"274","xrefs":["{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MHAM\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6202\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MHAM\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509012\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509038\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514929\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514990\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520030\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520869\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520871\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520872\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522278\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528059\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528377\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528910\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528912\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528914\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552183\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556509\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1488\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LCA3","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301475\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1298\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"30285347\",\"@Source\":\"PubMed\"},{\"$\":\"NBK531510\",\"@Source\":\"BookShelf\"}]}]}","medgen_id":"C1858677","alternate_names":["RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED","SPATA7-Related Retinitis Pigmentosa"],"name":"Leber congenital amaurosis 3","id":"2458","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"604232\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604232\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"609868.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"609868.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Leber+congenital+amaurosis+type+3/4137\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604232\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9661\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BTHS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301486\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1309\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"25299040\",\"@Source\":\"PubMed\"},{\"$\":\"NBK247162\",\"@Source\":\"BookShelf\"}]}]}","public_definition":"Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial gestalt (most evident in infancy); not all features may be present in a given patient. Cardiomyopathy, which is almost always present before age five years, is typically dilated cardiomyopathy with or without endocardial fibroelastosis (EFE) or left ventricular noncompaction (LVNC); rarely it is hypertrophic cardiomyopathy (HCM). Heart failure is a significant cause of morbidity and mortality; risk of arrhythmia and sudden death is increased. Neutropenia is most often associated with mouth ulcers, pneumonia, and sepsis. The non-progressive myopathy predominantly affects the proximal muscles, and results in early motor delays. Prepubertal growth delay is followed by a post-pubertal growth spurt with remarkable \"catch-up\" growth. Heterozygous females who have a normal karyotype are asymptomatic and have normal biochemical studies.","medgen_id":"C0574083","alternate_names":["Barth syndrome","CARDIOMYOPATHY, DILATED, X-LINKED FATAL INFANTILE","Dilated cardiomyopathy 3A","LEFT VENTRICULAR NONCOMPACTION, ISOLATED, X-LINKED","LEFT VENTRICULAR NONCOMPACTION, X-LINKED"],"name":"3-Methylglutaconic aciduria type 2","id":"487","alternate_symbols":["CDFI","CMD3A","EFE","EMFE","INVM","LVNCX","MGA2","MGCA2"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"302060\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"111\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"barth-syndrome\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Barth syndrome\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5890\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Barth syndrome\"}","{\"db\":\"OMIM\",\"id\":\"300069\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CARDIOMYOPATHY, DILATED, X-LINKED FATAL INFANTILE\"}","{\"db\":\"OMIM\",\"id\":\"300183\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEFT VENTRICULAR NONCOMPACTION, ISOLATED, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300183\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEFT VENTRICULAR NONCOMPACTION, X-LINKED\"}","{\"db\":\"OMIM\",\"id\":\"300069\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CDFI\"}","{\"db\":\"OMIM\",\"id\":\"300069\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMD3A\"}","{\"db\":\"OMIM\",\"id\":\"305300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EFE\"}","{\"db\":\"OMIM\",\"id\":\"305300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EMFE\"}","{\"db\":\"OMIM\",\"id\":\"300183\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"INVM\"}","{\"db\":\"OMIM\",\"id\":\"300183\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LVNCX\"}","{\"db\":\"OMIM\",\"id\":\"302060\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGA2\"}","{\"db\":\"OMIM\",\"id\":\"302060\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGCA2\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Barth+Syndrome/744\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"297231002\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK247162\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"302060\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5890\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PCTT","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"22379635\",\"@Source\":\"PubMed\"},{\"$\":\"NBK84399\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24624459\",\"@Source\":\"PubMed\"},{\"$\":\"NBK190101\",\"@Source\":\"BookShelf\"}]}]}","medgen_id":"C0238339","alternate_names":["Hereditary chronic pancreatitis","PRSS1-Related Hereditary Pancreatitis"],"name":"Hereditary pancreatitis","id":"3261","alternate_symbols":["CPANC","HP","HPC"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"167800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"676\"}","{\"db\":\"Orphanet\",\"id\":\"676\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hereditary chronic pancreatitis\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK84399\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PRSS1-Related Hereditary Pancreatitis\"}","{\"db\":\"OMIM\",\"id\":\"167800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HP\"}","{\"db\":\"OMIM\",\"id\":\"167800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HPC\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hereditary+pancreatitis/3373\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6632\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"68072000\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"167800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"NBIA5","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"23447832\",\"@Source\":\"PubMed\"},{\"$\":\"NBK121988\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"28211668\",\"@Source\":\"PubMed\"},{\"$\":\"NBK424403\",\"@Source\":\"BookShelf\"}]}]}","public_definition":"Beta-propeller protein-associated neurodegeneration (BPAN) is typically characterized by early-onset seizures, infantile-onset developmental delay, intellectual disability, absent to limited expressive language, motor dysfunction (ataxia), and abnormal behaviors often similar to autism spectrum disorder. Seizure types including generalized (absence, tonic, atonic, tonic-clonic and myoclonic), focal with impaired consciousness, and epileptic spasms, as well as epileptic syndromes (West syndrome and Lennox-Gastaut syndrome) can be seen. With age seizures tend to resolve or become less prominent, whereas cognitive decline and movement disorders (progressive parkinsonism and dystonia) emerge as characteristic findings.","medgen_id":"C3550973","alternate_names":["Neurodegeneration with brain iron accululation 5","STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD"],"name":"Neurodegeneration with brain iron accumulation 5","id":"17735","alternate_symbols":["BPAN","SENDA"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"300894\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"329284\"}","{\"db\":\"OMIM\",\"id\":\"300894\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD\"}","{\"db\":\"OMIM\",\"id\":\"300894\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BPAN\"}","{\"db\":\"OMIM\",\"id\":\"300894\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SENDA\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK424403\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"300894\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":["{\"Attribute\":{\"$\":\"loss of function\",\"@Type\":\"disease mechanism\",\"@integerValue\":\"273\"},\"XRef\":[{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000505068\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000507480\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000507942\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000522527\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000568367\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000246735\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000260631\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520063\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520447\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528528\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000552214\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000556520\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000558532\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000514924\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520414\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528516\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000551442\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000325415\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000512526\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528276\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528500\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528536\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000556501\"}]}"],"keywords":[],"content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"3009617\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301469\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1292\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"HFSA, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20610207\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2002\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"12735292\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Eng et al., 2006\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"16980809\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Salviati et al, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"2869001\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EuroGentest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21934708\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"AHA/ASA, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25355838\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23860966\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","public_definition":"Fabry disease results from deficient activity of the enzyme alpha-galactosidase A (-Gal A) and progressive lysosomal deposition of globotriaosylceramide (GL-3) in cells throughout the body. The classic form, occurring in males with less than 1% -Gal A enzyme activity, usually has its onset in childhood or adolescence with periodic crises of severe pain in the extremities (acroparesthesia), the appearance of vascular cutaneous lesions (angiokeratomas), sweating abnormalities (anhidrosis, hypohidrosis, and rarely hyperhidrosis), characteristic corneal and lenticular opacities, and proteinuria. Gradual deterioration of renal function to end-stage renal disease (ESRD) usually occurs in men in the third to fifth decade. In middle age, most males successfully treated for ESRD develop cardiac and/or cerebrovascular disease, a major cause of morbidity and mortality. Heterozygous females typically have milder symptoms at a later age of onset than males. Rarely, they may be relatively asymptomatic throughout a normal life span or may have symptoms as severe as those observed in males with the classic phenotype. In contrast, males with greater than 1% -Gal A activity may have: (1) a cardiac variant phenotype that usually presents in the sixth to eighth decade with left ventricular hypertrophy, cardiomyopathy and arrhythmia, and proteinuria, but without ESRD; or (2) a renal variant phenotype, associated with ESRD but without the skin lesions or pain; or (3) cerebrovascular disease presenting as stroke or transient ischemic attack.","medgen_id":"C0002986","alternate_names":["Angiokeratoma corporis diffusum","Fabry syndrome","Fabry's disease"],"name":"Fabry disease","disease_mechanism":"Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.","id":"1790","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"301500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"324\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Angiokeratoma corporis diffusum\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001071\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry syndrome\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Fabry+Disease/2690\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry's disease\"}","{\"db\":\"SNOMED CT\",\"id\":\"16652001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fabry's disease\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500007\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"fabry-disease\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6400\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1292\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"FAP1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301519\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1345\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ASCRS, 2001\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"11598466\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21368914\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO/ESMO, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25452455\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACG, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25645574\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","public_definition":"APC-associated polyposis conditions include: familial adenomatous polyposis (FAP), attenuated FAP, and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). FAP is a colon cancer predisposition syndrome in which hundreds to thousands of adenomatous colonic polyps develop, beginning, on average, at age 16 years (range 7-36 years). By age 35 years, 95% of individuals with FAP have polyps; without colectomy, colon cancer is inevitable. The mean age of colon cancer diagnosis in untreated individuals is 39 years (range 34-43 years). Extracolonic manifestations are variably present and include: polyps of the gastric fundus and duodenum, osteomas, dental anomalies, congenital hypertrophy of the retinal pigment epithelium (CHRPE), soft tissue tumors, desmoid tumors, and associated cancers. Attenuated FAP is characterized by multiple colonic polyps (average of 30), more proximally located polyps, and a diagnosis of colon cancer at a later age than in FAP. Certain extracolonic manifestations, such as gastric and duodenal polyps or cancers, are variably present in attenuated FAP; risk management may be substantially different between FAP and attenuated FAP. GAPPS is characterized by gastric fundic gland polyposis, increased risk of gastric cancer, and limited colonic involvement in most individuals reported.","medgen_id":"C2713442","alternate_names":["APC-Associated Polyposis Conditions","FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED","POLYPOSIS, ADENOMATOUS INTESTINAL"],"name":"Familial adenomatous polyposis 1","disease_mechanism":"loss of function","id":"15929","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"175100\",\"type\":\"MIM\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1345\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"APC-Associated Polyposis Conditions\"}","{\"db\":\"OMIM\",\"id\":\"611731.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0028\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0034\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0035\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0036\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0038\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0042\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0043\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"611731.0049\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"175100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"POLYPOSIS, ADENOMATOUS INTESTINAL\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000172265\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000321103\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330056\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500894\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501393\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501794\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508954\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512300\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512645\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515899\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520047\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520069\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520077\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520865\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520868\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520869\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520870\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520872\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521915\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522559\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527982\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528912\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529017\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530028\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530118\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552290\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552303\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558907\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1345\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"175100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"NSCLC","content":"{\"Citation\":[{\"@Abbrev\":\"FDA, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24868098\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Cooper et al., 2014\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"24673736\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"KCPSG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24627688\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"KCPSG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23667368\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NICE, 2013\",\"@Type\":\"practice guideline\",\"URL\":{\"$\":\"https://www.nice.org.uk/guidance/dg9\"}},{\"@Abbrev\":\"AHRQ, 2013\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin\"},\"URL\":{\"$\":\"https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf\"}}]}","public_definition":"Lung cancer is a disease in which certain cells in the lungs become abnormal and multiply uncontrollably to form a tumor. Lung cancer may not cause signs or symptoms in its early stages. Some people with lung cancer have chest pain, frequent coughing, blood in the mucus, breathing problems, trouble swallowing or speaking, loss of appetite and weight loss, fatigue, or swelling in the face or neck. Additional symptoms can develop if the cancer spreads (metastasizes) into other tissues. Lung cancer occurs most often in adults in their sixties or seventies. Most people who develop lung cancer have a history of long-term tobacco smoking; however, the condition can occur in people who have never smoked.Lung cancer is generally divided into two types, small cell lung cancer and non-small cell lung cancer, based on the size of the affected cells when viewed under a microscope. Non-small cell lung cancer accounts for 85 percent of lung cancer, while small cell lung cancer accounts for the remaining 15 percent.Small cell lung cancer grows quickly and in more than half of cases the cancer has spread beyond the lung by the time the condition is diagnosed. Small cell lung cancer often metastasizes, most commonly to the liver, brain, bones, and adrenal glands (small hormone-producing glands located on top of each kidney). After diagnosis, most people with small cell lung cancer survive for about 1 year; less than seven percent survive 5 years.Non-small cell lung cancer is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell lung carcinoma. Adenocarcinoma arises from the cells that line the small air sacs (alveoli) located throughout the lungs. Squamous cell carcinoma arises from squamous cells that line the passages leading from the windpipe (trachea) to the lungs (bronchi). Large cell carcinoma arises from epithelial cells that line the lungs. Large cell carcinoma encompasses non-small cell lung cancers that do not appear to be adenocarcinomas or squamous cell carcinomas. The 5-year survival rate for people with non-small cell lung cancer is usually between 11 and 17 percent; it can be lower or higher depending on the subtype and stage of the cancer.","medgen_id":"C0007131","alternate_names":["Non-small cell lung carcinoma"],"name":"Non-small cell lung cancer","disease_mechanism":"Other","id":"7728","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"283","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030358\",\"type\":\"primary\"}","{\"db\":\"MeSH\",\"id\":\"D002289\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030358\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Non-small cell lung carcinoma\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569448\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569877\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569888\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569891\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000571363\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Non-small+cell+lung+cancer/5250\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0030358\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7217\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"254637007\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"lung-cancer\",\"ref_field\":\"public_definition\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7217\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LQT1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301308\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1129\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]},{\"@Abbrev\":\"HRS/EHRA, 2012\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"21810866\",\"@Source\":\"PubMed\"}}]}","public_definition":"Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the ECG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.","medgen_id":"C4551647","alternate_names":[],"name":"Long QT syndrome 1","id":"2703","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"192500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"101016\"}","{\"db\":\"Orphanet\",\"id\":\"768\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Long+QT+syndrome+1/4297\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3284\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1129\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"192500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3284\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"NS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301303\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1124\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"AAP, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20876176\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}}]}","public_definition":"Noonan syndrome (NS) is characterized by characteristic facies, short stature, congenital heart defect, and developmental delay of variable degree. Other findings can include broad or webbed neck, unusual chest shape with superior pectus carinatum and inferior pectus excavatum, cryptorchidism, varied coagulation defects, lymphatic dysplasias, and ocular abnormalities. Although birth length is usually normal, final adult height approaches the lower limit of normal. Congenital heart disease occurs in 50%-80% of individuals. Pulmonary valve stenosis, often with dysplasia, is the most common heart defect and is found in 20%-50% of individuals. Hypertrophic cardiomyopathy, found in 20%-30% of individuals, may be present at birth or develop in infancy or childhood. Other structural defects include atrial and ventricular septal defects, branch pulmonary artery stenosis, and tetralogy of Fallot. Up to one fourth of affected individuals have mild intellectual disability, and language impairments in general are more common in NS than in the general population.","medgen_id":"C0028326","alternate_names":["Noonan's syndrome","Pseudo-Turner syndrome"],"name":"Noonan syndrome","disease_mechanism":"gain of function","id":"16513","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"274","xrefs":["{\"db\":\"MeSH\",\"id\":\"D009634\"}","{\"db\":\"OMIM\",\"id\":\"PS163950\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"648\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Noonan+Syndrome/5260\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Noonan's syndrome\"}","{\"db\":\"SNOMED CT\",\"id\":\"205824006\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Noonan's syndrome\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556456\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561810\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562242\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569093\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"noonan-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS163950\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7223\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"205824006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1124\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LDS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301312\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1133\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"CCS, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24882528\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173340\",\"@Source\":\"PubMed\"}}]}","public_definition":"Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant.","medgen_id":"C2697932","alternate_names":[],"name":"Loeys-Dietz syndrome","id":"16504","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS609192\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"60030\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Loeys-Dietz+Syndrome/4288\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"loeys-dietz-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS609192\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"446263001\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1133\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AAT1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301299\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1120\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"22237449\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173340\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C0345050","alternate_names":["AORTIC ANEURYSM, FAMILIAL THORACIC 1","Aortic aneurysm, thoracic"],"name":"Congenital aneurysm of ascending aorta","id":"4598","alternate_symbols":["FAA1"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"607086\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"229\"}","{\"db\":\"OMIM\",\"id\":\"607086\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"AORTIC ANEURYSM, FAMILIAL THORACIC 1\"}","{\"db\":\"CSER _CC_NCGL, University of Washington\",\"id\":\"UWMG_6261194\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Aortic aneurysm, thoracic\"}","{\"db\":\"OMIM\",\"id\":\"607086\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FAA1\"}","{\"db\":\"SNOMED CT\",\"id\":\"253646008\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"607086\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LFS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301488\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1311\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACS, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17392385\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}}]}","public_definition":"Li-Fraumeni syndrome (LFS) is a cancer predisposition syndrome associated with high risks for a diverse spectrum of childhood- and adult-onset malignancies. The lifetime risk of cancer in individuals with LFS is 70% for men and 90% for women. Five cancer types account for the majority of LFS tumors: adrenocortical carcinomas, breast cancer, central nervous system tumors, osteosarcomas, and soft-tissue sarcomas. LFS is associated with an increased risk of several additional cancers including leukemia, lymphoma, gastrointestinal cancers, cancers of head and neck, kidney, larynx, lung, skin (e.g., melanoma), ovary, pancreas, prostate, testis, and thyroid. Individuals with LFS are at increased risk for cancer in childhood and young adulthood; survivors are at increased risk for multiple primary cancers.","medgen_id":"C0085390","alternate_names":["Sarcoma family syndrome of Li and Fraumeni"],"name":"Li-Fraumeni syndrome","id":"10539","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS151623\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"524\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"li-fraumeni-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS151623\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"428850001\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1311\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"FA","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301575\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1401\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"18197057\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACOG, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19888064\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"FARF, 2008\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Fanconi Anemia Research Fund, Guidelines for Diagnosis and Management, 2008\"},\"URL\":{\"$\":\"http://www.fanconi.org/images/uploads/other/Guidelines_for_Diagnosis_and_Management.pdf\"}}]}","public_definition":"Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: short stature, abnormal skin pigmentation, skeletal malformations of the upper and lower limbs, microcephaly, and ophthalmic and genitourinary tract anomalies. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of acute myeloid leukemia is 13% by age 50 years. Solid tumors  particularly of the head and neck, skin, gastrointestinal tract, and genitourinary tract  are more common in individuals with FA.","medgen_id":"C0015625","alternate_names":["Fanconi's anemia"],"name":"Fanconi anemia","id":"1797","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS227650\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"84\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Fanconi+Anemia/2780\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fanconi's anemia\"}","{\"db\":\"SNOMED CT\",\"id\":\"30575002\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Fanconi's anemia\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"fanconi-anemia\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS227650\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6425\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"84\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1401\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"227650\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HSAN3","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301359\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1180\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"18197057\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACOG, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19888064\",\"@Source\":\"PubMed\"}}]}","public_definition":"Familial dysautonomia (FD) affects the development and survival of sensory, sympathetic, and parasympathetic neurons. It is a debilitating disease present from birth. Neuronal degeneration progresses throughout life. Affected individuals have gastrointestinal dysfunction, vomiting crises, recurrent pneumonia, altered sensitivity to pain and temperature perception, and cardiovascular instability. About 40% of individuals have autonomic crises. Hypotonia contributes to delay in acquisition of motor milestones. Older individuals often have a broad-based and ataxic gait that deteriorates over time. Life expectancy is decreased.","medgen_id":"C0013364","alternate_names":["FD","HSAN III","NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III"],"name":"Familial dysautonomia","disease_mechanism":"loss of function","id":"3177","alternate_symbols":["DYS"],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"223900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1764\"}","{\"db\":\"OMIM\",\"id\":\"223900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FD\"}","{\"db\":\"OMIM\",\"id\":\"223900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HSAN III\"}","{\"db\":\"OMIM\",\"id\":\"223900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III\"}","{\"db\":\"OMIM\",\"id\":\"223900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DYS\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561913\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569442\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569982\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570010\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570054\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000571198\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hereditary+sensory+and+autonomic+neuropathy+3/3379\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7581\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"29159009\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1180\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"223900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301544\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1370\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"18197057\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACOG, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19888064\",\"@Source\":\"PubMed\"}}]}","public_definition":"Acid sphingomyelinase (ASM) deficiency has been categorized in the past as either neuronopathic (Niemann-Pick disease type A [NPD-A]), with death in early childhood, or non-neuronopathic (Niemann-Pick disease type B [NPD-B]). While forms intermediate to these two extremes occur, all ASM deficiency that is not NPD-A is designated in this review as NPD-B, despite its wide range of manifestations and severity. The first symptom in NPD-A is hepatosplenomegaly, usually noted by age three months; over time the liver and spleen become massive. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year. NPD type B, later in onset and milder in manifestations than NPD type A, is characterized by hepatosplenomegaly with progressive hypersplenism and stable liver dysfunction, gradual deterioration in pulmonary function, osteopenia, and atherogenic lipid profile. Progressive and/or clinically significant neurologic manifestations occur infrequently. Survival to adulthood can occur.","medgen_id":"C0268242","alternate_names":["SPHINGOMYELIN LIPIDOSIS","SPHINGOMYELINASE DEFICIENCY"],"name":"Niemann-Pick disease, type A","disease_mechanism":"loss of function","id":"5650","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"257200\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"77292\"}","{\"db\":\"OMIM\",\"id\":\"257200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPHINGOMYELIN LIPIDOSIS\"}","{\"db\":\"OMIM\",\"id\":\"257200\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SPHINGOMYELINASE DEFICIENCY\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000051492\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000246735\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330870\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501745\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501749\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506506\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507864\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522527\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528634\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551442\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556495\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556506\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556507\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556508\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556520\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558532\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569406\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569442\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570010\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570054\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000571198\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Niemann-Pick+Disease%2C+Type+A/5226\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"52165006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1370\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301690\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1517\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"AHRQ, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"NBK248310\",\"@Source\":\"BookShelf\"}},{\"@Abbrev\":\"HRS/EHRA/APHRS, 2013\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"23994779\",\"@Source\":\"PubMed\"}}]}","public_definition":"Brugada syndrome is characterized by cardiac conduction abnormalities (ST-segment abnormalities in leads V1-V3 on ECG and a high risk for ventricular arrhythmias) that can result in sudden death. Brugada syndrome presents primarily during adulthood although age at diagnosis may range from infancy to late adulthood. The mean age of sudden death is approximately 40 years. Clinical presentations may also include sudden infant death syndrome (SIDS; death of a child during the first year of life without an identifiable cause) and the sudden unexpected nocturnal death syndrome (SUNDS), a typical presentation in individuals from Southeast Asia. Other conduction defects can include first-degree AV block, intraventricular conduction delay, right bundle branch block, and sick sinus syndrome.","medgen_id":"C1142166","alternate_names":["Sudden Unexplained Death Syndrome","Sudden Unexplained Nocturnal Death Syndrome (SUNDS)","Sudden unexplained nocturnal death syndrome"],"name":"Brugada syndrome","id":"16748","alternate_symbols":["BrS","SUNDS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS601144\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"130\"}","{\"db\":\"MeSH\",\"id\":\"D053840\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Sudden Unexplained Death Syndrome\"}","{\"db\":\"MeSH\",\"id\":\"D053840\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Sudden Unexplained Nocturnal Death Syndrome (SUNDS)\"}","{\"db\":\"OMIM\",\"id\":\"601144\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SUNDS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Brugada+Syndrome/982\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"brugada-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS601144\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1030\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"418818005\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1517\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"RP","mode_of_inheritance":"Autosomal dominant, autosomal recessive and X linked inheritance","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301590\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1417\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGentest, 2012\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"22234150\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Bakondi et al., 2015\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"26666451\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C0035334","alternate_names":["Retinotapetal degeneration","Tapetoretinal degeneration"],"name":"Retinitis pigmentosa","id":"9558","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000547\",\"type\":\"primary\"}","{\"db\":\"MeSH\",\"id\":\"D012174\"}","{\"db\":\"OMIM\",\"id\":\"268000\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"PS268000\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"791\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000547\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Retinotapetal degeneration\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000547\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Tapetoretinal degeneration\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561973\",\"ref_field\":\"mode_of_inheritance\"}","{\"db\":\"ADAM\",\"id\":\"CN038210\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Retinitis+pigmentosa/6248\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS268000\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5694\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"28835009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"268000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5694\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MFM1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301486\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1309\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301672\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1499\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"AAN, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25313375\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C1832370","alternate_names":["DESMIN-RELATED MYOPATHY WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY","Desminopathy","Dilated cardiomyopathy 1F","MYOFIBRILLAR MYOPATHY WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY","MYOPATHY, MYOFIBRILLAR, DESMIN-RELATED"],"name":"Myofibrillar myopathy 1","id":"3420","alternate_symbols":["CMD1F","LGMD2R"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"601419\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"98909\"}","{\"db\":\"OMIM\",\"id\":\"601419\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DESMIN-RELATED MYOPATHY WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY\"}","{\"db\":\"Orphanet\",\"id\":\"98909\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Desminopathy\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Dilated+cardiomyopathy+1F/8249\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dilated cardiomyopathy 1F\"}","{\"db\":\"OMIM\",\"id\":\"601419\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOFIBRILLAR MYOPATHY WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY\"}","{\"db\":\"OMIM\",\"id\":\"601419\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MYOPATHY, MYOFIBRILLAR, DESMIN-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"601419\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LGMD2R\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Myofibrillar+myopathy%2C+desmin-related/8941\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601419\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MPS2","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301451\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1274\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21863056\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Giugliani et al., 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25071396\",\"@Source\":\"PubMed\"}}]}","public_definition":"Mucopolysaccharidosis type II (MPS II; also known as Hunter syndrome) is an X-linked multisystem disorder characterized by glycosaminoglycan (GAG) accumulation. The vast majority of affected individuals are male; on rare occasion heterozygous females manifest findings. Age of onset, disease severity, and rate of progression vary significantly among affected males. In those with early progressive disease, CNS involvement (manifest primarily by progressive cognitive deterioration), progressive airway disease, and cardiac disease usually result in death in the first or second decade of life. In those with slowly progressive disease, the CNS is not (or is minimally) affected, although the effect of GAG accumulation on other organ systems may be early progressive to the same degree as in those who have progressive cognitive decline. Survival into the early adult years with normal intelligence is common in the slowly progressing form of the disease. Additional findings in both forms of MPS II include: short stature; macrocephaly with or without communicating hydrocephalus; macroglossia; hoarse voice; conductive and sensorineural hearing loss; hepatosplenomegaly; dysostosis multiplex; spinal stenosis; and carpal tunnel syndrome.","medgen_id":"C0026705","alternate_names":["Hunter Syndrome","IDS deficiency","MPS II","SIDS deficiency","Sulfoiduronate sulfatase deficiency"],"name":"Mucopolysaccharidosis, MPS-II","id":"10834","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"309900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"217085\"}","{\"db\":\"Orphanet\",\"id\":\"217093\"}","{\"db\":\"Orphanet\",\"id\":\"580\"}","{\"db\":\"OMIM\",\"id\":\"309900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MPS II\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mucopolysaccharidosis+type+II/4913\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"70737009\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1274\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"309900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"ACMG, 2002\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110944\",\"@Source\":\"pmc\"}}}","medgen_id":"C3266898","alternate_names":["Waardenburg's syndrome"],"name":"Waardenburg syndrome","id":"7993","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS193500\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"3440\"}","{\"db\":\"SNOMED CT\",\"id\":\"47434006\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Waardenburg's syndrome\"}","{\"db\":\"OMIM\",\"id\":\"PS193500\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5525\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"ACMG, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111030\",\"@Source\":\"pmc\"}}}","medgen_id":"C1386048","alternate_names":["In utero growth retardation","Intrauterine growth failure","Intrauterine growth retardation, IUGR","Intrauterine retardation","Prenatal growth deficiency","Prenatal growth failure","Prenatal growth retardation","Prenatal-onset growth retardation","Small for gestational age infant"],"name":"Intrauterine growth retardation","id":"22430","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001515\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008862\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008892\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008931\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"In utero growth retardation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Intrauterine growth failure\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Intrauterine growth retardation, IUGR\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Intrauterine retardation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prenatal growth deficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prenatal growth failure\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prenatal growth retardation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Prenatal-onset growth retardation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Small for gestational age infant\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001511\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"FPF","content":"{\"Citation\":{\"@Abbrev\":\"EMQN, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3500529\",\"@Source\":\"pmc\"}}}","medgen_id":"C1275126","alternate_names":[],"name":"TNF receptor-associated periodic fever syndrome (TRAPS)","id":"3288","alternate_symbols":["FHF","TRAPS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"142680\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"32960\"}","{\"db\":\"OMIM\",\"id\":\"142680\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FHF\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8457\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FHF\"}","{\"db\":\"OMIM\",\"id\":\"142680\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TRAPS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8457\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TRAPS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Periodic+fever%2C+familial%2C+autosomal+dominant/5672\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"403833009\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"142680\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8457\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"FCAS1","content":"{\"Citation\":{\"@Abbrev\":\"EMQN, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3500529\",\"@Source\":\"pmc\"}}}","medgen_id":"C4551895","alternate_names":["COLD-INDUCED AUTOINFLAMMATORY SYNDROME, FAMILIAL","CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 1","FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1"],"name":"Familial cold urticaria","id":"5063","alternate_symbols":["CAPS1","FCAS","FCU"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"120100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"47045\"}","{\"db\":\"OMIM\",\"id\":\"120100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"COLD-INDUCED AUTOINFLAMMATORY SYNDROME, FAMILIAL\"}","{\"db\":\"OMIM\",\"id\":\"120100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 1\"}","{\"db\":\"OMIM\",\"id\":\"120100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1\"}","{\"db\":\"OMIM\",\"id\":\"606416.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1\"}","{\"db\":\"OMIM\",\"id\":\"606416.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1\"}","{\"db\":\"OMIM\",\"id\":\"606416.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1\"}","{\"db\":\"OMIM\",\"id\":\"606416.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1\"}","{\"db\":\"OMIM\",\"id\":\"606416.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1\"}","{\"db\":\"OMIM\",\"id\":\"120100\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CAPS1\"}","{\"db\":\"OMIM\",\"id\":\"120100\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FCAS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9535\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FCAS\"}","{\"db\":\"OMIM\",\"id\":\"120100\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FCU\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+Cold+Autoinflammatory+Syndrome+%28FCAS%29/2732\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9535\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"238687000\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"120100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"AMP, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23978506\",\"@Source\":\"PubMed\"}}}","medgen_id":"C0027022","alternate_names":["Myeloproliferative disease"],"name":"Myeloproliferative disorder","id":"17629","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005547\",\"type\":\"primary\"}","{\"db\":\"MeSH\",\"id\":\"D009196\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005547\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"425333006\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24651602\",\"@Source\":\"PubMed\"}}}","medgen_id":"C1384666","alternate_names":["Congenital hearing loss","Hearing defect","Hypoacusis"],"name":"Hearing impairment","id":"17089","alternate_symbols":[],"type":"Finding","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000365\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000404\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001728\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001729\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001754\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008560\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008563\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000365\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital hearing loss\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000365\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hearing defect\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000365\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hypoacusis\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hearing+Impairment/3253\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000365\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}}}","medgen_id":"C2750405","alternate_names":[],"name":"Malignant rhabdoid tumor, somatic","disease_mechanism":"loss of function","id":"9191","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000309827\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551656\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552477\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568144\",\"ref_field\":\"disease_mechanism\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EJM","content":"{\"Citation\":{\"@Abbrev\":\"EFNS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20298421\",\"@Source\":\"PubMed\"}}}","medgen_id":"C0270853","alternate_names":[],"name":"Juvenile myoclonic epilepsy","id":"2103","alternate_symbols":["EJM1","JME"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"254770\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"PS254770\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"307\"}","{\"db\":\"OMIM\",\"id\":\"254770\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EJM1\"}","{\"db\":\"OMIM\",\"id\":\"254770\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"JME\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6808\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"JME\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Juvenile+myoclonic+epilepsy/3937\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6808\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"254770\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6808\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"NIHF","content":"{\"Citation\":{\"@Abbrev\":\"EMQN, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25052315\",\"@Source\":\"PubMed\"}}}","medgen_id":"C0455988","alternate_names":[],"name":"Non-immune hydrops fetalis","id":"14401","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"236750\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"363999\"}","{\"db\":\"SNOMED CT\",\"id\":\"276509008\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"236750\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"RCM","content":"{\"Citation\":{\"@Abbrev\":\"HRS/EHRA, 2012\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"21810866\",\"@Source\":\"PubMed\"}}}","public_definition":"Familial restrictive cardiomyopathy is a genetic form of heart disease. For the heart to beat normally, the heart (cardiac) muscle must contract and relax in a coordinated way. Oxygen-rich blood from the lungs travels first through the upper chambers of the heart (the atria), and then to the lower chambers of the heart (the ventricles).In people with familial restrictive cardiomyopathy, the heart muscle is stiff and cannot fully relax after each contraction. Impaired muscle relaxation causes blood to back up in the atria and lungs, which reduces the amount of blood in the ventricles.Familial restrictive cardiomyopathy can appear anytime from childhood to adulthood. The first signs and symptoms of this condition in children are failure to gain weight and grow at the expected rate (failure to thrive), extreme tiredness (fatigue), and fainting. Children who are severely affected may also have abnormal swelling or puffiness (edema), increased blood pressure, an enlarged liver, an abnormal buildup of fluid in the abdominal cavity (ascites), and lung congestion. Some children with familial restrictive cardiomyopathy do not have any obvious signs or symptoms, but they may die suddenly due to heart failure. Without treatment, the majority of affected children survive only a few years after they are diagnosed.Adults with familial restrictive cardiomyopathy typically first develop shortness of breath, fatigue, and a reduced ability to exercise. Some individuals have an irregular heart beat (arrhythmia) and may also experience a sensation of fluttering or pounding in the chest (palpitations) and dizziness. Abnormal blood clots are commonly seen in adults with this condition. Without treatment, approximately one-third of adults with familial restrictive cardiomyopathy do not survive more than five years after diagnosis.","medgen_id":"C0340429","alternate_names":[],"name":"Familial restrictive cardiomyopathy","id":"16785","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS115210\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"217635\"}","{\"db\":\"OMIM\",\"id\":\"PS115210\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"233878008\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"familial-restrictive-cardiomyopathy\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AUTS","content":"{\"Citation\":{\"@Abbrev\":\"ISCA, 2010\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"20466091\",\"@Source\":\"PubMed\"}}}","medgen_id":"C0004352","alternate_names":[],"name":"Autistic disorder of childhood onset","id":"474","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000717\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"209850\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Autistic+disorder+of+childhood+onset/7772\",\"ref_field\":\"name\"}","{\"db\":\"MeSH\",\"id\":\"D001321\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"43614003\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":["Hereditary cancer syndrome"],"symbol":"TGCT","content":"{\"Citation\":{\"@Abbrev\":\"NACB, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19042984\",\"@Source\":\"PubMed\"}}}","medgen_id":"C0153594","alternate_names":["GERM CELL TUMOR, SOMATIC","Primordial germ cell tumor susceptibility locus 1","TESTICULAR TERATOMA, SOMATIC","Testicular tumor, somatic"],"name":"Malignant tumor of testis","id":"8043","alternate_symbols":["MGCT","PGCT1"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"273300\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"164920.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GERM CELL TUMOR, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"603517.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"TESTICULAR TERATOMA, SOMATIC\"}","{\"db\":\"OMIM\",\"id\":\"273300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGCT\"}","{\"db\":\"OMIM\",\"id\":\"605288\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PGCT1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Malignant+tumor+of+testis/8785\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"363449006\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"273300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"DD","content":"{\"Citation\":{\"@Abbrev\":\"AAN/CNS, 2011\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"21956720\",\"@Source\":\"PubMed\"}}}","medgen_id":"C0557874","alternate_names":["Cognitive delay","Delayed cognitive development","Delayed development","Delayed developmental milestones","Delayed intellectual development","Delayed milestones","Delayed psychomotor development","Developmental delay in early childhood","Developmental retardation","Lack of psychomotor development","Mental and motor retardation","Motor and developmental delay","Psychomotor delay","Psychomotor development deficiency","Psychomotor development failure","Psychomotor developmental delay","Retarded development","Retarded mental development","Retarded psychomotor development"],"name":"Global developmental delay","disease_mechanism":"loss of function","id":"17050","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000754\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001255\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001277\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001292\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002433\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002473\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002532\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006793\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006867\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006885\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006935\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007005\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007094\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007106\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007174\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007224\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007228\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007342\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cognitive delay\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed cognitive development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed developmental milestones\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed intellectual development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed milestones\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Delayed psychomotor development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Developmental delay in early childhood\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Developmental retardation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lack of psychomotor development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mental and motor retardation\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Motor and developmental delay\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Psychomotor delay\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Psychomotor development deficiency\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Psychomotor development failure\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Psychomotor developmental delay\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Retarded development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Retarded mental development\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001263\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Retarded psychomotor development\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509471\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520936\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521543\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522222\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000553938\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558520\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568239\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569041\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501388\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SDS1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301722\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1756\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"Dror et al., 2011\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"22191555\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24624459\",\"@Source\":\"PubMed\"},{\"$\":\"NBK190101\",\"@Source\":\"BookShelf\"}]}]}","public_definition":"Shwachman-Diamond syndrome (SDS) is characterized by: exocrine pancreatic dysfunction with malabsorption, malnutrition, and growth failure; hematologic abnormalities with single- or multilineage cytopenias and susceptibility to myelodysplasia syndrome (MDS) and acute myelogeneous leukemia (AML); and bone abnormalities. In almost all affected children, persistent or intermittent neutropenia is a common presenting finding, often before the diagnosis of SDS is made. Short stature and recurrent infections are common.","medgen_id":"C4692625","alternate_names":[],"name":"Shwachman-Diamond syndrome 1","id":"4392","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"260400\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"811\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1756\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"260400\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CMTX1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301548\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1374\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2010\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"2987431\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301532\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1358\",\"@Source\":\"BookShelf\"}]}]}","public_definition":"GJB1 disorders are typically characterized by peripheral motor and sensory neuropathy with or without fixed CNS abnormalities and/or acute, self-limited episodes of transient neurologic dysfunction (especially weakness and dysarthria). Peripheral neuropathy typically manifests in affected males between ages five and 25 years. Although both men and women are affected, manifestations tend to be less severe in women, some of whom may remain asymptomatic. Less commonly, initial manifestations in some affected individuals are stroke-like episodes (acute fulminant episodes of reversible CNS dysfunction).","medgen_id":"C0393808","alternate_names":["CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1","Charcot-Marie-Tooth Neuropathy X Type 1"],"name":"X-linked hereditary motor and sensory neuropathy","id":"787","alternate_symbols":["CMT2","CMTX"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"302800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"101075\"}","{\"db\":\"OMIM\",\"id\":\"302800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1374\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Charcot-Marie-Tooth Neuropathy X Type 1\"}","{\"db\":\"OMIM\",\"id\":\"302800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMT2\"}","{\"db\":\"OMIM\",\"id\":\"302800\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMTX\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1258\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMTX\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Charcot-Marie-Tooth+Disease+X-Linked+1/1311\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"230552007\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1374\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"302800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PFHB1A","content":"{\"Citation\":{\"@Abbrev\":\"HRS/EHRA/APHRS, 2013\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"23994779\",\"@Source\":\"PubMed\"}}}","medgen_id":"C1879286","alternate_names":["HEART BLOCK, PROGRESSIVE FAMILIAL, TYPE I","PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA"],"name":"Progressive familial heart block type 1A","id":"4024","alternate_symbols":["HBBD","PFHBI","PFHBIA"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"113900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"871\"}","{\"db\":\"OMIM\",\"id\":\"113900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HEART BLOCK, PROGRESSIVE FAMILIAL, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"113900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA\"}","{\"db\":\"OMIM\",\"id\":\"600163.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA\"}","{\"db\":\"OMIM\",\"id\":\"600163.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA\"}","{\"db\":\"OMIM\",\"id\":\"600163.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA\"}","{\"db\":\"OMIM\",\"id\":\"600163.0031\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA\"}","{\"db\":\"OMIM\",\"id\":\"113900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HBBD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1093\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HBBD\"}","{\"db\":\"OMIM\",\"id\":\"113900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PFHBI\"}","{\"db\":\"OMIM\",\"id\":\"113900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PFHBIA\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Progressive+familial+heart+block+type+1A/5978\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1093\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"113900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1093\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"NCCN, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"22138009\",\"@Source\":\"PubMed\"}}}","medgen_id":"C0017638","alternate_names":[],"name":"Glioma","id":"18479","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009733\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS137800\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"182067\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009733\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS137800\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6513\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"393564001\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":["Hereditary cancer syndrome"],"content":"{\"Citation\":{\"@Abbrev\":\"Papastefanou et al., 2011\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"3135138\",\"@Source\":\"pmc\"}}}","medgen_id":"C0220633","alternate_names":[],"name":"Intraocular melanoma","id":"5470","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007716\",\"type\":\"primary\"}","{\"db\":\"MeSH\",\"id\":\"C536494\"}","{\"db\":\"OMIM\",\"id\":\"155720\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"39044\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Intraocular+melanoma/3855\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007716\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8621\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ASGD3","content":"{\"Citation\":{\"@Abbrev\":\"EuroGentest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"3061995\",\"@Source\":\"pmc\"}}}","medgen_id":"C1866560","alternate_names":["Iridogoniodysgenesis type1"],"name":"Anterior segment dysgenesis 3","id":"5346","alternate_symbols":["IGDA","IRID1"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"601631\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"91483\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Iridogoniodysgenesis+type1/3868\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Iridogoniodysgenesis type1\"}","{\"db\":\"OMIM\",\"id\":\"601631\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IGDA\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2978\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IGDA\"}","{\"db\":\"OMIM\",\"id\":\"601631\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IRID1\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2978\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"IRID1\"}","{\"db\":\"OMIM\",\"id\":\"601631\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BCM","content":"{\"Citation\":{\"@Abbrev\":\"EuroGentest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"3110038\",\"@Source\":\"pmc\"}}}","public_definition":"Blue cone (OPN1SW; 613522) monochromatism is a rare X-linked congenital stationary cone dysfunction syndrome characterized by the absence of functional long wavelength-sensitive and medium wavelength-sensitive cones in the retina. Color discrimination is severely impaired from birth, and vision is derived from the remaining preserved blue (S) cones and rod photoreceptors. BCM typically presents with reduced visual acuity, pendular nystagmus, and photophobia. Patients often have myopia (review by Gardner et al., 2009). There is evidence for progression of disease in some BCM families (Nathans et al., 1989; Ayyagari et al., 2000; Michaelides et al., 2005).","medgen_id":"C0339537","alternate_names":["Blue cone monochromacy","Blue cone monochromatism","S-cone monochromacy"],"name":"Cone monochromatism","id":"10837","alternate_symbols":["CBBM"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007939\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"303700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"16\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007939\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Blue cone monochromacy\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007939\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Blue cone monochromatism\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007939\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"S-cone monochromacy\"}","{\"db\":\"OMIM\",\"id\":\"303700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CBBM\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"917\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CBBM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cone+monochromatism/8037\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"24704003\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"303700\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"303700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"917\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":["{\"Attribute\":{\"$\":\"C0949658\",\"@Type\":\"CUI, rejected\"}}"],"keywords":[],"symbol":"CMH1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301559\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1385\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301725\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1768\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21267010\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"AHRQ, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"NBK248310\",\"@Source\":\"BookShelf\"}},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]}]}","public_definition":"Hypertrophic cardiomyopathy (HCM) is typically defined by the presence of unexplained left ventricular hypertrophy (LVH). Such LVH occurs in a non-dilated ventricle in the absence of other cardiac or systemic disease capable of producing the observed magnitude of increased LV wall thickness, such as pressure overload (e.g., long-standing hypertension, aortic stenosis) or storage/infiltrative disorders (e.g., Fabry disease, amyloidosis). The clinical manifestations of HCM range from asymptomatic LVH to progressive heart failure to sudden cardiac death (SCD), and vary from individual to individual even within the same family. Common symptoms include shortness of breath (particularly with exertion), chest pain, palpitations, orthostasis, presyncope, and syncope. Most often the LVH of HCM becomes apparent during adolescence or young adulthood, although it may also develop late in life, in infancy, or in childhood.","medgen_id":"C3495498","alternate_names":["MYH7-Related Familial Hypertrophic Cardiomyopathy"],"name":"Familial hypertrophic cardiomyopathy 1","id":"1311","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"192600\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+hypertrophic+cardiomyopathy+1/8382\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"192600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AD","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301340\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1161\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301414\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1236\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EFNS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20831773\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"AHRQ, 2010\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"21500874\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG/NSGC, 2011\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3326653\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"CCCDTD, 2014\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"24829003\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C0002395","alternate_names":["ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE","Alzheimer's disease","Presenile and senile dementia"],"name":"Alzheimer disease","id":"222","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002511\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006878\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007213\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"104300\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1020\"}","{\"db\":\"OMIM\",\"id\":\"104760.0022\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ALZHEIMER DISEASE, FAMILIAL, 1, AUTOSOMAL RECESSIVE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Alzheimer+Disease/349\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Alzheimer's disease\"}","{\"db\":\"SNOMED CT\",\"id\":\"26929004\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Alzheimer's disease\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002511\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"104300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"OI","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301472\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1295\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2006\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110960\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111019\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"EMQN, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3234509\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"Orphanet, 2008\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)\"},\"URL\":{\"$\":\"https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf\"}}]}","public_definition":"COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).","medgen_id":"C0029434","alternate_names":[],"name":"Osteogenesis imperfecta","id":"6312","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"MeSH\",\"id\":\"D010013\"}","{\"db\":\"OMIM\",\"id\":\"PS166200\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"666\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Osteogenesis+imperfecta/5451\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS166200\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1017\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"78314001\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1295\",\"ref_field\":\"public_definition\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1017\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HNPCC","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301390\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1211\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EGAPP, 2009\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"2743612\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ASCRS, 2001\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"11598466\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15604628\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23788249\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"AMA/NCHPEG, 2012\",\"@Type\":\"Suggested Reading\",\"URL\":{\"$\":\"http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf\"}},{\"@Abbrev\":\"MSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25070057\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CAPS, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3585492\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"MSTF, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25003300\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ASCO/ESMO, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25452455\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Mork et al., 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25711197\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Dutch SCG, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23535968\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACG, 2015\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25645574\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Mallorca group, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23408351\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25356965\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Recommendation\",\"ID\":[{\"$\":\"27854360\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2016.190\",\"@Source\":\"DOI\"}]},{\"@Abbrev\":\"SGO, 2014\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Society of Gynecologic Oncology (SGO) Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer\"},\"URL\":{\"$\":\"https://www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer\"}}]}","public_definition":"Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, stomach, ovary, small bowel, hepatobiliary tract, urinary tract, brain, and skin. In individuals with Lynch syndrome the following lifetime risks for cancer are seen: CRC: 52%-82% (mean age at diagnosis 44-61 years). Endometrial cancer in females: 25%-60% (mean age at diagnosis 48-62 years). Gastric cancer: 6%-13% (mean age at diagnosis 56 years). Ovarian cancer: 4%-12% (mean age at diagnosis 42.5 years; ~30% are diagnosed \u003c age 40 years). The risk for other Lynch syndrome-related cancers is lower, though substantially increased over general population rates.","medgen_id":"C1333990","alternate_names":[],"name":"Lynch syndrome","disease_mechanism":"loss of function","id":"14688","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS120435\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"144\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000316595\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000321105\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000322202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000325623\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332519\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512403\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512828\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515774\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515821\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000518997\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000518999\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519150\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519254\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520030\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520080\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520392\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520865\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520867\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520868\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520869\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520870\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520871\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520872\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522224\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522225\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522278\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522559\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527981\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528529\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528534\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528914\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528915\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528930\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529017\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530028\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530202\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551450\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551459\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551461\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551463\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551464\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552183\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552184\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552440\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558503\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558908\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561860\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562151\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568362\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568365\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569958\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570011\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"GeneTests\",\"id\":\"2622\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hereditary+Non-Polyposis+Colorectal+Cancer+%28HNPCC%29/3371\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9905\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1211\",\"ref_field\":\"public_definition\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9905\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ABL","content":"{\"Citation\":[{\"@Abbrev\":\"EuroGentest, 2012\",\"@Type\":\"Translational/Evidence-based\",\"URL\":{\"$\":\"http://www.nature.com/ejhg/journal/vaop/ncurrent/full/ejhg201230a.html\"}},{\"@Abbrev\":\"EFNS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20050888\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"30358967\",\"@Source\":\"PubMed\"},{\"$\":\"NBK532447\",\"@Source\":\"BookShelf\"}]}]}","public_definition":"Abetalipoproteinemia typically presents in infancy with failure to thrive, diarrhea, vomiting, and malabsorption of fat. Hematologic manifestations may include acanthocytosis (irregularly spiculated erythrocytes), anemia, reticulocytosis, and hemolysis with resultant hyperbilirubinemia. Malabsorption of fat-soluble vitamins (A, D, E, and K) can result in an increased international normalized ratio (INR). Untreated individuals may develop atypical pigmentation of the retina that may present with progressive loss of night vision and/or color vision in adulthood. Neuromuscular findings in untreated individuals including progressive loss of deep tendon reflexes, vibratory sense, and proprioception; muscle weakness; dysarthria; and ataxia typically manifest in the first or second decades of life.","medgen_id":"C0000744","alternate_names":["Abetalipoproteinemia","MTP DEFICIENCY"],"name":"Abetalipoproteinaemia","id":"61","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008181\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"200100\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"14\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0008181\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abetalipoproteinemia\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Abetalipoproteinemia\"}","{\"db\":\"OMIM\",\"id\":\"200100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MTP DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+Hypobetalipoproteinemia+%28FHBL%29/2751\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"190787008\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK532447\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"200100\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301293\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1114\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Weill-Marchesani syndrome (WMS) is a connective tissue disorder characterized by abnormalities of the lens of the eye, proportionate short stature, brachydactyly, and joint stiffness. The ocular problems, typically recognized in childhood, include microspherophakia (small spherical lens), myopia secondary to the abnormal shape of the lens, ectopia lentis (abnormal position of the lens), and glaucoma, which can lead to blindness. Height of adult males is 142-169 cm; height of adult females is 130-157 cm. Autosomal recessive and autosomal dominant WMS cannot be distinguished by clinical findings alone.","medgen_id":"C0265313","alternate_names":[],"name":"Weill-Marchesani syndrome","id":"9574","alternate_symbols":["WMS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS277600\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"3449\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4936\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"WMS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Weill-Marchesani+syndrome/7461\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"weill-marchesani-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS277600\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4936\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1114\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":["{\"Attribute\":{\"$\":\"loss of function\",\"@Type\":\"disease mechanism\",\"@integerValue\":\"273\"},\"XRef\":[{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000323271\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000525921\"}]}"],"keywords":[],"symbol":"THPH1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301327\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1148\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3160733","alternate_names":["Blood clot in vein","Prothrombin-Related Thrombophilia (Factor II)","THROMBOPHILIA DUE TO FACTOR 2 DEFECT","Thrombophilia","Thrombosis susceptibility"],"name":"Venous thrombosis","disease_mechanism":"gain of function","id":"24727","alternate_symbols":["F2"],"type":"Finding","disease_mechanism_id":"274","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004936\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"188050\",\"type\":\"MIM\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004936\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Blood clot in vein\"}","{\"db\":\"OMIM\",\"id\":\"188050\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"THROMBOPHILIA DUE TO FACTOR 2 DEFECT\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Thrombophilia/7086\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thrombophilia\"}","{\"db\":\"SNOMED CT\",\"id\":\"234467004\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Thrombophilia\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000500305\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"F2\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000025288\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000174333\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000321099\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000331922\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000331933\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332126\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502122\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502510\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000503192\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507481\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509249\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511144\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520021\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520078\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521336\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521660\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530629\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531243\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552060\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556387\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004936\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"188050\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301334\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1155\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C0013421","alternate_names":["Dystonic disease","Dystonic movements"],"name":"Dystonia","id":"16759","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001332\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002328\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS128100\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001332\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dystonic disease\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001332\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Dystonic movements\"}","{\"db\":\"GeneTests\",\"id\":\"25706\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Dystonia/2405\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS128100\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BDMR","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301337\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1158\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1838126","alternate_names":[],"name":"Brachydactyly-Mental Retardation syndrome","id":"1058","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"600430\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1001\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Brachydactyly-Mental+Retardation+syndrome/1525\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10202\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"600430\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BSCL","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301391\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1212\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality.","medgen_id":"C0221032","alternate_names":[],"name":"Congenital generalized lipodystrophy","id":"9462","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009059\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS608594\",\"type\":\"Phenotypic series\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009059\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1212\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":["FLNA-Related Disorders"],"symbol":"PVNH1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301392\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1213\",\"@Source\":\"BookShelf\"}]}}","public_definition":"FLNA-related periventricular nodular heterotopia (PVNH), a neuronal migration disorder, is characterized by the presence of uncalcified nodules of neurons ectopically situated along the surface of the lateral ventricles. Affected individuals are predominantly heterozygous females; males most often show early lethality. Affected females present with seizures at an average age of 14-15 years; intelligence ranges from normal to borderline. The risk for cardiovascular disease, stroke, and other vascular/coagulation problems appears to be increased.","medgen_id":"C1848213","alternate_names":["HETEROTOPIA, PERIVENTRICULAR, 1","Heterotopia, periventricular, Ehlers-Danlos variant","PERIVENTRICULAR NODULAR HETEROTOPIA 4","X-linked periventricular heterotopia"],"name":"Periventricular nodular heterotopia 1","id":"1645","alternate_symbols":["BPNH","NHBP","PVNH4"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"300049\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2149\"}","{\"db\":\"Orphanet\",\"id\":\"82004\"}","{\"db\":\"OMIM\",\"id\":\"300017.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HETEROTOPIA, PERIVENTRICULAR, 1\"}","{\"db\":\"OMIM\",\"id\":\"300017.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HETEROTOPIA, PERIVENTRICULAR, 1\"}","{\"db\":\"OMIM\",\"id\":\"300017.0019\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HETEROTOPIA, PERIVENTRICULAR, 1\"}","{\"db\":\"OMIM\",\"id\":\"300017.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HETEROTOPIA, PERIVENTRICULAR, 1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Heterotopia%2C+periventricular%2C+Ehlers-Danlos+variant/8549\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Heterotopia, periventricular, Ehlers-Danlos variant\"}","{\"db\":\"OMIM\",\"id\":\"300049\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PERIVENTRICULAR NODULAR HETEROTOPIA 4\"}","{\"db\":\"OMIM\",\"id\":\"300537\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PERIVENTRICULAR NODULAR HETEROTOPIA 4\"}","{\"db\":\"Genetic Alliance\",\"id\":\"X-linked+periventricular+heterotopia/7556\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"X-linked periventricular heterotopia\"}","{\"db\":\"SNOMED CT\",\"id\":\"448227009\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"X-linked periventricular heterotopia\"}","{\"db\":\"OMIM\",\"id\":\"300049\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BPNH\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7371\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BPNH\"}","{\"db\":\"OMIM\",\"id\":\"300049\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NHBP\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7371\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NHBP\"}","{\"db\":\"OMIM\",\"id\":\"300049\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PVNH4\"}","{\"db\":\"OMIM\",\"id\":\"300537\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PVNH4\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7371\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1213\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"300049\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7371\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PNKD1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301400\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1221\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Familial paroxysmal nonkinesigenic dyskinesia (PNKD) is characterized by unilateral or bilateral involuntary movements. Attacks are typically precipitated by coffee, tea, or alcohol; they can also be triggered by excitement, stress, or fatigue, or can be spontaneous. Attacks involve dystonic posturing with choreic and ballistic movements, may be accompanied by a preceding aura, occur while the individual is awake, and are not associated with seizures. Attacks last minutes to hours and rarely occur more than once per day. Attack frequency, duration, severity, and combinations of symptoms vary within and among families. Age of onset is typically in childhood or early teens but can be as late as age 50 years.","medgen_id":"C1869117","alternate_names":[],"name":"Paroxysmal non-kinesigenic dyskinesia","id":"40688","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Orphanet\",\"id\":\"98810\"}","{\"db\":\"Orphanet\",\"id\":\"98810\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1221\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":["Neoplasm"],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301413\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1235\",\"@Source\":\"BookShelf\"}]}}","public_definition":"The disorder hereditary multiple osteochondromas (HMO), previously called hereditary multiple exostoses (HME), is characterized by growths of multiple osteochondromas (benign cartilage-capped bone tumors that grow outward from the metaphyses of long bones). Osteochondromas can be associated with a reduction in skeletal growth, bony deformity, restricted joint motion, shortened stature, premature osteoarthrosis, and compression of peripheral nerves. The median age of diagnosis is three years; nearly all affected individuals are diagnosed by age 12 years. The risk for malignant degeneration to osteochondrosarcoma increases with age, although the lifetime risk of malignant degeneration is low (~1%).","medgen_id":"C0015306","alternate_names":["DIAPHYSEAL ACLASIS","MULTIPLE CARTILAGINOUS EXOSTOSES","MULTIPLE OSTEOCHONDROMAS","Multiple exostoses","OSTEOCHONDROMATOSIS"],"name":"Multiple congenital exostosis","id":"5053","alternate_symbols":["EXT"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002762\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"133700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"321\"}","{\"db\":\"OMIM\",\"id\":\"133700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIAPHYSEAL ACLASIS\"}","{\"db\":\"OMIM\",\"id\":\"133700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MULTIPLE CARTILAGINOUS EXOSTOSES\"}","{\"db\":\"OMIM\",\"id\":\"133700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MULTIPLE OSTEOCHONDROMAS\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002762\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Multiple exostoses\"}","{\"db\":\"OMIM\",\"id\":\"133700\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"OSTEOCHONDROMATOSIS\"}","{\"db\":\"OMIM\",\"id\":\"133700\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"EXT\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Multiple+congenital+exostosis/8916\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"254044004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1235\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301415\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1237\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Rothmund-Thomson syndrome (RTS) is characterized by a rash that progresses to poikiloderma; sparse hair, eyelashes, and/or eyebrows; small size; skeletal and dental abnormalities; cataracts; and an increased risk for cancer, especially osteosarcoma. The skin is typically normal at birth; the rash of RTS develops between ages three and six months as erythema, swelling, and blistering on the face, subsequently spreading to the buttocks and extremities. The rash evolves over months to years into the chronic pattern of reticulated hypo- and hyperpigmentation, punctate atrophy, and telangiectasias, collectively known as poikiloderma. Hyperkeratotic lesions occur in approximately one third of individuals. Skeletal abnormalities include radial ray defects, ulnar defects, absent or hypoplastic patella, and osteopenia.","medgen_id":"C0032339","alternate_names":[],"name":"Rothmund-Thomson syndrome","id":"4358","alternate_symbols":["RTS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS268400\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2909\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4392\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"RTS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Rothmund+Thomson+syndrome/6363\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"rothmund-thomson-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS268400\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"69093006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1237\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PKD1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301424\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1246\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Autosomal dominant polycystic kidney disease (ADPKD) is generally a late-onset multisystem disorder characterized by bilateral renal cysts, liver cysts, and an increased risk of intracranial aneurysms. Other manifestations include: cysts in the pancreas, seminal vesicles, and arachnoid membrane; dilatation of the aortic root and dissection of the thoracic aorta; mitral valve prolapse; and abdominal wall hernias. Renal manifestations include hypertension, renal pain, and renal insufficiency. Approximately 50% of individuals with ADPKD have end-stage renal disease (ESRD) by age 60 years. The prevalence of liver cysts increases with age and occasionally results in clinically significant severe polycystic liver disease (PLD). Overall the prevalence of intracranial aneurysms is fivefold higher than in the general population and further increased in those with a positive family history of aneurysms or subarachnoid hemorrhage. There is substantial variability in the severity of renal disease and other extrarenal manifestations even within the same family.","medgen_id":"C3149841","alternate_names":["POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE","POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE I","Polycystic Kidney, Autosomal Dominant","Polycystic kidney disease 1","Polycystic kidney disease 1, severe"],"name":"Polycystic kidney disease, adult type","id":"3359","alternate_symbols":["ADPKD","APKD1","PKD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"173900\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"173900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"POLYCYSTIC KIDNEY DISEASE 1 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE\"}","{\"db\":\"OMIM\",\"id\":\"173900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"POLYCYSTIC KIDNEY DISEASE, ADULT, TYPE I\"}","{\"db\":\"OMIM\",\"id\":\"173900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ADPKD\"}","{\"db\":\"OMIM\",\"id\":\"173900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"APKD1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Polycystic+kidney+disease%2C+adult+type/9125\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"28728008\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1246\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"173900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CBAVD","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301428\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1250\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include progressive obstructive lung disease with bronchiectasis, frequent hospitalizations for pulmonary disease, pancreatic insufficiency and malnutrition, recurrent sinusitis and bronchitis, and male infertility. Pulmonary disease is the major cause of morbidity and mortality in CF. Meconium ileus occurs at birth in 15%-20% of newborns with CF. More than 95% of males with CF are infertile. Congenital absence of the vas deferens (CAVD) is generally identified during evaluation of infertility or as an incidental finding at the time of a surgical procedure. Hypoplasia or aplasia of the vas deferens and seminal vesicles may occur either bilaterally or unilaterally. Testicular development and function and spermatogenesis are usually normal.","medgen_id":"C0403814","alternate_names":[],"name":"Congenital bilateral aplasia of vas deferens from CFTR mutation","disease_mechanism":"loss of function","id":"3944","alternate_symbols":["CAVD"],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"277180\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"48\"}","{\"db\":\"OMIM\",\"id\":\"277180\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CAVD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5461\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CAVD\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000028916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508890\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508893\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528606\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558875\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558928\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569639\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1250\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"277180\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5461\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HPS","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301464\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1287\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.","medgen_id":"C0079504","alternate_names":[],"name":"Hermansky-Pudlak syndrome","id":"2033","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS203300\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"79430\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hermansky-Pudlak+syndrome/3391\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"hermansky-pudlak-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS203300\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6643\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"9311003\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1287\",\"ref_field\":\"public_definition\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6643\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301465\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1288\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Nemaline myopathy is a disorder that primarily affects skeletal muscles, which are muscles that the body uses for movement. People with nemaline myopathy have muscle weakness (myopathy) throughout the body, but it is typically most severe in the muscles of the face; neck; trunk; and other muscles close to the center of the body (proximal muscles), such as those of the upper arms and legs. This weakness can worsen over time. Affected individuals may have feeding and swallowing difficulties, foot deformities, abnormal curvature of the spine (scoliosis), and joint deformities (contractures). Most people with nemaline myopathy are able to walk, although some affected children may begin walking later than usual. As the condition progresses, some people may require wheelchair assistance. In severe cases, the muscles used for breathing are affected and life-threatening breathing difficulties can occur.Nemaline myopathy is divided into six types. In order of decreasing severity, the types are: severe congenital, Amish, intermediate congenital, typical congenital, childhood-onset, and adult-onset. The types are distinguished by the age when symptoms first appear and the severity of symptoms; however, there is overlap among the various types. The severe congenital type is the most life-threatening. Most individuals with this type do not survive past early childhood due to respiratory failure. The Amish type solely affects the Old Order Amish population of Pennsylvania and is typically fatal in early childhood. The most common type of nemaline myopathy is the typical congenital type, which is characterized by muscle weakness and feeding problems beginning in infancy. Most of these individuals do not have severe breathing problems and can walk unassisted. People with the childhood-onset type usually develop muscle weakness in adolescence. The adult-onset type is the mildest of all the various types. People with this type usually develop muscle weakness between ages 20 and 50.","medgen_id":"C0206157","alternate_names":["Myopathies, Nemaline"],"name":"Nemaline myopathy","id":"9537","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS161800\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"607\"}","{\"db\":\"OMIM\",\"id\":\"PS161800\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"75072002\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"nemaline-myopathy\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LCA","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301475\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1298\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C0339527","alternate_names":["Leber's amaurosis"],"name":"Leber congenital amaurosis","id":"16716","alternate_symbols":["CRB"],"type":"Disease","xrefs":["{\"db\":\"MeSH\",\"id\":\"D057130\"}","{\"db\":\"OMIM\",\"id\":\"PS204000\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"65\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Leber+congenital+amaurosis/4130\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Leber's amaurosis\"}","{\"db\":\"SNOMED CT\",\"id\":\"193413001\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Leber's amaurosis\"}","{\"db\":\"OMIM\",\"id\":\"204000\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CRB\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"leber-congenital-amaurosis\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS204000\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"634\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"204000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"634\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301479\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1302\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Stickler syndrome is a connective tissue disorder that can include ocular findings of myopia, cataract, and retinal detachment; hearing loss that is both conductive and sensorineural; midfacial underdevelopment and cleft palate (either alone or as part of the Robin sequence); and mild spondyloepiphyseal dysplasia and/or precocious arthritis. Variable phenotypic expression of Stickler syndrome occurs both within and among families; interfamilial variability is in part explained by locus and allelic heterogeneity.","medgen_id":"C0265253","alternate_names":[],"name":"Stickler syndrome","id":"9571","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS108300\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"828\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"stickler-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS108300\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"78675000\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1302\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"RDPA","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301527\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1353\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Refsum disease is characterized by anosmia and early-onset retinitis pigmentosa, which are both universal findings with variable combinations of neuropathy, deafness, ataxia, and ichthyosis. Onset of symptoms ranges from age seven months to older than age 50 years. Cardiac arrhythmia and heart failure caused by cardiomyopathy are potentially severe health problems that develop later in life.","medgen_id":"C0034960","alternate_names":["HMSN IV","REFSUM DISEASE, CLASSIC"],"name":"Phytanic acid storage disease","disease_mechanism":"loss of function","id":"5851","alternate_symbols":["HMSN4"],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"Gene\",\"id\":\"8024\"}","{\"db\":\"OMIM\",\"id\":\"266500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"773\"}","{\"db\":\"OMIM\",\"id\":\"266500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HMSN IV\"}","{\"db\":\"OMIM\",\"id\":\"266500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"REFSUM DISEASE, CLASSIC\"}","{\"db\":\"OMIM\",\"id\":\"266500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HMSN4\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000004880\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000318975\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506571\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000506572\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515436\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000525961\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000553865\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561876\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569521\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Phytanic+acid+storage+disease/9107\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Refsum+disease+with+increased+pipecolic+acidemia/6182\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"25362006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1353\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"600964\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4371\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PBD9B","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301527\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1353\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Refsum disease is characterized by anosmia and early-onset retinitis pigmentosa, which are both universal findings with variable combinations of neuropathy, deafness, ataxia, and ichthyosis. Onset of symptoms ranges from age seven months to older than age 50 years. Cardiac arrhythmia and heart failure caused by cardiomyopathy are potentially severe health problems that develop later in life.","medgen_id":"CN159238","alternate_names":["PEROXISOME BIOGENESIS DISORDER, PEX7-RELATED, ATYPICAL"],"name":"Peroxisome biogenesis disorder 9B","id":"17440","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"614879\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"773\"}","{\"db\":\"OMIM\",\"id\":\"614879\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PEROXISOME BIOGENESIS DISORDER, PEX7-RELATED, ATYPICAL\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1353\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614879\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301549\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1375\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Congenital hyperinsulinism is a condition that causes individuals to have abnormally high levels of insulin, which is a hormone that helps control blood sugar levels. People with this condition have frequent episodes of low blood sugar (hypoglycemia). In infants and young children, these episodes are characterized by a lack of energy (lethargy), irritability, or difficulty feeding. Repeated episodes of low blood sugar increase the risk for serious complications such as breathing difficulties, seizures, intellectual disability, vision loss, brain damage, and coma.The severity of congenital hyperinsulinism varies widely among affected individuals, even among members of the same family. About 60 percent of infants with this condition experience a hypoglycemic episode within the first month of life. Other affected children develop hypoglycemia by early childhood. Unlike typical episodes of hypoglycemia, which occur most often after periods without food (fasting) or after exercising, episodes of hypoglycemia in people with congenital hyperinsulinism can also occur after eating.","medgen_id":"C3888018","alternate_names":[],"name":"Familial hyperinsulinism","disease_mechanism":"loss of function","id":"9496","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"Orphanet\",\"id\":\"276525\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000559250\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561792\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569442\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570010\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570054\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000571198\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"congenital-hyperinsulinism\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":["FLNA-Related Disorders"],"symbol":"FMD1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301567\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1393\",\"@Source\":\"BookShelf\"}]}}","public_definition":"The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following: Otopalatodigital syndrome type 1 (OPD1). Otopalatodigital syndrome type 2 (OPD2). Frontometaphyseal dysplasia type 1 (FMD1). Melnick-Needles syndrome (MNS). Terminal osseous dysplasia with pigmentary skin defects (TODPD). In OPD1, most manifestations are present at birth; females can present with severity similar to affected males, although some have only mild manifestations. In OPD2, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia resulting in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require respiratory support and assistance with feeding. In FMD1, females are less severely affected than related affected males. Males do not experience a progressive skeletal dysplasia but may have joint contractures and hand and foot malformations. Progressive scoliosis is observed in both affected males and females. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity. MNS in males results in perinatal lethality in all recorded cases. TODPD, seen only in females, is characterized by a skeletal dysplasia that is most prominent in the digits, pigmentary defects of the skin, and recurrent digital fibromata.","medgen_id":"C4281559","alternate_names":[],"name":"Frontometaphyseal dysplasia 1","id":"5165","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"305620\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1826\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1393\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"305620\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"JLNS","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301579\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1405\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually \u003e500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.","medgen_id":"C0022387","alternate_names":[],"name":"Jervell and Lange-Nielsen syndrome","id":"34624","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS220400\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"90647\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"jervell-and-lange-nielsen-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS220400\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"373905003\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1405\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CORD16","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301590\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1417\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C3281045","alternate_names":[],"name":"Cone-rod dystrophy 16","id":"16839","alternate_symbols":["C8orf37"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"614500\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cone-rod+dystrophy+16/8043\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"614500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301591\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1418\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Achromatopsia is characterized by reduced visual acuity, pendular nystagmus, increased sensitivity to light (photophobia), a small central scotoma, eccentric fixation, and reduced or complete loss of color discrimination. All individuals with achromatopsia (achromats) have impaired color discrimination along all three axes of color vision corresponding to the three cone classes: the protan or long-wavelength-sensitive cone axis (red), the deutan or middle-wavelength-sensitive cone axis (green), and the tritan or short-wavelength-sensitive cone axis (blue). Most individuals have complete achromatopsia, with total lack of function of all three types of cones. Rarely, individuals have incomplete achromatopsia, in which one or more cone types may be partially functioning. The manifestations are similar to those of individuals with complete achromatopsia, but generally less severe. Hyperopia is common in achromatopsia. Nystagmus develops during the first few weeks after birth followed by increased sensitivity to bright light. Best visual acuity varies with severity of the disease; it is 20/200 or less in complete achromatopsia and may be as high as 20/80 in incomplete achromatopsia. Visual acuity is usually stable over time; both nystagmus and sensitivity to bright light may improve slightly. Although the fundus is usually normal, macular changes (which may show early signs of progression) and vessel narrowing may be present in some affected individuals. Defects in the macula are visible on optical coherence tomography.","medgen_id":"C0152200","alternate_names":["Rod monochromacy"],"name":"Achromatopsia","id":"9454","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011516\",\"type\":\"primary\"}","{\"db\":\"Orphanet\",\"id\":\"49382\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011516\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Rod monochromacy\"}","{\"db\":\"GeneTests\",\"id\":\"2668\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Achromatopsia/9534\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0011516\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"56852002\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1418\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CLN6","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301601\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1428\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1866282","alternate_names":["CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE","CEROID LIPOFUSCINOSIS, NEURONAL, 6 (Kufs type)","CEROID LIPOFUSCINOSIS, NEURONAL, 6, VARIABLE AGE AT ONSET","CLN6-Related Neuronal Ceroid-Lipofuscinosis"],"name":"Ceroid lipofuscinosis neuronal 6","id":"770","alternate_symbols":["CLN4A","vLINCL"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"601780\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"168491\"}","{\"db\":\"Orphanet\",\"id\":\"228363\"}","{\"db\":\"OMIM\",\"id\":\"601780\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"601780\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEROID LIPOFUSCINOSIS, NEURONAL, 6 (Kufs type)\"}","{\"db\":\"OMIM\",\"id\":\"601780\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEROID LIPOFUSCINOSIS, NEURONAL, 6, VARIABLE AGE AT ONSET\"}","{\"db\":\"OMIM\",\"id\":\"601780\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CLN4A\"}","{\"db\":\"OMIM\",\"id\":\"601780\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"vLINCL\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Ceroid+Lipofuscinosis+Neuronal+6/1257\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1224\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"601780\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1224\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HSCR","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301612\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1439\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Hirschsprung disease (HSCR), or congenital intestinal aganglionosis, is a birth defect characterized by complete absence of neuronal ganglion cells from a portion of the intestinal tract. The aganglionic segment includes the distal rectum and a variable length of contiguous proximal intestine. In 80% of individuals, aganglionosis is restricted to the rectosigmoid colon (short-segment disease); in 15%-20%, aganglionosis extends proximal to the sigmoid colon (long-segment disease); in about 5%, aganglionosis affects the entire large intestine (total colonic aganglionosis). Rarely, the aganglionosis extends into the small bowel or even more proximally to encompass the entire bowel (total intestinal aganglionosis). HSCR is considered a neurocristopathy, a disorder of cells and tissues derived from the neural crest, and may occur as an isolated finding or as part of a multisystem disorder. Affected infants frequently present in the first two months of life with symptoms of impaired intestinal motility such as failure to pass meconium within the first 48 hours of life, constipation, emesis, abdominal pain or distention, and occasionally diarrhea. However, because the initial diagnosis of HSCR may be delayed until late childhood or adulthood, HSCR should be considered in anyone with lifelong severe constipation. Individuals with HSCR are at risk for enterocolitis and/or potentially lethal intestinal perforation.","medgen_id":"C0019569","alternate_names":["Hirschsprung's disease"],"name":"Hirschsprung disease","id":"16705","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"MeSH\",\"id\":\"D006627\"}","{\"db\":\"OMIM\",\"id\":\"PS142623\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"388\"}","{\"db\":\"SNOMED CT\",\"id\":\"204739008\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Hirschsprung's disease\"}","{\"db\":\"CSER _CC_NCGL, University of Washington\",\"id\":\"UWMG_2996999\",\"ref_field\":\"name\"}","{\"db\":\"CSER _CC_NCGL, University of Washington\",\"id\":\"UWMG_6421029\",\"ref_field\":\"name\"}","{\"db\":\"GeneTests\",\"id\":\"3084\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS142623\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"388\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1439\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"142623\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6660\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HSCR1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301612\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1439\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Hirschsprung disease (HSCR), or congenital intestinal aganglionosis, is a birth defect characterized by complete absence of neuronal ganglion cells from a portion of the intestinal tract. The aganglionic segment includes the distal rectum and a variable length of contiguous proximal intestine. In 80% of individuals, aganglionosis is restricted to the rectosigmoid colon (short-segment disease); in 15%-20%, aganglionosis extends proximal to the sigmoid colon (long-segment disease); in about 5%, aganglionosis affects the entire large intestine (total colonic aganglionosis). Rarely, the aganglionosis extends into the small bowel or even more proximally to encompass the entire bowel (total intestinal aganglionosis). HSCR is considered a neurocristopathy, a disorder of cells and tissues derived from the neural crest, and may occur as an isolated finding or as part of a multisystem disorder. Affected infants frequently present in the first two months of life with symptoms of impaired intestinal motility such as failure to pass meconium within the first 48 hours of life, constipation, emesis, abdominal pain or distention, and occasionally diarrhea. However, because the initial diagnosis of HSCR may be delayed until late childhood or adulthood, HSCR should be considered in anyone with lifelong severe constipation. Individuals with HSCR are at risk for enterocolitis and/or potentially lethal intestinal perforation.","medgen_id":"C3888239","alternate_names":["HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1","RET-Related Hirschsprung Disease"],"name":"Hirschsprung disease 1","id":"1649","alternate_symbols":["HD","MGC","RET"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"142623\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"388\"}","{\"db\":\"OMIM\",\"id\":\"142623\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0019\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0020\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0022\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0023\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0028\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0035\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0036\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0037\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0038\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"164761.0050\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1\"}","{\"db\":\"OMIM\",\"id\":\"142623\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MGC\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hirschsprung%27s+disease/3429\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6660\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1439\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"142623\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CHN1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301641\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1468\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C4721436","alternate_names":["Charcot-Marie-Tooth disease, type 4E","Congenital Hypomyelination","NEUROPATHY, CONGENITAL HYPOMYELINATING OR AMYELINATING, AUTOSOMAL RECESSIVE"],"name":"Congenital hypomyelinating neuropathy 1, autosomal recessive","id":"5635","alternate_symbols":["CHN","CMT4E"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"605253\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"99951\"}","{\"db\":\"OMIM\",\"id\":\"605253\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEUROPATHY, CONGENITAL HYPOMYELINATING OR AMYELINATING, AUTOSOMAL RECESSIVE\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9203\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CHN\"}","{\"db\":\"OMIM\",\"id\":\"605253\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMT4E\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9203\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMT4E\"}","{\"db\":\"OMIM\",\"id\":\"605253\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301654\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1481\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Three M syndrome is characterized by severe pre- and postnatal growth deficiency (final height 5-6 SD below the mean; i.e., 120-130 cm), characteristic facies, and normal intelligence. Additional features of three M syndrome include short broad neck, prominent trapezii, deformed sternum, short thorax, square shoulders, winged scapulae, hyperlordosis, short fifth fingers, prominent heels, and loose joints. Males with three M syndrome have hypogonadism and occasionally hypospadias.","medgen_id":"CN073943","alternate_names":[],"name":"Three M syndrome","id":"15549","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS273750\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2616\"}","{\"db\":\"OMIM\",\"id\":\"PS273750\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5667\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1481\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PPH1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301658\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1485\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Pulmonary arterial hypertension (PAH) is characterized by widespread obstruction and obliteration of the smallest pulmonary arteries. When a sufficient number of vessels are occluded, the resistance to blood flow through the lungs increases, and the right ventricle attempts to compensate by generating higher pressure to maintain pulmonary blood flow. When the right ventricle can no longer compensate for the increased resistance, progressive heart failure ensues. Initial symptoms include dyspnea (60%), fatigue (19%), syncope (8%), chest pain (7%), palpitations (5%), and leg edema (3%). All ages are affected, but the mean age at diagnosis is 36 years. Mean survival after diagnosis is 2.8 years; current therapy does improve clinical function but has modest effect on survival. The term \"heritable PAH\" (HPAH) includes familial PAH (PAH that occurs in two or more family members) and simplex PAH (i.e., a single occurrence in a family) when a pathogenic variant has been identified. Most heritable PAH (75%) is caused by a pathogenic variant in BMPR2; pathogenic variants in other genes (i.e., ACVRL1, KCNK3, CAV1, SMAD9, BMPR1B) are considerably less common (1%-3%). HPAH has identical symptoms, signs, and histology as PAH of unknown cause. The time from onset of symptoms to diagnosis may be shorter in individuals with familial PAH, possibly because of familial awareness of the disease. Three retrospective studies suggest that persons with PAH who have a BMPR2 pathogenic variant exhibit more severe disease.","medgen_id":"C4552070","alternate_names":["PULMONARY HYPERTENSION, PRIMARY, 1"],"name":"Primary pulmonary hypertension","id":"3581","alternate_symbols":["PAH","PHT"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"178600\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"422\"}","{\"db\":\"OMIM\",\"id\":\"178600\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0018\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0019\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0021\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0023\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0024\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"600799.0025\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PULMONARY HYPERTENSION, PRIMARY, 1\"}","{\"db\":\"OMIM\",\"id\":\"178600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PAH\"}","{\"db\":\"OMIM\",\"id\":\"178600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PHT\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Idiopathic+pulmonary+hypertension/3758\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"26174007\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1485\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"178600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BRGDA5","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301690\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1517\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Brugada syndrome is characterized by cardiac conduction abnormalities (ST-segment abnormalities in leads V1-V3 on ECG and a high risk for ventricular arrhythmias) that can result in sudden death. Brugada syndrome presents primarily during adulthood although age at diagnosis may range from infancy to late adulthood. The mean age of sudden death is approximately 40 years. Clinical presentations may also include sudden infant death syndrome (SIDS; death of a child during the first year of life without an identifiable cause) and the sudden unexpected nocturnal death syndrome (SUNDS), a typical presentation in individuals from Southeast Asia. Other conduction defects can include first-degree AV block, intraventricular conduction delay, right bundle branch block, and sick sinus syndrome.","medgen_id":"C2748541","alternate_names":[],"name":"Brugada syndrome 5","id":"10527","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"612838\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"130\"}","{\"db\":\"Orphanet\",\"id\":\"871\"}","{\"db\":\"GeneTests\",\"id\":\"318966\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Brugada+syndrome+5/7875\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1517\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"612838\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"TCS1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301704\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1532\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Treacher Collins syndrome (TCS) is characterized by bilateral and symmetric downslanting palpebral fissures, malar hypoplasia, micrognathia, and external ear abnormalities. Hypoplasia of the zygomatic bones and mandible can cause significant feeding and respiratory difficulties. About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities. Inner ear structures tend to be normal. Other, less common abnormalities include cleft palate and unilateral or bilateral choanal stenosis or atresia. Typically intellect is normal.","medgen_id":"CN119605","alternate_names":["MANDIBULOFACIAL DYSOSTOSIS"],"name":"Treacher Collins syndrome 1","id":"16740","alternate_symbols":["MFD1","TCS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"154500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"861\"}","{\"db\":\"OMIM\",\"id\":\"154500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MANDIBULOFACIAL DYSOSTOSIS\"}","{\"db\":\"OMIM\",\"id\":\"154500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MFD1\"}","{\"db\":\"OMIM\",\"id\":\"154500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TCS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Treacher+Collins+syndrome/7175\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1532\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"154500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301704\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1532\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Treacher Collins syndrome (TCS) is characterized by bilateral and symmetric downslanting palpebral fissures, malar hypoplasia, micrognathia, and external ear abnormalities. Hypoplasia of the zygomatic bones and mandible can cause significant feeding and respiratory difficulties. About 40%-50% of individuals have conductive hearing loss attributed most commonly to malformation of the ossicles and hypoplasia of the middle ear cavities. Inner ear structures tend to be normal. Other, less common abnormalities include cleft palate and unilateral or bilateral choanal stenosis or atresia. Typically intellect is normal.","medgen_id":"C0242387","alternate_names":["Mandibulofacial dysostosis"],"name":"Treacher Collins syndrome","id":"6070","alternate_symbols":["MFD1","TCOF","TCS"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005321\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS154500\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"861\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005321\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mandibulofacial dysostosis\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9124\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"MFD1\"}","{\"db\":\"OMIM\",\"id\":\"154500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TCOF\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9124\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TCOF\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9124\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"TCS\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"treacher-collins-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS154500\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9124\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"82203000\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1532\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":["Neoplasm"],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301728\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1828\",\"@Source\":\"BookShelf\"}]}}","public_definition":"GNPTAB-related disorders comprise the phenotypes mucolipidosis II (ML II) and mucolipidosis III/ (ML III/), and phenotypes intermediate between ML II and ML III/. ML II is evident at birth and slowly progressive; death most often occurs in early childhood. Orthopedic abnormalities present at birth may include thoracic deformity, kyphosis, clubfeet, deformed long bones, and/or dislocation of the hip(s). Growth often ceases in the second year of life; contractures develop in all large joints. The skin is thickened, facial features are coarse, and gingiva are hypertrophic. All children have cardiac involvement, most commonly thickening and insufficiency of the mitral valve and, less frequently, the aortic valve. Progressive mucosal thickening narrows the airways, and gradual stiffening of the thoracic cage contributes to respiratory insufficiency, the most common cause of death. ML III/ becomes evident at about age three years with slow growth rate and short stature; joint stiffness and pain initially in the shoulders, hips, and fingers; gradual mild coarsening of facial features; and normal to mildly impaired cognitive development. Pain from osteoporosis becomes more severe during adolescence. Cardiorespiratory complications (restrictive lung disease, thickening and insufficiency of the mitral and aortic valves, left and/or right ventricular hypertrophy) are common causes of death, typically in early to middle adulthood. Phenotypes intermediate between ML II and ML III/ are characterized by physical growth in infancy that resembles that of ML II and neuromotor and speech development that resemble that of ML III/.","medgen_id":"C2673377","alternate_names":["ML II ALPHA/BETA","Mucolipidosis II"],"name":"I cell disease","id":"3038","alternate_symbols":["GNPTA","ICD","ML II"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"252500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"576\"}","{\"db\":\"OMIM\",\"id\":\"252500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ML II ALPHA/BETA\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1828\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Mucolipidosis II\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6749\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GNPTA\"}","{\"db\":\"OMIM\",\"id\":\"252500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ICD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6749\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ICD\"}","{\"db\":\"OMIM\",\"id\":\"252500\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ML II\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mucolipidosis+II/3706\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6749\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1828\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CAMRQ1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301729\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1874\",\"@Source\":\"BookShelf\"}]}}","public_definition":"VLDLR cerebellar hypoplasia (VLDLR-CH) is characterized by non-progressive congenital ataxia that is predominantly truncal and results in delayed ambulation, moderate-to-profound intellectual disability, dysarthria, strabismus, and seizures. Children either learn to walk very late (often after age 6 years) or never achieve independent ambulation. Brain MRI findings include hypoplasia of the inferior portion of the cerebellar vermis and hemispheres, simplified gyration of the cerebral hemispheres, and small brain stem  particularly the pons.","medgen_id":"C4551552","alternate_names":["CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 1","CEREBELLAR ATAXIA, CONGENITAL, AND MENTAL RETARDATION, AUTOSOMAL RECESSIVE"],"name":"Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1","id":"15885","alternate_symbols":["VLDLRCH"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"224050\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1766\"}","{\"db\":\"OMIM\",\"id\":\"224050\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDAL LOCOMOTION 1\"}","{\"db\":\"OMIM\",\"id\":\"192977.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBELLAR ATAXIA, CONGENITAL, AND MENTAL RETARDATION, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"192977.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBELLAR ATAXIA, CONGENITAL, AND MENTAL RETARDATION, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"192977.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBELLAR ATAXIA, CONGENITAL, AND MENTAL RETARDATION, AUTOSOMAL RECESSIVE\"}","{\"db\":\"OMIM\",\"id\":\"224050\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBELLAR ATAXIA, CONGENITAL, AND MENTAL RETARDATION, AUTOSOMAL RECESSIVE\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1998\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"VLDLRCH\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1874\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"224050\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AO3","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301736\",\"@Source\":\"PubMed\"},{\"$\":\"NBK2534\",\"@Source\":\"BookShelf\"}]}}","public_definition":"The FLNB disorders include a spectrum of phenotypes ranging from mild to severe. At the mild end are spondylocarpotarsal synostosis (SCT) syndrome and Larsen syndrome; at the severe end are the phenotypic continuum of atelosteogenesis types I (AOI) and III (AOIII) and Piepkorn osteochondrodysplasia (POCD). SCT syndrome is characterized by postnatal disproportionate short stature, scoliosis and lordosis, clubfeet, hearing loss, dental enamel hypoplasia, carpal and tarsal synostosis, and vertebral fusions. Larsen syndrome is characterized by congenital dislocations of the hip, knee, and elbow; clubfeet (equinovarus or equinovalgus foot deformities); scoliosis and cervical kyphosis, which can be associated with a cervical myelopathy; short, broad, spatulate distal phalanges; distinctive craniofacies (prominent forehead, depressed nasal bridge, malar flattening, and widely spaced eyes); vertebral anomalies; and supernumerary carpal and tarsal bone ossification centers. Individuals with SCT syndrome and Larsen syndrome can have midline cleft palate and hearing loss. AOI and AOIII are characterized by severe short-limbed dwarfism; dislocated hips, knees, and elbows; and clubfeet. AOI is lethal in the perinatal period. In individuals with AOIII, survival beyond the neonatal period is possible with intensive and invasive respiratory support. Piepkorn osteochondrodysplasia (POCD) is a perinatal-lethal micromelic dwarfism characterized by flipper-like limbs (polysyndactyly with complete syndactyly of all fingers and toes, hypoplastic or absent first digits, and duplicated intermediate and distal phalanges), macrobrachycephaly, prominant forehead, hypertelorism, and exophthalmos. Occasional features include cleft palate, omphalocele, and cardiac and genitourinary anomalies. The radiographic features at mid-gestation are characteristic.","medgen_id":"C3668942","alternate_names":["Atelosteogenesis Type III"],"name":"Atelosteogenesis type 3","id":"351","alternate_symbols":["AOIII"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"108721\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"56305\"}","{\"db\":\"OMIM\",\"id\":\"108721\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AOIII\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10608\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AOIII\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Atelosteogenesis+Type+3/642\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10608\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK2534\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"108721\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10608\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"AO1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301736\",\"@Source\":\"PubMed\"},{\"$\":\"NBK2534\",\"@Source\":\"BookShelf\"}]}}","public_definition":"The FLNB disorders include a spectrum of phenotypes ranging from mild to severe. At the mild end are spondylocarpotarsal synostosis (SCT) syndrome and Larsen syndrome; at the severe end are the phenotypic continuum of atelosteogenesis types I (AOI) and III (AOIII) and Piepkorn osteochondrodysplasia (POCD). SCT syndrome is characterized by postnatal disproportionate short stature, scoliosis and lordosis, clubfeet, hearing loss, dental enamel hypoplasia, carpal and tarsal synostosis, and vertebral fusions. Larsen syndrome is characterized by congenital dislocations of the hip, knee, and elbow; clubfeet (equinovarus or equinovalgus foot deformities); scoliosis and cervical kyphosis, which can be associated with a cervical myelopathy; short, broad, spatulate distal phalanges; distinctive craniofacies (prominent forehead, depressed nasal bridge, malar flattening, and widely spaced eyes); vertebral anomalies; and supernumerary carpal and tarsal bone ossification centers. Individuals with SCT syndrome and Larsen syndrome can have midline cleft palate and hearing loss. AOI and AOIII are characterized by severe short-limbed dwarfism; dislocated hips, knees, and elbows; and clubfeet. AOI is lethal in the perinatal period. In individuals with AOIII, survival beyond the neonatal period is possible with intensive and invasive respiratory support. Piepkorn osteochondrodysplasia (POCD) is a perinatal-lethal micromelic dwarfism characterized by flipper-like limbs (polysyndactyly with complete syndactyly of all fingers and toes, hypoplastic or absent first digits, and duplicated intermediate and distal phalanges), macrobrachycephaly, prominant forehead, hypertelorism, and exophthalmos. Occasional features include cleft palate, omphalocele, and cardiac and genitourinary anomalies. The radiographic features at mid-gestation are characteristic.","medgen_id":"C0265283","alternate_names":[],"name":"Atelosteogenesis type 1","id":"462","alternate_symbols":["AOI"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"108720\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1190\"}","{\"db\":\"OMIM\",\"id\":\"108720\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AOI\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9287\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AOI\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Atelosteogenesis+Type+1/640\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9287\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK2534\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"108720\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BOOMD","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301736\",\"@Source\":\"PubMed\"},{\"$\":\"NBK2534\",\"@Source\":\"BookShelf\"}]}}","public_definition":"The FLNB disorders include a spectrum of phenotypes ranging from mild to severe. At the mild end are spondylocarpotarsal synostosis (SCT) syndrome and Larsen syndrome; at the severe end are the phenotypic continuum of atelosteogenesis types I (AOI) and III (AOIII) and Piepkorn osteochondrodysplasia (POCD). SCT syndrome is characterized by postnatal disproportionate short stature, scoliosis and lordosis, clubfeet, hearing loss, dental enamel hypoplasia, carpal and tarsal synostosis, and vertebral fusions. Larsen syndrome is characterized by congenital dislocations of the hip, knee, and elbow; clubfeet (equinovarus or equinovalgus foot deformities); scoliosis and cervical kyphosis, which can be associated with a cervical myelopathy; short, broad, spatulate distal phalanges; distinctive craniofacies (prominent forehead, depressed nasal bridge, malar flattening, and widely spaced eyes); vertebral anomalies; and supernumerary carpal and tarsal bone ossification centers. Individuals with SCT syndrome and Larsen syndrome can have midline cleft palate and hearing loss. AOI and AOIII are characterized by severe short-limbed dwarfism; dislocated hips, knees, and elbows; and clubfeet. AOI is lethal in the perinatal period. In individuals with AOIII, survival beyond the neonatal period is possible with intensive and invasive respiratory support. Piepkorn osteochondrodysplasia (POCD) is a perinatal-lethal micromelic dwarfism characterized by flipper-like limbs (polysyndactyly with complete syndactyly of all fingers and toes, hypoplastic or absent first digits, and duplicated intermediate and distal phalanges), macrobrachycephaly, prominant forehead, hypertelorism, and exophthalmos. Occasional features include cleft palate, omphalocele, and cardiac and genitourinary anomalies. The radiographic features at mid-gestation are characteristic.","medgen_id":"C0432201","alternate_names":[],"name":"Boomerang dysplasia","id":"514","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"112310\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1263\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Boomerang+Dysplasia/895\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"933\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"254054000\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK2534\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"112310\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SCT","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301736\",\"@Source\":\"PubMed\"},{\"$\":\"NBK2534\",\"@Source\":\"BookShelf\"}]}}","public_definition":"The FLNB disorders include a spectrum of phenotypes ranging from mild to severe. At the mild end are spondylocarpotarsal synostosis (SCT) syndrome and Larsen syndrome; at the severe end are the phenotypic continuum of atelosteogenesis types I (AOI) and III (AOIII) and Piepkorn osteochondrodysplasia (POCD). SCT syndrome is characterized by postnatal disproportionate short stature, scoliosis and lordosis, clubfeet, hearing loss, dental enamel hypoplasia, carpal and tarsal synostosis, and vertebral fusions. Larsen syndrome is characterized by congenital dislocations of the hip, knee, and elbow; clubfeet (equinovarus or equinovalgus foot deformities); scoliosis and cervical kyphosis, which can be associated with a cervical myelopathy; short, broad, spatulate distal phalanges; distinctive craniofacies (prominent forehead, depressed nasal bridge, malar flattening, and widely spaced eyes); vertebral anomalies; and supernumerary carpal and tarsal bone ossification centers. Individuals with SCT syndrome and Larsen syndrome can have midline cleft palate and hearing loss. AOI and AOIII are characterized by severe short-limbed dwarfism; dislocated hips, knees, and elbows; and clubfeet. AOI is lethal in the perinatal period. In individuals with AOIII, survival beyond the neonatal period is possible with intensive and invasive respiratory support. Piepkorn osteochondrodysplasia (POCD) is a perinatal-lethal micromelic dwarfism characterized by flipper-like limbs (polysyndactyly with complete syndactyly of all fingers and toes, hypoplastic or absent first digits, and duplicated intermediate and distal phalanges), macrobrachycephaly, prominant forehead, hypertelorism, and exophthalmos. Occasional features include cleft palate, omphalocele, and cardiac and genitourinary anomalies. The radiographic features at mid-gestation are characteristic.","medgen_id":"C1848934","alternate_names":[],"name":"Spondylocarpotarsal synostosis syndrome","id":"4449","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"272460\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3275\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spondylocarpotarsal+synostosis+syndrome/6801\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4974\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK2534\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"272460\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4974\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LRS","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301736\",\"@Source\":\"PubMed\"},{\"$\":\"NBK2534\",\"@Source\":\"BookShelf\"}]}}","public_definition":"The FLNB disorders include a spectrum of phenotypes ranging from mild to severe. At the mild end are spondylocarpotarsal synostosis (SCT) syndrome and Larsen syndrome; at the severe end are the phenotypic continuum of atelosteogenesis types I (AOI) and III (AOIII) and Piepkorn osteochondrodysplasia (POCD). SCT syndrome is characterized by postnatal disproportionate short stature, scoliosis and lordosis, clubfeet, hearing loss, dental enamel hypoplasia, carpal and tarsal synostosis, and vertebral fusions. Larsen syndrome is characterized by congenital dislocations of the hip, knee, and elbow; clubfeet (equinovarus or equinovalgus foot deformities); scoliosis and cervical kyphosis, which can be associated with a cervical myelopathy; short, broad, spatulate distal phalanges; distinctive craniofacies (prominent forehead, depressed nasal bridge, malar flattening, and widely spaced eyes); vertebral anomalies; and supernumerary carpal and tarsal bone ossification centers. Individuals with SCT syndrome and Larsen syndrome can have midline cleft palate and hearing loss. AOI and AOIII are characterized by severe short-limbed dwarfism; dislocated hips, knees, and elbows; and clubfeet. AOI is lethal in the perinatal period. In individuals with AOIII, survival beyond the neonatal period is possible with intensive and invasive respiratory support. Piepkorn osteochondrodysplasia (POCD) is a perinatal-lethal micromelic dwarfism characterized by flipper-like limbs (polysyndactyly with complete syndactyly of all fingers and toes, hypoplastic or absent first digits, and duplicated intermediate and distal phalanges), macrobrachycephaly, prominant forehead, hypertelorism, and exophthalmos. Occasional features include cleft palate, omphalocele, and cardiac and genitourinary anomalies. The radiographic features at mid-gestation are characteristic.","medgen_id":"C1835564","alternate_names":[],"name":"Larsen syndrome, dominant type","id":"2664","alternate_symbols":["LRS1"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"150250\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"503\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3183\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"LRS1\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Larsen+syndrome%2C+dominant+type/4094\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"3183\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK2534\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"150250\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301749\",\"@Source\":\"PubMed\"},{\"$\":\"NBK3823\",\"@Source\":\"BookShelf\"}]}}","public_definition":"22q11.2 duplication is a condition caused by an extra copy of a small piece of chromosome 22. The duplication occurs near the middle of the chromosome at a location designated q11.2.The features of this condition vary widely, even among members of the same family. Affected individuals may have developmental delay, intellectual disability, slow growth leading to short stature, and weak muscle tone (hypotonia). Many people with the duplication have no apparent physical or intellectual disabilities.","medgen_id":"C2675369","alternate_names":[],"name":"22q11.2 duplication syndrome","id":"4800","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"608363\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1727\"}","{\"db\":\"Genetic Alliance\",\"id\":\"22q11.2+Duplication+Syndrome/21\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10557\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"22q112-duplication\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ARSD","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301771\",\"@Source\":\"PubMed\"},{\"$\":\"NBK8828\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Spondylocostal dysostosis (SCDO), defined radiographically as multiple segmentation defects of the vertebrae (M-SDV) in combination with abnormalities of the ribs, is characterized clinically by: a short trunk in proportion to height; short neck; non-progressive mild scoliosis in most affected individuals, and occasionally, more significant scoliosis. Respiratory function in neonates may be compromised by reduced size of the thorax. By age two years lung growth may improve sufficiently to support relatively normal growth and development; however, even then life-threatening complications can occur, especially pulmonary hypertension in children with severely restricted lung capacity from birth. Males with SCDO appear to be at increased risk for inguinal hernia.","medgen_id":"C0265343","alternate_names":["Spondylocostal dysostosis"],"name":"Jarcho-Levin syndrome","id":"16660","alternate_symbols":[],"ghr_links":"spondylocostal dysostosis","type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS277300\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2311\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spondylothoracic+dysostosis/6845\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6798\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"61367005\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK8828\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"ASCO, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24493721\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Gonzalez et al., 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23360189\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"SSP, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24129426\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"FDA, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25096067\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NICE, 2012\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma\"},\"URL\":{\"$\":\"http://www.nice.org.uk/guidance/ta269/chapter/guidance\"}}]}","public_definition":"Melanoma is a type of skin cancer that begins in pigment-producing cells called melanocytes. This cancer typically occurs in areas that are only occasionally sun-exposed; tumors are most commonly found on the back in men and on the legs in women. Melanoma usually occurs on the skin (cutaneous melanoma), but in about 5 percent of cases it develops in melanocytes in other tissues, including the eyes (uveal melanoma) or mucous membranes that line the body's cavities, such as the moist lining of the mouth (mucosal melanoma). Melanoma can develop at any age, but it most frequently occurs in people in their fifties to seventies and is becoming more common in teenagers and young adults.Melanoma may develop from an existing mole or other normal skin growth that becomes cancerous (malignant); however, many melanomas are new growths. Melanomas often have ragged edges and an irregular shape. They can range from a few millimeters to several centimeters across. They can also be a variety of colors: brown, black, red, pink, blue, or white.Most melanomas affect only the outermost layer of skin (the epidermis). If a melanoma becomes thicker and involves multiple layers of skin, it can spread to other parts of the body (metastasize).A large number of moles or other pigmented skin growths on the body, generally more than 25, is associated with an increased risk of developing melanoma. Melanoma is also a common feature of genetic syndromes affecting the skin such as xeroderma pigmentosum. Additionally, individuals who have previously had melanoma are nearly nine times more likely than the general population to develop melanoma again. It is estimated that about 90 percent of individuals with melanoma survive at least 5 years after being diagnosed.","medgen_id":"C0025202","alternate_names":["Malignant melanoma, somatic"],"name":"Cutaneous melanoma","id":"18337","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012056\",\"type\":\"primary\"}","{\"db\":\"MeSH\",\"id\":\"D008545\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012056\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"melanoma\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"GPHYSD1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301776\",\"@Source\":\"PubMed\"},{\"$\":\"NBK11168\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Geleophysic dysplasia, a progressive condition resembling a lysosomal storage disorder, is characterized by short stature, short hands and feet, progressive joint limitation and contractures, distinctive facial features, progressive cardiac valvular disease, and thickened skin. Intellect is normal. Major findings are likely to be present in the first year of life. Cardiac, respiratory, and lung involvement result in death before age five years in approximately 33% of individuals with ADAMTSL2-related geleophysic dysplasia.","medgen_id":"C3278147","alternate_names":[],"name":"Geleophysic dysplasia 1","id":"15941","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"231050\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2623\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK11168\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"231050\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301779\",\"@Source\":\"PubMed\"},{\"$\":\"NBK22301\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Dyskeratosis congenita (DC), a telomere biology disorder, is characterized by a classic triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia. The classic triad may not be present in all individuals. People with DC are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML), solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include: abnormal pigmentation changes not restricted to the upper chest and neck, eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), and dental abnormalities (caries, periodontal disease, taurodauntism). Although most persons with DC have normal psychomotor development and normal neurologic function, significant developmental delay is present in the two variants in which additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome). Onset and progression of manifestations of DC vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.","medgen_id":"C0265965","alternate_names":[],"name":"Dyskeratosis congenita","id":"15989","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS127550\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"1775\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Dyskeratosis+congenita/9566\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS127550\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"74911008\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK22301\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CARASIL","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20437615\",\"@Source\":\"PubMed\"},{\"$\":\"NBK32533\",\"@Source\":\"BookShelf\"}]}}","public_definition":"HTRA1 disorder is a phenotypic spectrum in which some individuals have few to no symptoms and others manifest with the more severe CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy) phenotype. Those who have a heterozygous HTRA1 pathogenic variant may have mild neurologic findings (sometimes identified only on neuroimaging) or mild-to-moderate neurologic signs and symptoms of CARASIL. In this chapter, the term \"classic CARASIL\" refers to the more severe phenotype associated with biallelic pathogenic variants, and \"HTRA1 cerebral small vessel disease\" (HTRA1-CSVD) refers to the milder phenotype associated with a heterozygous HTRA1 pathogenic variant. Classic CARASIL is characterized by early-onset changes in the deep white matter of the brain observed on MRI, and associated neurologic findings. The most frequent initial symptom is gait disturbance from spasticity beginning between ages 20 and 40 years. Forty-four percent of affected individuals have stroke-like episodes before age 40 years. Mood changes (apathy and irritability), pseudobulbar palsy, and cognitive dysfunction begin between ages 20 and 50 years. The disease progresses slowly following the onset of neurologic symptoms. Scalp alopecia and acute mid- to lower-back pain (lumbago) before age 30 years are characteristic. The most frequent initial symptom in individuals with HTRA1-CSVD is slowly progressive gait disturbance after age 40 years, which may be followed by the development of mood changes and cognitive dysfunction. A majority of affected individuals have a stroke-like episode after age 40 years. Spondylosis and alopecia are seen in a minority of individuals with HTRA1-CSVD.","medgen_id":"C1838577","alternate_names":[],"name":"Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy","id":"1341","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"600142\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"199354\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cerebral+Autosomal+Recessive+Arteriopathy+with+Subcortical+Infarcts+and+Leukoencephalopathy/1222\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10424\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK32533\",\"ref_field\":\"public_definition\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK32533\",\"ref_field\":\"symbol\"}","{\"db\":\"OMIM\",\"id\":\"600142\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10424\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LBSL","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20506600\",\"@Source\":\"PubMed\"},{\"$\":\"NBK43417\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL) is characterized by slowly progressive cerebellar ataxia and spasticity with dorsal column dysfunction (decreased position and vibration sense) in most patients. The neurologic dysfunction involves the legs more than the arms. The tendon reflexes are retained. Deterioration of motor skills usually starts in childhood or adolescence, but occasionally not until adulthood. Dysarthria develops over time. Occasional findings include: epilepsy; learning problems; cognitive decline; and reduced consciousness, neurologic deterioration, and fever following minor head trauma. Many affected individuals become wheelchair dependent in their teens or twenties. Neonatal or early-infantile onset patients have a severe disease course and may die, whereas late-infantile and early-childhood onset is associated with early wheelchair dependency.","medgen_id":"C1970180","alternate_names":["LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION, MILD","MITOCHONDRIAL ASPARTYL-tRNA SYNTHETASE DEFICIENCY"],"name":"Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation","id":"2478","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"611105\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"137898\"}","{\"db\":\"OMIM\",\"id\":\"610956.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION, MILD\"}","{\"db\":\"OMIM\",\"id\":\"611105\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MITOCHONDRIAL ASPARTYL-tRNA SYNTHETASE DEFICIENCY\"}","{\"db\":\"GeneTests\",\"id\":\"293673\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Leukoencephalopathy+with+Brainstem+and+Spinal+Cord+Involvement+and+Lactate+Elevation/8742\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK43417\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"611105\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"22649802\",\"@Source\":\"PubMed\"},{\"$\":\"NBK97260\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome is a disorder of the urea cycle and ornithine degradation pathway. Clinical manifestations and age of onset vary among individuals even in the same family. Neonatal onset (~8% of affected individuals). Manifestations of hyperammonemia usually begin 24-48 hours after feeding begins and can include lethargy, somnolence, refusal to feed, vomiting, tachypnea with respiratory alkalosis, and/or seizures. Infantile, childhood, and adult onset (~92%). Affected individuals may present with: Chronic neurocognitive deficits (including developmental delay, ataxia, spasticity, learning disabilities, cognitive deficits, and/or unexplained seizures); Acute encephalopathy secondary to hyperammonemic crisis precipitated by a variety of factors; and Chronic liver dysfunction (unexplained elevation of liver transaminases with or without mild coagulopathy, with or without mild hyperammonemia and protein intolerance). Neurologic findings and cognitive abilities can continue to deteriorate despite early metabolic control that prevents hyperammonemia.","medgen_id":"C0268540","alternate_names":[],"name":"Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome","id":"5287","alternate_symbols":["HHH","HHHS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"238970\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"415\"}","{\"db\":\"OMIM\",\"id\":\"238970\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HHH\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2830\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HHH\"}","{\"db\":\"OMIM\",\"id\":\"238970\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HHHS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2830\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HHHS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Ornithine+translocase+deficiency+syndrome/5413\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2830\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"30287008\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK97260\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HLD7","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"22855961\",\"@Source\":\"PubMed\"},{\"$\":\"NBK99167\",\"@Source\":\"BookShelf\"}]}}","public_definition":"POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings: Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions). Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth). Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty. Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe. POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include: Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome); Ataxia, delayed dentition, and hypomyelination (ADDH); Tremor-ataxia with central hypomyelination (TACH); Leukodystrophy with oligodontia (LO); Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC). Age of onset is typically in early childhood but later-onset cases have also been reported. An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in POLR3A on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome.","medgen_id":"C2676243","alternate_names":["ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION","LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA","LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA AND HYPOGONADOTROPIC HYPOGONADISM","LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM","LEUKODYSTROPHY, HYPOMYELINATING, 7, WITHOUT OLIGODONTIA OR HYPOGONADOTROPIC HYPOGONADISM","LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION","Leukodystrophy with oligodontia","Leukodystrophy, hypomyelinating, with hypodontia and hypogonadotropic hypogonadism"],"name":"Hypomyelinating leukodystrophy 7","id":"5403","alternate_symbols":["ADDH"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"607694\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"137639\"}","{\"db\":\"Orphanet\",\"id\":\"447893\"}","{\"db\":\"Orphanet\",\"id\":\"447896\"}","{\"db\":\"Orphanet\",\"id\":\"77295\"}","{\"db\":\"Orphanet\",\"id\":\"88637\"}","{\"db\":\"OMIM\",\"id\":\"607694\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION\"}","{\"db\":\"OMIM\",\"id\":\"614258.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA\"}","{\"db\":\"OMIM\",\"id\":\"614258.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA\"}","{\"db\":\"OMIM\",\"id\":\"614258.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA\"}","{\"db\":\"OMIM\",\"id\":\"614258.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA AND HYPOGONADOTROPIC HYPOGONADISM\"}","{\"db\":\"OMIM\",\"id\":\"614258.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OLIGODONTIA AND HYPOGONADOTROPIC HYPOGONADISM\"}","{\"db\":\"OMIM\",\"id\":\"607694\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM\"}","{\"db\":\"OMIM\",\"id\":\"614258.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM\"}","{\"db\":\"OMIM\",\"id\":\"614258.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITHOUT OLIGODONTIA OR HYPOGONADOTROPIC HYPOGONADISM\"}","{\"db\":\"OMIM\",\"id\":\"614258.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKODYSTROPHY, HYPOMYELINATING, 7, WITHOUT OLIGODONTIA OR HYPOGONADOTROPIC HYPOGONADISM\"}","{\"db\":\"OMIM\",\"id\":\"607694\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"9632\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Leukodystrophy with oligodontia\"}","{\"db\":\"OMIM\",\"id\":\"607694\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ADDH\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Leukodystrophy+with+oligodontia/4200\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK99167\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"607694\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"APRTD","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"22934314\",\"@Source\":\"PubMed\"},{\"$\":\"NBK100238\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Adenine phosphoribosyltransferase (APRT) deficiency is characterized by excessive production and renal excretion of 2,8-dihydroxyadenine (DHA), which leads to kidney stone formation and crystal-induced kidney damage (i.e., DHA crystal nephropathy) causing acute kidney injury episodes and progressive chronic kidney disease (CKD). Kidney stones, the most common clinical manifestation of APRT deficiency, can occur at any age; in at least 50% of affected persons symptoms do not occur until adulthood. If adequate treatment is not provided, approximately 20%-25% of affected individuals develop end-stage renal disease (ESRD), usually in adult life.","medgen_id":"C0268120","alternate_names":["NEPHROLITHIASIS, DHA","UROLITHIASIS, 2,8-DIHYDROXYADENINE"],"name":"Adenine phosphoribosyltransferase deficiency","id":"6494","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"614723\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"976\"}","{\"db\":\"OMIM\",\"id\":\"614723\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEPHROLITHIASIS, DHA\"}","{\"db\":\"OMIM\",\"id\":\"614723\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"UROLITHIASIS, 2,8-DIHYDROXYADENINE\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"546\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK100238\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614723\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HDLS","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"22934315\",\"@Source\":\"PubMed\"},{\"$\":\"NBK100239\",\"@Source\":\"BookShelf\"}]}}","public_definition":"CSF1R-related adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is characterized by executive dysfunction, memory decline, personality changes, motor impairments, and seizures. A frontal lobe syndrome (e.g., loss of judgment, lack of social inhibitors, lack of insight, and motor persistence) usually appears early in the disease course. The mean age of onset is usually in the fourth decade. Affected individuals eventually become bedridden with spasticity and rigidity. The disease course ranges from two to 30 or more years (mean: 8 years).","medgen_id":"C3711381","alternate_names":["CSF1R-Related Hereditary Diffuse Leukoencephalopathy with Spheroids","DEMENTIA, FAMILIAL, NEUMANN TYPE","Gliosis, familial progressive subcortical","LEUKOENCEPHALOPATHY, ADULT-ONSET, WITH AXONAL SPHEROIDS AND PIGMENTED GLIA","SUBCORTICAL GLIOSIS OF NEUMANN"],"name":"Hereditary diffuse leukoencephalopathy with spheroids","id":"2226","alternate_symbols":["ALSP","GPSC"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"221820\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"313808\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK100239\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CSF1R-Related Hereditary Diffuse Leukoencephalopathy with Spheroids\"}","{\"db\":\"OMIM\",\"id\":\"221820\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DEMENTIA, FAMILIAL, NEUMANN TYPE\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Gliosis%2C+familial+progressive+subcortical/8471\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Gliosis, familial progressive subcortical\"}","{\"db\":\"OMIM\",\"id\":\"221820\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEUKOENCEPHALOPATHY, ADULT-ONSET, WITH AXONAL SPHEROIDS AND PIGMENTED GLIA\"}","{\"db\":\"OMIM\",\"id\":\"221820\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SUBCORTICAL GLIOSIS OF NEUMANN\"}","{\"db\":\"OMIM\",\"id\":\"221820\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ALSP\"}","{\"db\":\"OMIM\",\"id\":\"221820\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"GPSC\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK100239\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"221820\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HMNDYT1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"22934317\",\"@Source\":\"PubMed\"},{\"$\":\"NBK100241\",\"@Source\":\"BookShelf\"}]}}","public_definition":"The disorder dystonia/parkinsonism, hypermanganesemia, polycythemia, and chronic liver disease is characterized by the following: A movement disorder resulting from manganese accumulation in the basal ganglia. Whole-blood manganese concentrations that often exceed 2000 nmol/L (normal: \u003c320 nmol/L). Polycythemia. Hepatomegaly with variable hepatic fibrosis/cirrhosis. Neurologic findings can manifest: in childhood (ages 2-15 years) as four-limb dystonia, leading to a characteristic high-stepping gait (\"cock-walk gait\"), dysarthria, fine tremor, and bradykinesia or on occasion spastic paraplegia; or in adulthood as parkinsonism (shuffling gait, rigidity, bradykinesia, hypomimia, and monotone speech) unresponsive to L-dopa treatment. Hepatic failure, secondary complications of cirrhosis, and the neurologic disorder shorten life expectancy.","medgen_id":"C2750442","alternate_names":["Dystonia/Parkinsonism, Hypermanganesemia, Polycythemia, and Chronic Liver Disease","Hepatic Cirrhosis, Dystonia, Polycythemia and Hypermanganesemia"],"name":"Hypermanganesemia with dystonia 1","id":"6768","alternate_symbols":["HMDPC"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"613280\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"309854\"}","{\"db\":\"OMIM\",\"id\":\"613280\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HMDPC\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hypermanganesemia+with+dystonia+polycythemia+and+cirrhosis/3580\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10706\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK100241\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"613280\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"STSL","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"23556150\",\"@Source\":\"PubMed\"},{\"$\":\"NBK131810\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Sitosterolemia is characterized by: Tendon xanthomas or tuberous (i.e., planar) xanthomas that can occur in childhood and in unusual locations (heels, knees, elbows, and buttocks); Premature atherosclerosis that can lead to angina, aortic valve involvement, myocardial infarction, and sudden death; Hemolytic anemia, abnormally shaped erythrocytes (stomatocytes), and large platelets (macrothrombocytopenia). On occasion, the abnormal hematologic findings may be the initial presentation. The phenotypic spectrum of sitosterolemia is probably not fully appreciated due to underdiagnosis and the fact that clinical findings in infants are likely to be highly dependent on diet.","medgen_id":"C0342907","alternate_names":[],"name":"Sitosterolemia","id":"3731","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS210250\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2882\"}","{\"db\":\"GeneTests\",\"id\":\"3093\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Sitosterolemia/6620\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS210250\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7653\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"238104009\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK131810\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"210250\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MRXSSR","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"23805436\",\"@Source\":\"PubMed\"},{\"$\":\"NBK144284\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Snyder-Robinson syndrome (SRS) is an X-linked intellectual disability syndrome characterized by asthenic build, facial dysmorphism with a prominent lower lip, kyphoscoliosis, osteoporosis, speech abnormalities, and seizures. Developmental delay usually presents as failure to meet early developmental milestones and then evolves to moderate to profound intellectual disability (which appears to remain stable over time) and variable motor disability. Asthenic habitus and low muscle mass usually develop during the first year, even in males who are ambulatory. During the first decade, males with SRS develop osteoporosis, resulting in fractures in the absence of trauma.","medgen_id":"C0796160","alternate_names":["MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE","SNYDER-ROBINSON MENTAL RETARDATION SYNDROME","Spermine synthase deficiency"],"name":"Snyder Robinson syndrome","id":"2899","alternate_symbols":["SRS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"309583\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"3063\"}","{\"db\":\"OMIM\",\"id\":\"300105.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300105.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300105.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300105.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE\"}","{\"db\":\"OMIM\",\"id\":\"300105.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE\"}","{\"db\":\"OMIM\",\"id\":\"309583\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE\"}","{\"db\":\"OMIM\",\"id\":\"309583\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SNYDER-ROBINSON MENTAL RETARDATION SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"309583\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SRS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5615\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"SRS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Snyder+Robinson+syndrome/6654\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5615\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK144284\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"309583\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24027799\",\"@Source\":\"PubMed\"},{\"$\":\"NBK154653\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Cranioectodermal dysplasia (CED), a ciliopathy also known as Sensenbrenner syndrome, is a multisystem disorder with skeletal involvement (narrow thorax, shortened proximal limbs, and brachydactyly), ectodermal features (widely-spaced hypoplastic teeth, hypodontia, sparse hair, skin laxity, abnormal nails), joint laxity, growth retardation, and characteristic facial features (frontal bossing, low-set simple ears, high forehead, telecanthus/epicanthus, full cheeks, everted lower lip). Most affected children develop nephronophthisis that often leads to end-stage renal disease (ESRD) in infancy or childhood, a major cause of morbidity and mortality. Hepatic fibrosis and retinal dystrophy, other manifestations of ciliopathies, are also observed. Dolichocephaly, often secondary to sagittal craniosynostosis, is a primary manifestation that distinguishes CED from most other ciliopathies. Brain malformations and developmental delay may also occur.","medgen_id":"CN119432","alternate_names":["Cranioectoderma"],"name":"Cranioectodermal dysplasia","id":"16704","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS218330\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"1515\"}","{\"db\":\"OMIM\",\"id\":\"PS218330\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"359\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"254093009\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK154653\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":["Neoplasm"],"symbol":"MNG1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"24761742\",\"@Source\":\"PubMed\"},{\"$\":\"NBK196157\",\"@Source\":\"BookShelf\"}]}}","public_definition":"DICER1-related disorders are a familial tumor susceptibility syndrome that confers increased risk most commonly for pleuropulmonary blastoma (PPB); ovarian sex cord-stromal tumors (Sertoli-Leydig cell tumor, juvenile granulosa cell tumor, and gynandroblastoma); cystic nephroma; and thyroid gland neoplasia (multinodular goiter, adenomas, or differentiated thyroid cancer). Less commonly observed tumors are ciliary body medulloepithelioma; botryoid-type embryonal rhabdomyosarcoma of the cervix or other sites; nasal chondromesenchymal hamartoma; renal sarcoma; pituitary blastoma; and pineoblastoma. Novel phenotypes continue to be discovered. The majority of tumors in families with a DICER1 germline pathogenic variant occur in individuals younger than age 40 years. PPB, a neoplasm that arises during lung development or shortly after birth, typically presents in infants and children younger than age six years. Age of onset of ovarian sex cord-stromal tumors is not well defined. CN presents in children younger than age four years.","medgen_id":"C0018022","alternate_names":["GOITER, NONTOXIC, WITH INTRATHYROIDAL CALCIFICATION","Goiter, Endemic","MULTINODULAR GOITER, ADOLESCENT","SIMPLE GOITER"],"name":"Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors","id":"1940","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"138800\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"276399\"}","{\"db\":\"OMIM\",\"id\":\"138800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GOITER, NONTOXIC, WITH INTRATHYROIDAL CALCIFICATION\"}","{\"db\":\"OMIM\",\"id\":\"138800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MULTINODULAR GOITER, ADOLESCENT\"}","{\"db\":\"OMIM\",\"id\":\"138800\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SIMPLE GOITER\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Goiter%2C+multinodular+1%2C+with+or+without+sertoli-leydig+cell+tumors/8492\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK196157\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"138800\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MSUD3","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"25032271\",\"@Source\":\"PubMed\"},{\"$\":\"NBK220444\",\"@Source\":\"BookShelf\"}]}}","public_definition":"The phenotypes of dihydrolipoamide dehydrogenase (DLD) deficiency are an overlapping continuum that ranges from early-onset neurologic manifestations to adult-onset isolated liver involvement. Early-onset DLD deficiency typically manifests as a hypotonic infant with lactic acidosis. Affected infants frequently do not survive their initial metabolic decompensation, or die within the first few years of life during a recurrent metabolic decompensation. Children who live beyond the first two to three years frequently exhibit growth deficiencies and residual neurologic deficits (intellectual disability, spasticity, ataxia, and seizures). In contrast, isolated liver involvement can present as early as the neonatal period and as late as the third decade. Evidence of liver injury/failure is preceded by nausea and emesis and frequently associated with encephalopathy and/or coagulopathy. Acute metabolic episodes are frequently associated with lactate elevations, hyperammonemia, and hepatomegaly. With resolution of the acute episodes patients frequently return to baseline with no residual neurologic deficit or intellectual disability. Liver failure can result in death, even in those with late-onset disease.","medgen_id":"CN043137","alternate_names":["DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY","Dihydrolipoamide Dehydrogenase (E3) Deficiency","Dihydrolipoamide Dehydrogenase E3 Deficiency","E3 DEFICIENCY","MAPLE SYRUP URINE DISEASE, TYPE III"],"name":"Maple syrup urine disease, type 3","id":"9028","alternate_symbols":["DLDD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"246900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2394\"}","{\"db\":\"Orphanet\",\"id\":\"765\"}","{\"db\":\"OMIM\",\"id\":\"238331.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0010\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"238331.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"246900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"246900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"E3 DEFICIENCY\"}","{\"db\":\"OMIM\",\"id\":\"246900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MAPLE SYRUP URINE DISEASE, TYPE III\"}","{\"db\":\"OMIM\",\"id\":\"246900\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"DLDD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Maple+syrup+urine+disease+type+1B/4456\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK220444\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"27077170\",\"@Source\":\"PubMed\"},{\"$\":\"NBK355754\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Adams-Oliver syndrome (AOS) is characterized by aplasia cutis congenita (ACC) of the scalp and terminal transverse limb defects (TTLD). ACC lesions usually occur in the midline of the parietal or occipital regions, but can also occur on the abdomen or limbs. At birth, an ACC lesion may already have the appearance of a healed scar. ACC lesions less than 5 cm often involve only the skin and almost always heal over a period of months; larger lesions are more likely to involve the skull and possibly the dura, and are at greater risk for complications, which can include infection, hemorrhage, or thrombosis, and can result in death. The limb defects range from mild (unilateral or bilateral short distal phalanges) to severe (complete absence of all toes or fingers, feet or hands, or more, often resembling an amputation). The lower extremities are almost always more severely affected than the upper extremities. Additional major features frequently include cardiovascular malformations/dysfunction (23%), brain anomalies, and less frequently renal, liver, and eye anomalies.","medgen_id":"C0265268","alternate_names":[],"name":"Adams-Oliver syndrome","id":"17000","alternate_symbols":["AOS"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS100300\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"974\"}","{\"db\":\"OMIM\",\"id\":\"100300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AOS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5739\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"AOS\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"adams-oliver-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS100300\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"34748004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK355754\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"27336129\",\"@Source\":\"PubMed\"},{\"$\":\"NBK368475\",\"@Source\":\"BookShelf\"}]}}","public_definition":"The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Lken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).","medgen_id":"C0687120","alternate_names":["juvenile nephronophthisis"],"name":"Nephronophthisis","id":"16739","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000090\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004748\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS256100\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"655\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000090\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"juvenile nephronophthisis\"}","{\"db\":\"GeneTests\",\"id\":\"72016\",\"ref_field\":\"name\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0000090\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS256100\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"204958008\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK368475\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"TPDS","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"27748099\",\"@Source\":\"PubMed\"},{\"$\":\"NBK390611\",\"@Source\":\"BookShelf\"}]}}","public_definition":"BAP1 tumor predisposition syndrome (BAP1-TPDS) is associated with an increased risk for the specific skin lesion  atypical Spitz tumors  and the following cancers, in descending order of frequency: uveal (eye) melanoma (UM), malignant mesothelioma (MMe), cutaneous melanoma (CM), clear cell renal cell carcinoma (ccRCC), and basal cell carcinoma (BCC). Affected individuals can have more than one type of primary cancer. In general the median age of onset of these tumors is younger than in the general population. UM tends to be a more aggressive class 2 tumor with higher risk for metastasis and reduced survival compared to UM that occurs in the general population. However, because of the limited number of families reported to date, the penetrance, natural history, and frequencies of the BAP1-associated tumors are yet to be determined. Other suspected but unconfirmed tumors in BAP1-TPDS include (in alphabetic order): breast cancer, cholangiocarcinoma, non-small cell lung adenocarcinoma (NSCLC), meningioma, and neuroendocrine carcinoma.","medgen_id":"C3280492","alternate_names":["Tumor predisposition syndrome"],"name":"Tumor susceptibility linked to germline BAP1 mutations","id":"16619","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"614327\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"289539\"}","{\"db\":\"Genetic Alliance\",\"id\":\"TUMOR+PREDISPOSITION+SYNDROME/9432\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Tumor predisposition syndrome\"}","{\"db\":\"Orphanet\",\"id\":\"289539\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK390611\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"614327\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"29517885\",\"@Source\":\"PubMed\"},{\"$\":\"NBK487394\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Schwannomatosis is characterized by a predisposition to develop multiple schwannomas and, less frequently, meningiomas. Individuals with schwannomatosis most commonly present between the second and fourth decade of life. The most common presenting feature is localized or diffuse pain or asymptomatic mass. Schwannomas most often affect peripheral nerves and spinal nerves. Meningiomas occur in about 5% of individuals with schwannomatosis and have only been reported in individuals with SMARCB1-related schwannomatosis. Malignancy remains a theoretic risk especially in individuals with a SMARCB1 pathogenic variant.","medgen_id":"C1335929","alternate_names":[],"name":"Schwannomatosis","id":"36278","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS162091\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"93921\"}","{\"db\":\"GeneTests\",\"id\":\"3487\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Schwannomatosis/6452\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS162091\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4768\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"142071000119101\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK487394\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":["Neoplasm"],"symbol":"SWNTS1","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"29517885\",\"@Source\":\"PubMed\"},{\"$\":\"NBK487394\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Schwannomatosis is characterized by a predisposition to develop multiple schwannomas and, less frequently, meningiomas. Individuals with schwannomatosis most commonly present between the second and fourth decade of life. The most common presenting feature is localized or diffuse pain or asymptomatic mass. Schwannomas most often affect peripheral nerves and spinal nerves. Meningiomas occur in about 5% of individuals with schwannomatosis and have only been reported in individuals with SMARCB1-related schwannomatosis. Malignancy remains a theoretic risk especially in individuals with a SMARCB1 pathogenic variant.","medgen_id":"C4048809","alternate_names":[],"name":"Schwannomatosis 1","disease_mechanism":"loss of function","id":"3703","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"162091\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"93921\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000309827\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000335543\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000335548\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520069\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522322\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528460\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528885\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528886\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528909\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528930\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551659\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552305\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552306\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552308\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552477\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569525\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK487394\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"162091\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SEDC","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"31021589\",\"@Source\":\"PubMed\"},{\"$\":\"NBK540447\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Spondyloepiphyseal dysplasia congenita is an autosomal dominant chondrodysplasia characterized by disproportionate short stature (short trunk), abnormal epiphyses, and flattened vertebral bodies. Skeletal features are manifested at birth and evolve with time. Other features include myopia and/or retinal degeneration with retinal detachment and cleft palate (summary by Anderson et al., 1990).","medgen_id":"C2745959","alternate_names":["Spondyloepiphyseal dysplasia congenita"],"name":"Spondyloepiphyseal dysplasia","id":"4455","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002655\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002776\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005893\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"183900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"94068\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Spondyloepiphyseal+dysplasia+congenita/6821\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Spondyloepiphyseal dysplasia congenita\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002655\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7687\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"183900\",\"type\":\"MIM\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"183900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4987\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"OSCDP","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"31021589\",\"@Source\":\"PubMed\"},{\"$\":\"NBK540447\",\"@Source\":\"BookShelf\"}]}}","medgen_id":"C1858079","alternate_names":[],"name":"Osteoarthritis with mild chondrodysplasia","id":"3131","alternate_symbols":["NHD"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"604864\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"604864\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NHD\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Osteoarthritis+with+mild+chondrodysplasia/9052\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"604864\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MPS3A","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"31536183\",\"@Source\":\"PubMed\"},{\"$\":\"NBK546574\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Mucopolysaccharidosis type III (MPS III) is a multisystem lysosomal storage disease characterized by progressive central nervous system degeneration manifest as severe intellectual disability (ID), developmental regression, and other neurologic manifestations including autism spectrum disorder (ASD), behavioral problems, and sleep disturbances. Disease onset is typically before age ten years. Disease course may be rapidly or slowly progressive; some individuals with an extremely attenuated disease course present in mid-to-late adulthood with early-onset dementia with or without a history of ID. Systemic manifestations can include musculoskeletal problems (joint stiffness, contractures, scoliosis, and hip dysplasia), hearing loss, respiratory tract and sinopulmonary infections, and cardiac disease (valvular thickening, defects in the cardiac conduction system). Neurologic decline is seen in all affected individuals; however, clinical severity varies within and among the four MPS III subtypes (defined by the enzyme involved) and even among members of the same family. Death usually occurs in the second or third decade of life secondary to neurologic regression or respiratory tract infections.","medgen_id":"C0086647","alternate_names":["MPS III A","MUCOPOLYSACCHARIDOSIS, TYPE IIIA, ATTENUATED","SULFAMIDASE DEFICIENCY"],"name":"Mucopolysaccharidosis, MPS-III-A","id":"3220","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"252900\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"581\"}","{\"db\":\"Orphanet\",\"id\":\"79269\"}","{\"db\":\"OMIM\",\"id\":\"605270.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MUCOPOLYSACCHARIDOSIS, TYPE IIIA, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"605270.0012\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MUCOPOLYSACCHARIDOSIS, TYPE IIIA, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"605270.0013\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MUCOPOLYSACCHARIDOSIS, TYPE IIIA, ATTENUATED\"}","{\"db\":\"OMIM\",\"id\":\"252900\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"SULFAMIDASE DEFICIENCY\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Mucopolysaccharidosis+type+IIIA/4915\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"41572006\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK546574\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"252900\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"SQSD","content":"{\"Citation\":{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"32027475\",\"@Source\":\"PubMed\"},{\"$\":\"NBK553533\",\"@Source\":\"BookShelf\"}]}}","public_definition":"Squalene synthase deficiency (SQSD) is a rare inborn error of cholesterol biosynthesis with multisystem clinical manifestations similar to Smith-Lemli-Optiz syndrome. Key clinical features include facial dysmorphism, a generalized seizure disorder presenting in the neonatal period, nonspecific structural brain malformations, cortical visual impairment, optic nerve hypoplasia, profound developmental delay / intellectual disability, dry skin with photosensitivity, and genital malformations in males.","medgen_id":"C4748427","alternate_names":["NEURODEVELOPMENTAL DISORDER WITH LOW CHOLESTEROL AND ABNORMAL URINE ORGANIC ACIDS"],"name":"SQUALENE SYNTHASE DEFICIENCY","id":"40736","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"618156\",\"type\":\"MIM\"}","{\"db\":\"OMIM\",\"id\":\"618156\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"NEURODEVELOPMENTAL DISORDER WITH LOW CHOLESTEROL AND ABNORMAL URINE ORGANIC ACIDS\"}","{\"db\":\"GeneTests\",\"id\":\"320637\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"184420.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"184420.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"184420.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"618156\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK553533\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"618156\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"ES, 2012\",\"@Type\":\"practice guideline\",\"ID\":[{\"$\":\"22962670\",\"@Source\":\"PubMed\"},{\"$\":\"3431581\",\"@Source\":\"pmc\"}]}}","medgen_id":"C0020479","alternate_names":[],"name":"Familial type 3 hyperlipoproteinemia","id":"12902","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"617347\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"412\"}","{\"db\":\"SNOMED CT\",\"id\":\"398796005\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":{\"@Abbrev\":\"Nguyen et al., 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"10.1371/currents.RRN1236.\",\"@Source\":\"DOI\"}}}","medgen_id":"C0021390","alternate_names":[],"name":"Inflammatory bowel disease","id":"32724","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS266600\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"104012\"}","{\"db\":\"OMIM\",\"id\":\"PS266600\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"24526004\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HCM","mode_of_inheritance":"Various modes of inheritance","content":"{\"Citation\":[{\"@Abbrev\":\"ACC/ESC, 2003\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"14607462\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301725\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1768\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"HRS/EHRA, 2012\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"21810866\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C0949658","alternate_names":[],"name":"Primary familial hypertrophic cardiomyopathy","id":"8483","alternate_symbols":["ASH","CMH"],"type":"Disease","xrefs":["{\"db\":\"MeSH\",\"id\":\"D024741\"}","{\"db\":\"OMIM\",\"id\":\"PS192600\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"155\"}","{\"db\":\"Orphanet\",\"id\":\"99739\"}","{\"db\":\"OMIM\",\"id\":\"192600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ASH\"}","{\"db\":\"OMIM\",\"id\":\"192600\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMH\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Primary+familial+hypertrophic+cardiomyopathy/9162\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"83978005\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"NINDS Fact Sheet\",\"@Type\":\"review\",\"URL\":{\"$\":\"https://www.ninds.nih.gov/disorders/autism/detail_autism.htm\"}},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111012\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG, 2005\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110947\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111019\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ISCA, 2010\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"20466091\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23519317\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NCCN, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25190698\",\"@Source\":\"PubMed\"}}]}","public_definition":"Autism spectrum disorder (ASD) is a condition that appears very early in childhood development, varies in severity, and is characterized by impaired social skills, communication problems, and repetitive behaviors. These difficulties can interfere with affected individuals' ability to function in social, academic, and employment settings. People with ASD also have an increased risk of psychiatric problems such as anxiety, depression, obsessive-compulsive disorder, and eating disorders.From as early as 1 to 2 years of age, people with ASD have an impaired ability to interact with other people; they are often more comfortable dealing with objects. Affected individuals have difficulty understanding and using non-verbal social cues such as eye contact, facial expressions, gestures, and body language. Inability to recognize and use these cues makes it hard for affected individuals to understand the feelings of others or communicate their own feelings appropriately. Behavioral signs of ASD, such as reduced eye contact and social interaction, can sometimes be detected before age 2. However, the condition is usually diagnosed between ages 2 and 4, when more advanced communication and social skills, such as learning to play with others, typically begin to develop.Repetitive behaviors in ASD can include simple actions such as rocking, hand-flapping, or repetition of words or noises (echolalia). Affected individuals often dwell on or repeatedly express particular thoughts; this behavior is called perseveration. People with ASD tend to be rigid about their established routines and may strongly resist disruptions such as changes in schedule. They may also have difficulty tolerating sensory stimuli such as loud noises or bright lights.While social and communication difficulties and unusual behaviors define ASD, affected individuals can have a wide range of intellectual abilities and language skills. A majority of people with ASD have mild to moderate intellectual disability, while others have average to above-average intelligence. Some have particular cognitive abilities that greatly surpass their overall level of functioning, often in areas such as music, mathematics, or memory.Some people with ASD do not speak at all, while others use language fluently. However, fluent speakers with ASD often have problems associated with verbal communication. They might speak in a monotone voice, have unusual vocal mannerisms, or choose unusual topics of conversation.Several diagnoses that used to be classified as separate conditions are now grouped together under the diagnosis of ASD. For example, autistic disorder was a term that was used when affected individuals had limited or absent verbal communication, often in combination with intellectual disability. By contrast, Asperger syndrome was a diagnosis formerly applied to affected individuals of average or above-average intelligence who were not delayed in their language development. The broader diagnosis of ASD was established because many affected individuals fall outside of the strict definitions of the narrower diagnoses, and their intellectual and communication abilities may change over time. However, some individuals who were previously diagnosed with one of the subtypes now do not meet all the criteria of the new umbrella diagnosis.","medgen_id":"C1510586","alternate_names":["Autism spectrum disorders","Autism susceptibility"],"name":"Autism spectrum disorder","id":"9460","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS209850\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"106\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Autism+Spectrum+Disorders/7767\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Autism spectrum disorders\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"autism-spectrum-disorder\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CF","content":"{\"Citation\":[{\"@Abbrev\":\"ACMG/ACOG, 2001\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"11280952\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2004\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110945\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301428\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1250\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACOG, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19888064\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NSGC, 2005\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"15789152\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2008\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110977\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"CPGPT/CF FPT Committees, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20675678\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ECFS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20605539\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CFF, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19914445\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CFF, 2009\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"19914443\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG ACT Sheets, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"21938795\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG Lab QA, 2002\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"12394352\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CDC, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"22475884\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Accurso et al., 2010\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"3148255\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACOG, 2011\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"21422883\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CPIC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"4026598\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"NSGC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24014130\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"HGS Australasia, 2014\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"25431289\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Wainwright et al., 2015\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"25981758\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"CFF, 2007\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"17761616\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"DailyMed Drug Label, 2012\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"DailyMed Drug Label, KALYDECO, 2012\"},\"URL\":{\"$\":\"https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25\"}}]}","public_definition":"Cystic fibrosis (CF) is a multisystem disease affecting epithelia of the respiratory tract, exocrine pancreas, intestine, hepatobiliary system, and exocrine sweat glands. Morbidities include progressive obstructive lung disease with bronchiectasis, frequent hospitalizations for pulmonary disease, pancreatic insufficiency and malnutrition, recurrent sinusitis and bronchitis, and male infertility. Pulmonary disease is the major cause of morbidity and mortality in CF. Meconium ileus occurs at birth in 15%-20% of newborns with CF. More than 95% of males with CF are infertile. Congenital absence of the vas deferens (CAVD) is generally identified during evaluation of infertility or as an incidental finding at the time of a surgical procedure. Hypoplasia or aplasia of the vas deferens and seminal vesicles may occur either bilaterally or unilaterally. Testicular development and function and spermatogenesis are usually normal.","medgen_id":"C0010674","alternate_names":[],"name":"Cystic fibrosis","disease_mechanism":"loss of function","id":"1695","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"219700\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"586\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000004176\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000005248\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000025280\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000028916\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000074114\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000209428\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000226639\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000246717\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000277984\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000320929\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000328569\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000330969\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000332363\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501918\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501920\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501921\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507003\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507006\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507010\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507864\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507950\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508782\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508810\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508811\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508812\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508889\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508890\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508893\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508894\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000514611\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520059\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521905\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522527\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528606\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529460\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530118\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556535\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556536\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558875\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558928\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568279\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569406\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569426\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569602\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569639\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569790\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569791\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569946\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569960\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569982\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000569983\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570010\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570019\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570054\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570317\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000571198\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cystic+Fibrosis/2071\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"219700\",\"type\":\"MIM\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6233\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"190905008\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1250\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"219700\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6233\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":["{\"Attribute\":{\"$\":\"gain of function\",\"@Type\":\"disease mechanism\",\"@integerValue\":\"274\"},\"XRef\":[{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000515534\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000520081\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528059\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528379\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000528912\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000508960\"},{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000515803\"}]}"],"keywords":["Hereditary cancer syndrome","Neoplasm"],"content":"{\"Citation\":[{\"@Abbrev\":\"Biesecker et al., 1998\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"10360391\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Turner et al., 2004\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"15372514\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Lindhurst et al., 2011\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"21793738\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"22876373\",\"@Source\":\"PubMed\"},{\"$\":\"NBK99495\",\"@Source\":\"BookShelf\"}]}]}","public_definition":"Proteus syndrome is characterized by progressive segmental or patchy overgrowth most commonly affecting the skeleton, skin, adipose, and central nervous systems. In most individuals Proteus syndrome has modest or no manifestations at birth, develops and progresses rapidly beginning in the toddler period, and relentlessly progresses through childhood, causing severe overgrowth and disfigurement. It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism.","medgen_id":"C0085261","alternate_names":["PROTEUS SYNDROME, SOMATIC"],"name":"Proteus syndrome","disease_mechanism":"loss of function","id":"4046","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"176920\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"744\"}","{\"db\":\"OMIM\",\"id\":\"164730.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"PROTEUS SYNDROME, SOMATIC\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551654\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552540\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000570020\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Proteus+syndrome/6005\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"proteus-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"7475\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"23150001\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK99495\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":["{\"Attribute\":{\"$\":\"imprinting disorder\",\"@Type\":\"mode of inheritance\"},\"XRef\":{\"@DB\":\"Genetic Testing Registry (GTR)\",\"@ID\":\"GTR000260593\"}}"],"keywords":[],"symbol":"AS","mode_of_inheritance":"AS is caused by disruption of maternally imprinted UBE3A located within the 15q11.2-q13 Angelman syndrome/Prader-Willi syndrome (AS/PWS) region.","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301323\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1144\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ACMG, 2001\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3111049\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"Eurogentest, 2008\",\"@Type\":\"Translational/Evidence-based\",\"URL\":{\"$\":\"http://www.eurogentest.org/web/files/public/unit3/ClinicalUtilityGeneCards/Indication%20criteria%20-%20AS.pdf\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23519317\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ESHG/ASHG, 2015\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"25782669\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2016\",\"@Type\":\"Position Statement\",\"ID\":{\"$\":\"27467454\",\"@Source\":\"PubMed\"}}]}","public_definition":"Angelman syndrome (AS) is characterized by severe developmental delay or intellectual disability, severe speech impairment, gait ataxia and/or tremulousness of the limbs, and a unique behavior with an inappropriate happy demeanor that includes frequent laughing, smiling, and excitability. Microcephaly and seizures are also common. Developmental delays are first noted at around age six months; however, the unique clinical features of AS do not become manifest until after age one year, and it can take several years before the correct clinical diagnosis is obvious.","medgen_id":"C0162635","alternate_names":["HAPPY PUPPET SYNDROME"],"name":"Angelman syndrome","disease_mechanism":"loss of function","id":"404","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"105830\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"72\"}","{\"db\":\"OMIM\",\"id\":\"105830\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HAPPY PUPPET SYNDROME\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000226643\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000260593\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000331374\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000503131\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000507771\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508896\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508937\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000509438\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519272\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519582\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520979\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520995\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520996\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520998\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521642\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522320\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000525860\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000525867\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000527540\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000529013\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530102\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530118\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000531722\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551668\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552178\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552326\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552341\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556577\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556612\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558215\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558216\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558805\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558906\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568029\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000568371\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501320\",\"ref_field\":\"mode_of_inheritance\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Angelman+Syndrome/452\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"angelman-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5810\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"76880004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1144\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"105830\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5810\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"DFNX","content":"{\"Citation\":[{\"@Abbrev\":\"ACMG, 2002\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"3110944\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"ACMG, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"24651602\",\"@Source\":\"PubMed\"}}]}","public_definition":"Nonsyndromic hearing loss is a partial or total loss of hearing that is not associated with other signs and symptoms. In contrast, syndromic hearing loss occurs with signs and symptoms affecting other parts of the body.Nonsyndromic hearing loss can be classified in several different ways. One common way is by the condition's pattern of inheritance: autosomal dominant (DFNA), autosomal recessive (DFNB), X-linked (DFNX), or mitochondrial (which does not have a special designation). Each of these types of hearing loss includes multiple subtypes. DFNA, DFNB, and DFNX subtypes are numbered in the order in which they were first described. For example, DFNA1 was the first type of autosomal dominant nonsyndromic hearing loss to be identified.The characteristics of nonsyndromic hearing loss vary among the different types. Hearing loss can affect one ear (unilateral) or both ears (bilateral). Degrees of hearing loss range from mild (difficulty understanding soft speech) to profound (inability to hear even very loud noises). The term \"deafness\" is often used to describe severe-to-profound hearing loss. Hearing loss can be stable, or it may be progressive, becoming more severe as a person gets older. Particular types of nonsyndromic hearing loss show distinctive patterns of hearing loss. For example, the loss may be more pronounced at high, middle, or low tones.Most forms of nonsyndromic hearing loss are described as sensorineural, which means they are associated with a permanent loss of hearing caused by damage to structures in the inner ear. The inner ear processes sound and sends the information to the brain in the form of electrical nerve impulses. Less commonly, nonsyndromic hearing loss is described as conductive, meaning it results from changes in the middle ear. The middle ear contains three tiny bones that help transfer sound from the eardrum to the inner ear. Some forms of nonsyndromic hearing loss, particularly a type called DFNX2, involve changes in both the inner ear and the middle ear. This combination is called mixed hearing loss.Depending on the type, nonsyndromic hearing loss can become apparent at any time from infancy to old age. Hearing loss that is present before a child learns to speak is classified as prelingual or congenital. Hearing loss that occurs after the development of speech is classified as postlingual.","medgen_id":"CN043651","alternate_names":[],"name":"Deafness, X-linked","id":"9547","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS304500\",\"type\":\"Phenotypic series\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Deafness%2C+X-Linked%2C+DFN/2162\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS304500\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1715\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"nonsyndromic-hearing-loss\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":[{\"@Type\":\"review\",\"ID\":{\"$\":\"22704258\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"23447832\",\"@Source\":\"PubMed\"},{\"$\":\"NBK121988\",\"@Source\":\"BookShelf\"}]}]}","public_definition":"Pantothenate kinase-associated neurodegeneration (formerly called Hallervorden-Spatz syndrome) is a disorder of the nervous system. This condition is characterized by progressive difficulty with movement, typically beginning in childhood. Movement abnormalities include involuntary muscle spasms, rigidity, and trouble with walking that worsens over time. Many people with this condition also develop problems with speech (dysarthria), and some develop vision loss. Additionally, affected individuals may experience a loss of intellectual function (dementia) and psychiatric symptoms such as behavioral problems, personality changes, and depression.Pantothenate kinase-associated neurodegeneration is characterized by an abnormal buildup of iron in certain areas of the brain. A particular change called the eye-of-the-tiger sign, which indicates an accumulation of iron, is typically seen on magnetic resonance imaging (MRI) scans of the brain in people with this disorder.Researchers have described classic and atypical forms of pantothenate kinase-associated neurodegeneration. The classic form usually appears in early childhood, causing severe problems with movement that worsen rapidly. Features of the atypical form appear later in childhood or adolescence and progress more slowly. Signs and symptoms vary, but the atypical form is more likely than the classic form to involve speech defects and psychiatric problems.A condition called HARP (hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration), which was historically described as a separate syndrome, is now considered part of pantothenate kinase-associated neurodegeneration. Although HARP is much rarer than classic pantothenate kinase-associated neurodegeneration, both conditions involve problems with movement, dementia, and vision abnormalities.","medgen_id":"CN043643","alternate_names":[],"name":"Neurodegeneration with brain iron accumulation","id":"9539","alternate_symbols":["NBIA"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS234200\",\"type\":\"Phenotypic series\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6564\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"NBIA\"}","{\"db\":\"GeneTests\",\"id\":\"156905\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS234200\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6564\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"pantothenate-kinase-associated-neurodegeneration\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"ALS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301623\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1450\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EFNS, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"21914052\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"Orphanet, 2007\",\"@Type\":\"practice guideline\",\"CitationText\":{\"$\":\"Orphanet, Amyotrophic lateral sclerosis, 2007\"},\"URL\":{\"$\":\"https://www.orpha.net/data/patho/Pro/en/Emergency_AmyotrophicLateralSclerosis.pdf\"}}]}","public_definition":"Amyotrophic lateral sclerosis (ALS) is a progressive disease that affects motor neurons, which are specialized nerve cells that control muscle movement. These nerve cells are found in the spinal cord and the brain. In ALS, motor neurons die (atrophy) over time, leading to muscle weakness, a loss of muscle mass, and an inability to control movement.There are many different types of ALS; these types are distinguished by their signs and symptoms and their genetic cause or lack of clear genetic association. Most people with ALS have a form of the condition that is described as sporadic, which means it occurs in people with no apparent history of the disorder in their family. People with sporadic ALS usually first develop features of the condition in their late fifties or early sixties. A small proportion of people with ALS, estimated at 5 to 10 percent, have a family history of ALS or a related condition called frontotemporal dementia (FTD), which is a progressive brain disorder that affects personality, behavior, and language. The signs and symptoms of familial ALS typically first appear in one's late forties or early fifties. Rarely, people with familial ALS develop symptoms in childhood or their teenage years. These individuals have a rare form of the disorder known as juvenile ALS.The first signs and symptoms of ALS may be so subtle that they are overlooked. The earliest symptoms include muscle twitching, cramping, stiffness, or weakness. Affected individuals may develop slurred speech (dysarthria) and, later, difficulty chewing or swallowing (dysphagia). Many people with ALS experience malnutrition because of reduced food intake due to dysphagia and an increase in their body's energy demands (metabolism) due to prolonged illness. Muscles become weaker as the disease progresses, and arms and legs begin to look thinner as muscle tissue atrophies. Individuals with ALS eventually lose muscle strength and the ability to walk. Affected individuals eventually become wheelchair-dependent and increasingly require help with personal care and other activities of daily living. Over time, muscle weakness causes affected individuals to lose the use of their hands and arms. Breathing becomes difficult because the muscles of the respiratory system weaken. Most people with ALS die from respiratory failure within 2 to 10 years after the signs and symptoms of ALS first appear; however, disease progression varies widely among affected individuals.Approximately 20 percent of individuals with ALS also develop FTD. Changes in personality and behavior may make it difficult for affected individuals to interact with others in a socially appropriate manner. Communication skills worsen as the disease progresses. It is unclear how the development of ALS and FTD are related. Individuals who develop both conditions are diagnosed as having ALS-FTD.A rare form of ALS that often runs in families is known as ALS-parkinsonism-dementia complex (ALS-PDC). This disorder is characterized by the signs and symptoms of ALS, in addition to a pattern of movement abnormalities known as parkinsonism, and a progressive loss of intellectual function (dementia). Signs of parkinsonism include unusually slow movements (bradykinesia), stiffness, and tremors. Affected members of the same family can have different combinations of signs and symptoms.","medgen_id":"C0002736","alternate_names":["Charcot disease","Lou gehrig's disease"],"name":"Amyotrophic lateral sclerosis","id":"9457","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007354\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS105400\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"803\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007354\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Lou gehrig's disease\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007354\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS105400\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5786\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"86044005\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"amyotrophic-lateral-sclerosis\",\"ref_field\":\"public_definition\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"5786\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":["neoplasm"],"content":"{\"Citation\":[{\"@Abbrev\":\"AMP, 2012\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"22918138\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23619274\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C0027651","alternate_names":["Neoplasia","Oncological abnormality","Oncology","Tumor","Tumour"],"name":"Neoplasm","id":"32759","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002664\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0003008\",\"type\":\"secondary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0006741\",\"type\":\"secondary\"}","{\"db\":\"MeSH\",\"id\":\"D009369\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002664\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Neoplasia\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002664\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Oncological abnormality\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002664\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Oncology\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002664\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Tumor\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002664\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Tumour\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002664\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"108369006\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":["Hereditary cancer syndrome","PTEN HAMARTOMA TUMOR SYNDROME"],"symbol":"CS","content":"{\"Citation\":[{\"@Abbrev\":\"ACMG, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"23519317\",\"@Source\":\"PubMed\"}},{\"@Abbrev\":\"NCCN, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25190698\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C0018553","alternate_names":["BANNAYAN-ZONANA SYNDROME","Cowden disease","Cowden syndrome 2","Cowden-like syndrome","MACROCEPHALY, MULTIPLE LIPOMAS, AND HEMANGIOMATA","MACROCEPHALY, PSEUDOPAPILLEDEMA, AND MULTIPLE HEMANGIOMATA","RILEY-SMITH SYNDROME","RUVALCABA-MYHRE-SMITH SYNDROME"],"name":"Cowden syndrome","disease_mechanism":"gain of function","id":"33122","alternate_symbols":["BBRS","BZS","CD","CWS2","PHTS","RMSS"],"type":"Disease","disease_mechanism_id":"274","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS158350\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"201\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BANNAYAN-ZONANA SYNDROME\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6202\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cowden disease\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cowden-like+syndrome/8104\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cowden-like syndrome\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MACROCEPHALY, MULTIPLE LIPOMAS, AND HEMANGIOMATA\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"MACROCEPHALY, PSEUDOPAPILLEDEMA, AND MULTIPLE HEMANGIOMATA\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RILEY-SMITH SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RUVALCABA-MYHRE-SMITH SYNDROME\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BBRS\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BZS\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CD\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6202\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CD\"}","{\"db\":\"OMIM\",\"id\":\"612359\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CWS2\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"PHTS\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"RMSS\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000512190\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515803\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520069\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520394\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530118\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530120\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552107\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552245\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000557801\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558905\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"keywords\",\"ref_field_element\":\"PTEN HAMARTOMA TUMOR SYNDROME\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Cowden+Syndrome/1947\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"cowden-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"58037000\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"158350\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6202\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"LQTS","mode_of_inheritance":"Various modes of inheritance","content":"{\"Citation\":[{\"@Abbrev\":\"AHRQ, 2013\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"NBK248310\",\"@Source\":\"BookShelf\"}},{\"@Abbrev\":\"HRS/EHRA/APHRS, 2013\",\"@Type\":\"Suggested Reading\",\"ID\":{\"$\":\"23994779\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C0023976","alternate_names":[],"name":"Long QT syndrome","disease_mechanism":"loss of function","id":"16506","alternate_symbols":["LQT"],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"MeSH\",\"id\":\"D008133\"}","{\"db\":\"OMIM\",\"id\":\"PS192500\",\"type\":\"Phenotypic series\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501111\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511116\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000515873\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519089\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520063\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520446\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520456\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520458\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520478\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522197\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000522200\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000523361\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000525920\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528497\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528500\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528536\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552174\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000552322\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000555634\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000558315\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000559512\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Long+QT+Syndrome/4296\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS192500\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"9651007\",\"ref_field\":\"name\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CFC1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301365\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1186\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}}]}","public_definition":"Cardiofaciocutaneous (CFC) syndrome is characterized by cardiac abnormalities (pulmonic stenosis and other valve dysplasias, septal defects, hypertrophic cardiomyopathy, rhythm disturbances), distinctive craniofacial appearance, and cutaneous abnormalities (including xerosis, hyperkeratosis, ichthyosis, keratosis pilaris, ulerythema ophryogenes, eczema, pigmented moles, hemangiomas, and palmoplantar hyperkeratosis). The hair is typically sparse, curly, fine or thick, woolly or brittle; eyelashes and eyebrows may be absent or sparse. Nails may be dystrophic or fast growing. Some form of neurologic and/or cognitive delay (ranging from mild to severe) is seen in all affected individuals. Neoplasia, mostly acute lymphoblastic leukemia, has been reported in some individuals.","medgen_id":"CN029449","alternate_names":[],"name":"Cardiofaciocutaneous syndrome 1","disease_mechanism":"gain of function","id":"667","alternate_symbols":[],"type":"Disease","disease_mechanism_id":"274","xrefs":["{\"db\":\"OMIM\",\"id\":\"115150\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"1340\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000273063\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000326240\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501680\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000501683\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502541\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502573\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502575\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000505949\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000505951\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000508882\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511170\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511407\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511408\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511409\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000511410\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520039\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000520875\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521399\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521418\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528536\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528542\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551628\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551630\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000561717\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562242\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1186\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"115150\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"MMD1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301480\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1303\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"AAN, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25313375\",\"@Source\":\"PubMed\"}}]}","public_definition":"Dysferlinopathy includes a spectrum of muscle disease characterized by two main phenotypes: Miyoshi myopathy with primarily distal weakness and limb-girdle muscular dystrophy type 2B (LGMD2B) with primarily proximal weakness. Miyoshi myopathy (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes are scapuloperoneal syndrome, distal myopathy with anterior tibial onset, elevated serum CK concentration only, and congenital muscular dystrophy.","medgen_id":"C1850808","alternate_names":[],"name":"Miyoshi muscular dystrophy 1","id":"2959","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"254130\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"45448\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1303\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"254130\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"NSML","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301557\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1383\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ESC, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25173338\",\"@Source\":\"PubMed\"}}]}","public_definition":"Noonan syndrome with multiple lentigines (NSML) is a condition in which the cardinal features consist of lentigines, hypertrophic cardiomyopathy, short stature, pectus deformity, and dysmorphic facial features, including widely spaced eyes and ptosis. Multiple lentigines present as dispersed flat, black-brown macules, mostly on the face, neck and upper part of the trunk with sparing of the mucosa. In general, lentigines do not appear until age four to five years but then increase to the thousands by puberty. Some individuals with NSML do not exhibit lentigines. Approximately 85% of affected individuals have heart defects, including hypertrophic cardiomyopathy (HCM) (typically appearing during infancy and sometimes progressive) and pulmonary valve stenosis. Postnatal growth retardation resulting in short stature occurs in fewer than 50% of affected persons, although most affected individuals have a height that is less than the 25th percentile for age. Sensorineural hearing deficits, present in approximately 20%, are poorly characterized. Intellectual disability, typically mild, is observed in approximately 30% of persons with NSML.","medgen_id":"C0175704","alternate_names":["LEOPARD syndrome"],"name":"Noonan syndrome with multiple lentigines","id":"6424","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS151100\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"500\"}","{\"db\":\"Genetic Alliance\",\"id\":\"LEOPARD+syndrome/4176\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEOPARD syndrome\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"1100\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"LEOPARD syndrome\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"noonan-syndrome-with-multiple-lentigines\",\"ref_field\":\"name\"}","{\"db\":\"Orphanet\",\"id\":\"500\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1383\",\"ref_field\":\"public_definition\"}","{\"db\":\"Orphanet\",\"id\":\"500\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"CCHS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301600\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1427\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"ATS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20208042\",\"@Source\":\"PubMed\"}}]}","public_definition":"Congenital central hypoventilation syndrome (CCHS) is a rare disorder of respiratory and autonomic regulation. It is typically characterized by a classic presentation in newborns and, rarely, a milder later-onset (LO-CCHS) presentation in toddlers, children, and adults. Classic CCHS presents in newborns as: Apparent hypoventilation with monotonous respiratory rates and shallow breathing either during sleep only or while awake as well as asleep; Autonomic nervous system dysregulation (ANSD); and In some individuals, altered development of neural crest-derived structures (i.e., Hirschsprung disease) and/or tumors of neural crest origin (neuroblastoma, ganglioneuroma, and ganglioneuroblastoma). Individuals with CCHS who have been diagnosed as newborns and ventilated conservatively and consistently throughout childhood have now reached the age of 20 to 30 years; they are highly functional and live independently. LO-CCHS manifests as nocturnal alveolar hypoventilation and mild ANSD. Individuals with LO-CCHS who were not identified until age 20 years or older have now reached the age of 30 to 55 years.","medgen_id":"C1275808","alternate_names":[],"name":"Congenital central hypoventilation","disease_mechanism":"gain of function","id":"576","alternate_symbols":["RET"],"type":"Disease","disease_mechanism_id":"274","xrefs":["{\"db\":\"OMIM\",\"id\":\"209880\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"661\"}","{\"db\":\"Orphanet\",\"id\":\"99803\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000502996\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510468\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510469\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510930\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510951\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510954\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510955\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510956\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510957\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510960\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510965\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510968\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510969\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000510972\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000519456\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000521924\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528367\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000528368\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551865\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551868\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551870\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000556815\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000562004\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"SNOMED CT\",\"id\":\"399040002\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1427\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"209880\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"8535\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"EDMD","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301609\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1436\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"AAN, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25313375\",\"@Source\":\"PubMed\"}}]}","public_definition":"Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement that may manifest as palpitations, presyncope and syncope, poor exercise tolerance, and congestive heart failure along with variable cardiac rhythm disturbances. Age of onset, severity, and progression of muscle and cardiac involvement demonstrate both inter- and intrafamilial variability. Clinical variability ranges from early onset with severe presentation in childhood to late onset with slow progression in adulthood. In general, joint contractures appear during the first two decades, followed by muscle weakness and wasting. Cardiac involvement usually occurs after the second decade and respiratory function may be impaired in some individuals.","medgen_id":"C0410189","alternate_names":[],"name":"Emery-Dreifuss muscular dystrophy","id":"9490","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS310300\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"261\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"emery-dreifuss-muscular-dystrophy\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS310300\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6329\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"111508004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1436\",\"ref_field\":\"public_definition\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6329\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HDDD","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301545\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1371\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EFNS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20298421\",\"@Source\":\"PubMed\"}}]}","public_definition":"The spectrum of GRN frontotemporal dementia (GRN-FTD) includes the behavioral variant (bvFTD), primary progressive aphasia (PPA; further subcategorized as progressive non-fluent aphasia [PNFA] and semantic dementia [SD]), and movement disorders with extrapyramidal features such as parkinsonism and corticobasal syndrome (CBS). A broad range of clinical features both within and between families is observed. The age of onset ranges from 35 to 87 years. Behavioral disturbances are the most common early feature, followed by progressive aphasia. Impairment in executive function manifests as loss of judgment and insight. In early stages, PPA often manifests as deficits in naming, word finding, or word comprehension. In late stages, affected individuals often become mute and lose their ability to communicate. Early findings of parkinsonism include rigidity, bradykinesia or akinesia (slowing or absence of movements), limb dystonia, apraxia (loss of ability to carry out learned purposeful movements), and disequilibrium. Late motor findings may include myoclonus, dysarthria, and dysphagia. Most affected individuals eventually lose the ability to walk. Disease duration is three to 12 years.","medgen_id":"C1843792","alternate_names":["FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, GRN-RELATED","FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED","FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS","FTLD-TDP, GRN-RELATED","GRN-Related Frontotemporal Dementia"],"name":"Frontotemporal dementia, ubiquitin-positive","disease_mechanism":"loss of function","id":"5167","alternate_symbols":["FTDU","FTLDU"],"type":"Disease","disease_mechanism_id":"273","xrefs":["{\"db\":\"OMIM\",\"id\":\"607485\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"100070\"}","{\"db\":\"Orphanet\",\"id\":\"282\"}","{\"db\":\"OMIM\",\"id\":\"607485\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, GRN-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"607485\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED\"}","{\"db\":\"OMIM\",\"id\":\"138945.0001\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0002\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0003\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0004\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0005\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0006\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0007\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0008\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0009\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0011\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0014\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0015\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0016\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0017\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"138945.0019\",\"type\":\"Allelic variant\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"607485\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS\"}","{\"db\":\"OMIM\",\"id\":\"607485\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"FTLD-TDP, GRN-RELATED\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1371\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GRN-Related Frontotemporal Dementia\"}","{\"db\":\"OMIM\",\"id\":\"607485\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FTDU\"}","{\"db\":\"OMIM\",\"id\":\"607485\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"FTLDU\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000530102\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Testing Registry (GTR)\",\"id\":\"GTR000551442\",\"ref_field\":\"disease_mechanism\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Frontotemporal+Dementia%2C+Ubiquitin-Positive/2945\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1371\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"607485\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"10004\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HYPP","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301669\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1496\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EFNS, 2010\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"20298421\",\"@Source\":\"PubMed\"}}]}","public_definition":"Hyperkalemic periodic paralysis (hyperPP) is characterized by attacks of flaccid limb weakness (which may also include weakness of the muscles of the eyes, throat, and trunk), hyperkalemia (serum potassium concentration \u003e5 mmol/L) or an increase of serum potassium concentration of at least 1.5 mmol/L during an attack of weakness and/or provoking/worsening of an attack by oral potassium intake, normal serum potassium between attacks, and onset before age 20 years. Although the absence of paramyotonia (muscle stiffness aggravated by cold and exercise) was originally postulated as a means of distinguishing hyperPP from paramyotonia congenita (PMC), approximately 45% of individuals with hyperPP have paramyotonia. In approximately half of affected individuals, attacks of flaccid muscle weakness begin in the first decade of life, with 25% reporting their first attack at age ten years or older. Initially infrequent, the attacks then increase in frequency and severity over time until approximately age 50 years, after which the frequency of attacks declines considerably. Potassium-rich food or rest after exercise may precipitate an attack. A cold environment and emotional stress provoke or worsen the attacks. A spontaneous attack commonly starts in the morning before breakfast, lasts for 15 minutes to one hour, and then disappears. Cardiac arrhythmia or respiratory insufficiency usually does not occur during attacks. Between attacks, approximately half of individuals with hyperPP have mild myotonia (muscle stiffness) that does not impede voluntary movements. More than 80% of individuals with hyperPP older than 40 years report permanent muscle weakness and about one third develop a chronic progressive myopathy.","medgen_id":"CN074266","alternate_names":["ADYNAMIA EPISODICA HEREDITARIA WITH OR WITHOUT MYOTONIA","GAMSTORP DISEASE"],"name":"Hyperkalemic Periodic Paralysis Type 1","id":"15911","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"170500\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"682\"}","{\"db\":\"OMIM\",\"id\":\"170500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ADYNAMIA EPISODICA HEREDITARIA WITH OR WITHOUT MYOTONIA\"}","{\"db\":\"OMIM\",\"id\":\"170500\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GAMSTORP DISEASE\"}","{\"db\":\"GeneTests\",\"id\":\"2133\",\"ref_field\":\"name\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Hyperkalemic+Periodic+Paralysis+Type+1/8591\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1496\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"170500\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PD","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301402\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1223\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EFNS/MDS-ES, 2013\",\"@Type\":\"Recommendation\",\"ID\":{\"$\":\"23279440\",\"@Source\":\"PubMed\"}}]}","medgen_id":"C0030567","alternate_names":[],"name":"Parkinson disease","id":"33364","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS168600\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"319705\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Parkinson+Disease/5603\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS168600\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"49049000\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"168600\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BSVD1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301768\",\"@Source\":\"PubMed\"},{\"$\":\"NBK7046\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"AHA/ASA, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25355838\",\"@Source\":\"PubMed\"}}]}","public_definition":"The spectrum of COL4A1-related disorders includes: small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (retinal arterial tortuosity, Axenfeld-Rieger anomaly, cataract) and systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia). On imaging studies, small-vessel brain disease is manifest as diffuse periventricular leukoencephalopathy, lacunar infarcts, microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages. Clinically, small-vessel brain disease manifests as infantile hemiparesis, seizures, single or recurrent hemorrhagic stroke, ischemic stroke, and isolated migraine with aura. Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability; however, on occasion it can be an incidental finding. HANAC (hereditary angiopathy with nephropathy, aneurysms, and muscle cramps) syndrome usually associates asymptomatic small-vessel brain disease, cerebral large vessel involvement (i.e., aneurysms), and systemic findings involving the kidney, muscle, and small vessels of the eye. Two additional phenotypes include isolated retinal artery tortuosity and nonsyndromic autosomal dominant congenital cataract.","medgen_id":"C4551998","alternate_names":["Autosomal Dominant Type 1 Porencephaly","COL4A1-Related Disorders","RETINAL ARTERIOLAR TORTUOSITY, INFANTILE HEMIPARESIS, AND LEUKOENCEPHALOPATHY, AUTOSOMAL DOMINANT"],"name":"Brain small vessel disease 1 with or without ocular anomalies","id":"4009","alternate_symbols":["ADT1P","POREN1","T1P"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"175780\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"2940\"}","{\"db\":\"Orphanet\",\"id\":\"99810\"}","{\"db\":\"OMIM\",\"id\":\"175780\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RETINAL ARTERIOLAR TORTUOSITY, INFANTILE HEMIPARESIS, AND LEUKOENCEPHALOPATHY, AUTOSOMAL DOMINANT\"}","{\"db\":\"OMIM\",\"id\":\"175780\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ADT1P\"}","{\"db\":\"OMIM\",\"id\":\"175780\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"POREN1\"}","{\"db\":\"OMIM\",\"id\":\"175780\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"T1P\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK7046\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"175780\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BSVD","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301768\",\"@Source\":\"PubMed\"},{\"$\":\"NBK7046\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"AHA/ASA, 2014\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"25355838\",\"@Source\":\"PubMed\"}}]}","public_definition":"The spectrum of COL4A1-related disorders includes: small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (retinal arterial tortuosity, Axenfeld-Rieger anomaly, cataract) and systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia). On imaging studies, small-vessel brain disease is manifest as diffuse periventricular leukoencephalopathy, lacunar infarcts, microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages. Clinically, small-vessel brain disease manifests as infantile hemiparesis, seizures, single or recurrent hemorrhagic stroke, ischemic stroke, and isolated migraine with aura. Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability; however, on occasion it can be an incidental finding. HANAC (hereditary angiopathy with nephropathy, aneurysms, and muscle cramps) syndrome usually associates asymptomatic small-vessel brain disease, cerebral large vessel involvement (i.e., aneurysms), and systemic findings involving the kidney, muscle, and small vessels of the eye. Two additional phenotypes include isolated retinal artery tortuosity and nonsyndromic autosomal dominant congenital cataract.","medgen_id":"C4013035","alternate_names":["BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES","COL4A1-Related Disorders","INFANTILE HEMIPARESIS","RETINAL ARTERIOLAR TORTUOSITY, INFANTILE HEMIPARESIS, AND LEUKOENCEPHALOPATHY, AUTOSOMAL DOMINANT"],"name":"Brain small vessel disease with hemorrhage","id":"533","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"607595\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES\"}","{\"db\":\"OMIM\",\"id\":\"607595\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"INFANTILE HEMIPARESIS\"}","{\"db\":\"OMIM\",\"id\":\"607595\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"RETINAL ARTERIOLAR TORTUOSITY, INFANTILE HEMIPARESIS, AND LEUKOENCEPHALOPATHY, AUTOSOMAL DOMINANT\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Brain+small+vessel+disease+with+hemorrhage/7863\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK7046\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"607595\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"PCD","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301301\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1122\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"PCD Foundation, 2016\",\"@Type\":\"practice guideline\",\"ID\":{\"$\":\"4912005\",\"@Source\":\"pmc\"}}]}","public_definition":"Primary ciliary dyskinesia is a disorder characterized by chronic respiratory tract infections, abnormally positioned internal organs, and the inability to have children (infertility). The signs and symptoms of this condition are caused by abnormal cilia and flagella. Cilia are microscopic, finger-like projections that stick out from the surface of cells. They are found in the linings of the airway, the reproductive system, and other organs and tissues. Flagella are tail-like structures, similar to cilia, that propel sperm cells forward.In the respiratory tract, cilia move back and forth in a coordinated way to move mucus towards the throat. This movement of mucus helps to eliminate fluid, bacteria, and particles from the lungs. Most babies with primary ciliary dyskinesia experience breathing problems at birth, which suggests that cilia play an important role in clearing fetal fluid from the lungs. Beginning in early childhood, affected individuals develop frequent respiratory tract infections. Without properly functioning cilia in the airway, bacteria remain in the respiratory tract and cause infection. People with primary ciliary dyskinesia also have year-round nasal congestion and a chronic cough. Chronic respiratory tract infections can result in a condition called bronchiectasis, which damages the passages, called bronchi, leading from the windpipe to the lungs and can cause life-threatening breathing problems.Some individuals with primary ciliary dyskinesia have abnormally placed organs within their chest and abdomen. These abnormalities arise early in embryonic development when the differences between the left and right sides of the body are established. About 50 percent of people with primary ciliary dyskinesia have a mirror-image reversal of their internal organs (situs inversus totalis). For example, in these individuals the heart is on the right side of the body instead of on the left. Situs inversus totalis does not cause any apparent health problems. When someone with primary ciliary dyskinesia has situs inversus totalis, they are often said to have Kartagener syndrome.Approximately 12 percent of people with primary ciliary dyskinesia have a condition known as heterotaxy syndrome or situs ambiguus, which is characterized by abnormalities of the heart, liver, intestines, or spleen. These organs may be structurally abnormal or improperly positioned. In addition, affected individuals may lack a spleen (asplenia) or have multiple spleens (polysplenia). Heterotaxy syndrome results from problems establishing the left and right sides of the body during embryonic development. The severity of heterotaxy varies widely among affected individuals.Primary ciliary dyskinesia can also lead to infertility. Vigorous movements of the flagella are necessary to propel the sperm cells forward to the female egg cell. Because their sperm do not move properly, males with primary ciliary dyskinesia are usually unable to father children. Infertility occurs in some affected females and is likely due to abnormal cilia in the fallopian tubes.Another feature of primary ciliary dyskinesia is recurrent ear infections (otitis media), especially in young children. Otitis media can lead to permanent hearing loss if untreated. The ear infections are likely related to abnormal cilia within the inner ear.Rarely, individuals with primary ciliary dyskinesia have an accumulation of fluid in the brain (hydrocephalus), likely due to abnormal cilia in the brain.","medgen_id":"C0008780","alternate_names":["Ciliary dyskinesia"],"name":"Primary ciliary dyskinesia","id":"15219","alternate_symbols":["CILD","ICS"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012265\",\"type\":\"primary\"}","{\"db\":\"OMIM\",\"id\":\"PS244400\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"244\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0012265\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Ciliary dyskinesia\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4484\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"ICS\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Primary+ciliary+dyskinesia/5941\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS244400\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"4484\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"primary-ciliary-dyskinesia\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"BBS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301537\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1363\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGentest, 2010\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"3061994\",\"@Source\":\"pmc\"}}]}","public_definition":"Bardet-Biedl syndrome (BBS) is characterized by rod-cone dystrophy, truncal obesity, postaxial polydactyly, cognitive impairment, male hypogonadotropic hypogonadism, complex female genitourinary malformations, and renal abnormalities. The visual prognosis for children with BBS is poor. Night blindness is usually evident by age seven to eight years; the mean age of legal blindness is 15.5 years. Birth weight is usually normal, but significant weight gain begins within the first year and becomes a lifelong issue for most individuals. A majority of individuals have significant learning difficulties; a minority have severe impairment on IQ testing. Renal disease is a major cause of morbidity and mortality.","medgen_id":"C0752166","alternate_names":[],"name":"Bardet-Biedl syndrome","id":"376","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS209900\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"110\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Bardet-Biedl+Syndrome/723\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"bardet-biedl-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS209900\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6866\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"5619004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1363\",\"ref_field\":\"public_definition\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6866\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"GAN1","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301315\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1136\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2010\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"2987431\",\"@Source\":\"pmc\"}}]}","public_definition":"Giant axonal neuropathy (GAN) is an early-onset fatal neurodegenerative disorder. GAN starts as severe peripheral motor and sensory neuropathy during infancy and evolves into central nervous system impairment (intellectual disability, seizures, cerebellar signs, and pyramidal tract signs). Most individuals become wheelchair dependent in the second decade of life and eventually bedridden with severe polyneuropathy, ataxia, and dementia. Death usually occurs in the third decade.","medgen_id":"C1850386","alternate_names":["GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE"],"name":"Giant axonal neuropathy 1","id":"1369","alternate_symbols":[],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"256850\",\"type\":\"MIM\"}","{\"db\":\"Orphanet\",\"id\":\"643\"}","{\"db\":\"OMIM\",\"id\":\"256850\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6500\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1136\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"256850\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6500\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"HPE","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301702\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1530\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"3039493\",\"@Source\":\"pmc\"}}]}","public_definition":"Holoprosencephaly (HPE) is a structural anomaly of the brain in which there is failed or incomplete separation of the forebrain early in gestation. Classic HPE encompasses a continuum of brain malformations including (in order of decreasing severity): alobar, semilobar, lobar, and middle interhemispheric variant (MIHV) type HPE; a septopreoptic type has also been described. Other CNS abnormalities not specific to HPE may also occur. HPE is accompanied by a spectrum of characteristic craniofacial anomalies in approximately 80% of individuals with HPE. Developmental delay is present in virtually all individuals with the HPE spectrum of CNS anomalies. Seizures and pituitary dysfunction are common. Most affected fetuses do not survive; severely affected children typically do not survive beyond early infancy, while a significant proportion of more mildly affected children survive past 12 months. Mildly manifesting individuals without appreciable brain anomalies on conventional neuroimaging may be described as having \"microform\" HPE.","medgen_id":"C0079541","alternate_names":["ARHINENCEPHALY","HOLOPROSENCEPHALY, FAMILIAL ALOBAR","HPE, FAMILIAL","Holoprosencephaly","Single brain ventricle"],"name":"Holoprosencephaly sequence","id":"5260","alternate_symbols":["HPEC"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001360\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0009807\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS236100\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"2162\"}","{\"db\":\"OMIM\",\"id\":\"236100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ARHINENCEPHALY\"}","{\"db\":\"OMIM\",\"id\":\"236100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HOLOPROSENCEPHALY, FAMILIAL ALOBAR\"}","{\"db\":\"OMIM\",\"id\":\"236100\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"HPE, FAMILIAL\"}","{\"db\":\"CSER _CC_NCGL, University of Washington\",\"id\":\"UWMG_2366672\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Holoprosencephaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001360\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Holoprosencephaly\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6665\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Holoprosencephaly\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0001360\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Single brain ventricle\"}","{\"db\":\"OMIM\",\"id\":\"236100\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HPEC\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Holoprosencephaly+sequence/8565\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"30915001\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1530\",\"ref_field\":\"public_definition\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6665\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"DBA","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301769\",\"@Source\":\"PubMed\"},{\"$\":\"NBK7047\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"3083626\",\"@Source\":\"pmc\"}}]}","public_definition":"Diamond-Blackfan anemia (DBA) in its classic form is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, congenital malformations in up to 50% of affected individuals, and growth retardation in 30% of affected individuals. The hematologic complications occur in 90% of affected individuals during the first year of life. The phenotypic spectrum ranges from a mild form (e.g., mild anemia, no anemia with only subtle erythroid abnormalities, physical malformations without anemia) to a severe form of fetal anemia resulting in nonimmune hydrops fetalis. DBA is associated with an increased risk for acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), and solid tumors including osteogenic sarcoma.","medgen_id":"C1260899","alternate_names":["ANEMIA, CONGENITAL HYPOPLASTIC, OF BLACKFAN AND DIAMOND","Aase syndrome","Aase-Smith syndrome II","Congenital hypoplastic anemia"],"name":"Diamond-Blackfan anemia","id":"1485","alternate_symbols":["BDS"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004810\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0005545\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS105650\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"124\"}","{\"db\":\"OMIM\",\"id\":\"105650\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"ANEMIA, CONGENITAL HYPOPLASTIC, OF BLACKFAN AND DIAMOND\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0004810\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Congenital hypoplastic anemia\"}","{\"db\":\"OMIM\",\"id\":\"105650\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BDS\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6274\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"BDS\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"diamond-blackfan-anemia\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS105650\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6274\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"88854002\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK7047\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"105650\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6274\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":[],"content":"{\"Citation\":[{\"@Abbrev\":\"MDA Consensus document - CMT testing, 2011\",\"@Type\":\"general\",\"ID\":{\"$\":\"3058597\",\"@Source\":\"pmc\"}},{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301532\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1358\",\"@Source\":\"BookShelf\"}]}]}","public_definition":"Charcot-Marie-Tooth disease encompasses a group of disorders called hereditary sensory and motor neuropathies that damage the peripheral nerves. Peripheral nerves connect the brain and spinal cord to muscles and to sensory cells that detect sensations such as touch, pain, heat, and sound. Damage to the peripheral nerves that worsens over time can result in alteration or loss of sensation and wasting (atrophy) of muscles in the feet, legs, and hands.Charcot-Marie-Tooth disease usually becomes apparent in adolescence or early adulthood, but onset may occur anytime from early childhood through late adulthood. Symptoms of Charcot-Marie-Tooth disease vary in severity and age of onset even among members of the same family. Some people never realize they have the disorder because their symptoms are so mild, but most have a moderate amount of physical disability. A small percentage of people experience severe weakness or other problems which, in very rare cases, can be life-threatening. In most affected individuals, however, Charcot-Marie-Tooth disease does not affect life expectancy.Typically, the earliest symptoms of Charcot-Marie-Tooth disease result from muscle atrophy in the feet. Affected individuals may have foot abnormalities such as high arches (pes cavus), flat feet (pes planus), or curled toes (hammer toes). They often have difficulty flexing the foot or walking on the heel of the foot. These difficulties may cause a higher than normal step (steppage gait) and increase the risk of ankle injuries and tripping. As the disease worsens, muscles in the lower legs usually weaken, but leg and foot problems rarely require the use of a wheelchair.Affected individuals may also develop weakness in the hands, causing difficulty with daily activities such as writing, fastening buttons, and turning doorknobs. People with Charcot-Marie-Tooth disease typically experience a decreased sensitivity to touch, heat, and cold in the feet and lower legs, but occasionally feel aching or burning sensations. In rare cases, affected individuals have loss of vision or gradual hearing loss that sometimes leads to deafness.There are several types of Charcot-Marie-Tooth disease, which are differentiated by their effects on nerve cells and patterns of inheritance. Type 1 (CMT1) is characterized by abnormalities in myelin, the fatty substance that covers nerve cells, protecting them and helping to transmit nerve impulses. These abnormalities slow the transmission of nerve impulses and can affect the health of the nerve fiber. Type 2 (CMT2) is characterized by abnormalities in the fiber, or axon, that extends from a nerve cell body to muscles or to sense organs. These abnormalities reduce the strength of the nerve impulse. In forms of Charcot-Marie-Tooth disease classified as intermediate type, the nerve impulses are both slowed and reduced in strength, probably due to abnormalities in both myelin and axons. Type 4 (CMT4) is distinguished from the other types by its pattern of inheritance; it can affect either the axons or the myelin. Type X Charcot-Marie-Tooth disease (CMTX) is caused by mutations in genes on the X chromosome, one of the two sex chromosomes. Within the various types of Charcot-Marie-Tooth disease, subtypes (such as CMT1A, CMT1B, CMT2A, CMT4A, and CMTX1) indicate different genetic causes.Sometimes other, historical names are used to refer to particular forms of Charcot-Marie-Tooth disease. For example, Roussy-Levy syndrome is a form of CMT11 with the additional feature of rhythmic shaking (tremors). Dejerine-Sottas syndrome is a term sometimes used to describe a severe, early childhood form of Charcot-Marie-Tooth disease; it is also sometimes called type 3 (CMT3). Depending on the specific gene that is altered, this severe, early-onset form of the disorder may also be classified as CMT1 or CMT4. CMTX5 is also known as Rosenberg-Chutorian syndrome.","medgen_id":"C0007959","alternate_names":["Charcot-Marie-Tooth Neuropathy"],"name":"Charcot-Marie-Tooth disease","id":"13540","alternate_symbols":["CMT","HMSN"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"PS118220\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"166\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6034\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CMT\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6034\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"HMSN\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Charcot-Marie-Tooth+Disease/1276\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"charcot-marie-tooth-disease\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS118220\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6034\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"50548001\",\"ref_field\":\"name\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"charcot-marie-tooth-disease\",\"ref_field\":\"public_definition\"}"]}
{"attribute_content":[],"keywords":[],"symbol":"JBTS","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301500\",\"@Source\":\"PubMed\"},{\"$\":\"NBK1325\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21448235\",\"@Source\":\"PubMed\"}}]}","public_definition":"Classic Joubert syndrome (JS) is characterized by three primary findings: A distinctive cerebellar and brain stem malformation called the molar tooth sign (MTS). Hypotonia. Developmental delays. Often these findings are accompanied by episodic tachypnea or apnea and/or atypical eye movements. In general, the breathing abnormalities improve with age, truncal ataxia develops over time, and acquisition of gross motor milestones is delayed. Cognitive abilities are variable, ranging from severe intellectual disability to normal. Additional findings can include retinal dystrophy, renal disease, ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. Both intra- and interfamilial variation are seen.","medgen_id":"C0431399","alternate_names":["Agenesis of cerebellar vermis","CEREBELLOPARENCHYMAL DISORDER IV","Cerebellar vermis aplasia","Familial aplasia of the vermis"],"name":"Joubert syndrome","id":"1878","alternate_symbols":["CPD4"],"type":"Disease","xrefs":["{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002335\",\"type\":\"primary\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0007125\",\"type\":\"secondary\"}","{\"db\":\"OMIM\",\"id\":\"PS213300\",\"type\":\"Phenotypic series\"}","{\"db\":\"Orphanet\",\"id\":\"475\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002335\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Agenesis of cerebellar vermis\"}","{\"db\":\"OMIM\",\"id\":\"213300\",\"type\":\"MIM\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"CEREBELLOPARENCHYMAL DISORDER IV\"}","{\"db\":\"Human Phenotype Ontology\",\"id\":\"HP:0002335\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Cerebellar vermis aplasia\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Familial+aplasia+of+the+vermis/8373\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Familial aplasia of the vermis\"}","{\"db\":\"SNOMED CT\",\"id\":\"253175003\",\"ref_field\":\"alternate_names\",\"ref_field_element\":\"Familial aplasia of the vermis\"}","{\"db\":\"OMIM\",\"id\":\"213300\",\"type\":\"MIM\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CPD4\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6802\",\"ref_field\":\"alternate_symbols\",\"ref_field_element\":\"CPD4\"}","{\"db\":\"Genetics Home Reference\",\"id\":\"joubert-syndrome\",\"ref_field\":\"name\"}","{\"db\":\"OMIM\",\"id\":\"PS213300\",\"type\":\"Phenotypic series\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"6802\",\"ref_field\":\"name\"}","{\"db\":\"SNOMED CT\",\"id\":\"716997004\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK1325\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"213300\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}"]}
{"attribute_content":[],"keywords":["Hereditary cancer syndrome"],"symbol":"DKCX","content":"{\"Citation\":[{\"@Abbrev\":\"GeneReviews\",\"@Type\":\"review\",\"ID\":[{\"$\":\"20301779\",\"@Source\":\"PubMed\"},{\"$\":\"NBK22301\",\"@Source\":\"BookShelf\"}]},{\"@Abbrev\":\"EuroGenetest, 2011\",\"@Type\":\"Translational/Evidence-based\",\"ID\":{\"$\":\"21610750\",\"@Source\":\"PubMed\"}}]}","public_definition":"Dyskeratosis congenita (DC), a telomere biology disorder, is characterized by a classic triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia. The classic triad may not be present in all individuals. People with DC are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML), solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include: abnormal pigmentation changes not restricted to the upper chest and neck, eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), and dental abnormalities (caries, periodontal disease, taurodauntism). Although most persons with DC have normal psychomotor development and normal neurologic function, significant developmental delay is present in the two variants in which additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome). Onset and progression of manifestations of DC vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.","medgen_id":"C1148551","alternate_names":["Zinsser-Cole-Engman Syndrome"],"name":"Dyskeratosis congenita X-linked","id":"1509","alternate_symbols":["DKC"],"type":"Disease","xrefs":["{\"db\":\"OMIM\",\"id\":\"305000\",\"type\":\"MIM\"}","{\"db\":\"Genetic Alliance\",\"id\":\"Dyskeratosis+Congenita+X-Linked/2385\",\"ref_field\":\"name\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2007\",\"ref_field\":\"name\"}","{\"db\":\"GeneReviews\",\"id\":\"NBK22301\",\"ref_field\":\"public_definition\"}","{\"db\":\"OMIM\",\"id\":\"305000\",\"type\":\"MIM\",\"ref_field\":\"symbol\"}","{\"db\":\"Office of Rare Diseases\",\"id\":\"2007\",\"ref_field\":\"symbol\"}"]}
